
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Maternal Exposure to Medications and the Risk of Congenital and Early‐Onset Hearing Loss in Children: A Systematic Review and a Meta‐Analysis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15251C338AEEF613051C33003293C0AC.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375940/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Basic &amp; Clinical Pharmacology &amp; Toxicology">
<meta name="citation_title" content="Maternal Exposure to Medications and the Risk of Congenital and Early‐Onset Hearing Loss in Children: A Systematic Review and a Meta‐Analysis">
<meta name="citation_author" content="Asli Sena Kücükyildiz">
<meta name="citation_author_institution" content="Department of Clinical Medicine, Aarhus University, Aarhus, Denmark">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark">
<meta name="citation_author" content="Mette Østergaard Thunbo">
<meta name="citation_author_institution" content="Department of Clinical Medicine, Aarhus University, Aarhus, Denmark">
<meta name="citation_author_institution" content="Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark">
<meta name="citation_author" content="Christer Zøylner Swan">
<meta name="citation_author_institution" content="Department of Clinical Medicine, Aarhus University, Aarhus, Denmark">
<meta name="citation_author_institution" content="Otorhinolaryngology Private Practice, Denmark">
<meta name="citation_author" content="David P Burgner">
<meta name="citation_author_institution" content="Murdoch Children&#x27;s Research Institute, The Royal Children&#x27;s Hospital, Parkville, Victoria, Australia">
<meta name="citation_author_institution" content="Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia">
<meta name="citation_author_institution" content="Department of Paediatrics, Monash University, Clayton, Victoria, Australia">
<meta name="citation_author" content="Jessica E Miller">
<meta name="citation_author_institution" content="Department of Clinical Medicine, Aarhus University, Aarhus, Denmark">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark">
<meta name="citation_author_institution" content="Murdoch Children&#x27;s Research Institute, The Royal Children&#x27;s Hospital, Parkville, Victoria, Australia">
<meta name="citation_author_institution" content="Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia">
<meta name="citation_author" content="Therese Ovesen">
<meta name="citation_author_institution" content="Department of Clinical Medicine, Aarhus University, Aarhus, Denmark">
<meta name="citation_author_institution" content="Department of Otorhinolaryngology, Gødstrup Hospital, Herning, Denmark">
<meta name="citation_author" content="Lars Henning Pedersen">
<meta name="citation_author_institution" content="Department of Clinical Medicine, Aarhus University, Aarhus, Denmark">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark">
<meta name="citation_author_institution" content="Department of Biomedicine, Aarhus University, Aarhus, Denmark">
<meta name="citation_publication_date" content="2025 Aug 25">
<meta name="citation_volume" content="137">
<meta name="citation_issue" content="3">
<meta name="citation_firstpage" content="e70090">
<meta name="citation_doi" content="10.1111/bcpt.70090">
<meta name="citation_pmid" content="40851451">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375940/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375940/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375940/pdf/BCPT-137-0.pdf">
<meta name="description" content="Congenital hearing loss (CHL) affects approximately 1–2 in 1000 children and significantly impacts development. Exposure to medications during pregnancy may impact offspring hearing; however, the ototoxic effects of different drugs have not been ...">
<meta name="og:title" content="Maternal Exposure to Medications and the Risk of Congenital and Early‐Onset Hearing Loss in Children: A Systematic Review and a Meta‐Analysis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Congenital hearing loss (CHL) affects approximately 1–2 in 1000 children and significantly impacts development. Exposure to medications during pregnancy may impact offspring hearing; however, the ototoxic effects of different drugs have not been ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375940/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12375940">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1111/bcpt.70090"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/BCPT-137-0.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12375940%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12375940/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12375940/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375940/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1111/bcpt.70090" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Basic Clin Pharmacol Toxicol</button></div>. 2025 Aug 25;137(3):e70090. doi: <a href="https://doi.org/10.1111/bcpt.70090" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1111/bcpt.70090</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Basic%20Clin%20Pharmacol%20Toxicol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Basic%20Clin%20Pharmacol%20Toxicol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Basic%20Clin%20Pharmacol%20Toxicol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Basic%20Clin%20Pharmacol%20Toxicol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Maternal Exposure to Medications and the Risk of Congenital and Early‐Onset Hearing Loss in Children: A Systematic Review and a Meta‐Analysis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22K%C3%BCc%C3%BCkyildiz%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Asli Sena Kücükyildiz</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Asli Sena Kücükyildiz</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22K%C3%BCc%C3%BCkyildiz%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Asli Sena Kücükyildiz</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thunbo%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Mette Østergaard Thunbo</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Mette Østergaard Thunbo</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark</div>
<div class="p">
<sup>
<sup>3</sup>
</sup>Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thunbo%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mette Østergaard Thunbo</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Swan%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Christer Zøylner Swan</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Christer Zøylner Swan</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark</div>
<div class="p">
<sup>
<sup>4</sup>
</sup>Otorhinolaryngology Private Practice, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Swan%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Christer Zøylner Swan</span></a>
</div>
</div>
<sup>1,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Burgner%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">David P Burgner</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">David P Burgner</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, Victoria, Australia</div>
<div class="p">
<sup>
<sup>6</sup>
</sup>Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia</div>
<div class="p">
<sup>
<sup>7</sup>
</sup>Department of Paediatrics, Monash University, Clayton, Victoria, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Burgner%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">David P Burgner</span></a>
</div>
</div>
<sup>5,</sup><sup>6,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miller%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Jessica E Miller</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Jessica E Miller</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark</div>
<div class="p">
<sup>
<sup>5</sup>
</sup>Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, Victoria, Australia</div>
<div class="p">
<sup>
<sup>6</sup>
</sup>Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miller%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jessica E Miller</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>5,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ovesen%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Therese Ovesen</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Therese Ovesen</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark</div>
<div class="p">
<sup>
<sup>8</sup>
</sup>Department of Otorhinolaryngology, Gødstrup Hospital, Herning, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ovesen%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Therese Ovesen</span></a>
</div>
</div>
<sup>1,</sup><sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pedersen%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Lars Henning Pedersen</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Lars Henning Pedersen</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark</div>
<div class="p">
<sup>
<sup>9</sup>
</sup>Department of Biomedicine, Aarhus University, Aarhus, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pedersen%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lars Henning Pedersen</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>9</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="bcpt70090-aff-0001">
<sup>
<sup>1</sup>
</sup>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark</div>
<div id="bcpt70090-aff-0002">
<sup>
<sup>2</sup>
</sup>Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark</div>
<div id="bcpt70090-aff-0003">
<sup>
<sup>3</sup>
</sup>Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark</div>
<div id="bcpt70090-aff-0004">
<sup>
<sup>4</sup>
</sup>Otorhinolaryngology Private Practice, Denmark</div>
<div id="bcpt70090-aff-0005">
<sup>
<sup>5</sup>
</sup>Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, Victoria, Australia</div>
<div id="bcpt70090-aff-0006">
<sup>
<sup>6</sup>
</sup>Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia</div>
<div id="bcpt70090-aff-0007">
<sup>
<sup>7</sup>
</sup>Department of Paediatrics, Monash University, Clayton, Victoria, Australia</div>
<div id="bcpt70090-aff-0008">
<sup>
<sup>8</sup>
</sup>Department of Otorhinolaryngology, Gødstrup Hospital, Herning, Denmark</div>
<div id="bcpt70090-aff-0009">
<sup>
<sup>9</sup>
</sup>Department of Biomedicine, Aarhus University, Aarhus, Denmark</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Asli Sena Kücükyildiz (<span>ask@clin.au.dk</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jul 8; Received 2025 Apr 22; Accepted 2025 Jul 28; Issue date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Basic &amp; Clinical Pharmacology &amp; Toxicology</em> published by John Wiley &amp; Sons Ltd on behalf of Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12375940  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40851451/" class="usa-link">40851451</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<section id="bcpt70090-sec-0001"><h3 class="pmc_sec_title">Background</h3>
<p>Congenital hearing loss (CHL) affects approximately 1–2 in 1000 children and significantly impacts development. Exposure to medications during pregnancy may impact offspring hearing; however, the ototoxic effects of different drugs have not been systematically investigated.</p></section><section id="bcpt70090-sec-0002"><h3 class="pmc_sec_title">Methods</h3>
<p>This systematic review and meta‐analysis was conducted following PRISMA guidelines and analysed 21 experimental and observational studies examining 60 drugs across various categories.</p></section><section id="bcpt70090-sec-0003"><h3 class="pmc_sec_title">Findings</h3>
<p>Magnesium sulphate and systemic steroids, alone or in combination, showed potential protective effects towards CHL. Specific antibiotics (e.g., gentamicin and metronidazole) and non‐steroidal anti‐inflammatory drugs were associated with an increased risk of CHL. Modest evidence indicated that low‐dose acetylsalicylic acid increased risk, whereas higher doses did not. Other drugs, such as anti‐neoplastic agents and valproic acid, showed weaker associations with CHL. Most studies had methodological limitations.</p></section><section id="bcpt70090-sec-0004"><h3 class="pmc_sec_title">Conclusion</h3>
<p>Our findings highlight the urgent need for robust research to minimise preventable hearing loss in children.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> congenital hearing loss, intrauterine drug exposure, pregnancy, reproductive toxicology, systematic review</p></section></section><section class="abstract" id="BCPT70090-abs-5001"><h2>Summary</h2>
<p>Hearing loss present at birth or in early childhood can significantly affect a child's development. Some medications taken during pregnancy may potentially influence the risk of hearing loss in infants, but this has not been thoroughly studied. We reviewed 21 studies investigating 60 different drugs to gain a better understanding of their effects. We found that certain medications, such as magnesium sulphate and steroids, might offer protection against hearing loss. Conversely, others, including some antibiotics and anti‐inflammatory drugs such as acetylsalicylic acid, may increase the risk. Our findings underscore the need for further research to inform safer medication use during pregnancy and reduce preventable hearing loss in children.</p></section><section id="bcpt70090-sec-0005"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Congenital hearing loss (CHL) affects 1–2 in 1000 children worldwide [<a href="#bcpt70090-bib-0001" class="usa-link" aria-describedby="bcpt70090-bib-0001">1</a>, <a href="#bcpt70090-bib-0002" class="usa-link" aria-describedby="bcpt70090-bib-0002">2</a>] and negatively affects language development, academic performance and social and emotional well‐being [<a href="#bcpt70090-bib-0003" class="usa-link" aria-describedby="bcpt70090-bib-0003">3</a>]. Several recognised risk factors for CHL in children include hereditary HL, in utero infection with cytomegalovirus (CMV) and prolonged neonatal intensive care [<a href="#bcpt70090-bib-0004" class="usa-link" aria-describedby="bcpt70090-bib-0004">4</a>]. However, the aetiology remains unknown for 25%–40% of affected children [<a href="#bcpt70090-bib-0003" class="usa-link" aria-describedby="bcpt70090-bib-0003">3</a>, <a href="#bcpt70090-bib-0005" class="usa-link" aria-describedby="bcpt70090-bib-0005">5</a>, <a href="#bcpt70090-bib-0006" class="usa-link" aria-describedby="bcpt70090-bib-0006">6</a>, <a href="#bcpt70090-bib-0007" class="usa-link" aria-describedby="bcpt70090-bib-0007">7</a>].</p>
<p>The development of the inner ear begins around the fourth gestational week. By the sixth gestational week, formation of the cochlear duct commences; the bony labyrinth is ossified by the 23rd week and fetal hearing commences by approximately 27 weeks gestation. The inner ear, however, remains vulnerable to external stimuli throughout pregnancy and postnatally until the age of 4 years, as several structures of the inner ear, such as hair cells and neurons, continue development [<a href="#bcpt70090-bib-0008" class="usa-link" aria-describedby="bcpt70090-bib-0008">8</a>, <a href="#bcpt70090-bib-0009" class="usa-link" aria-describedby="bcpt70090-bib-0009">9</a>].</p>
<p>Pregnancy exposure to drugs may contribute to CHL. In adults, several classes of drugs can potentially damage or impair the function of the inner ear, including some classes of antibiotics, loop diuretics, salicylates and antimalarial drugs [<a href="#bcpt70090-bib-0010" class="usa-link" aria-describedby="bcpt70090-bib-0010">10</a>, <a href="#bcpt70090-bib-0011" class="usa-link" aria-describedby="bcpt70090-bib-0011">11</a>, <a href="#bcpt70090-bib-0012" class="usa-link" aria-describedby="bcpt70090-bib-0012">12</a>, <a href="#bcpt70090-bib-0013" class="usa-link" aria-describedby="bcpt70090-bib-0013">13</a>]. For example, aminoglycosides are known to generate reactive oxygen species (ROS), leading to apoptosis in cochlear hair cells [<a href="#bcpt70090-bib-0014" class="usa-link" aria-describedby="bcpt70090-bib-0014">14</a>]. Salicylates impact outer hair cell electromotility and cochlear blood flow, causing reversible hearing changes [<a href="#bcpt70090-bib-0015" class="usa-link" aria-describedby="bcpt70090-bib-0015">15</a>, <a href="#bcpt70090-bib-0016" class="usa-link" aria-describedby="bcpt70090-bib-0016">16</a>]. Loop diuretics impair endolymph production by disrupting ion transport in the stria vascularis of the cochlear duct, leading to a collapse of the endocochlear potential and causing transient, reversible hearing loss [<a href="#bcpt70090-bib-0017" class="usa-link" aria-describedby="bcpt70090-bib-0017">17</a>]. Finally, some antineoplastic agents accumulate in cochlear structures, leading to excessive ROS production and DNA damage in cochlear cells [<a href="#bcpt70090-bib-0018" class="usa-link" aria-describedby="bcpt70090-bib-0018">18</a>]. As most drugs cross the placental barrier [<a href="#bcpt70090-bib-0004" class="usa-link" aria-describedby="bcpt70090-bib-0004">4</a>], specific drugs may affect the development of the fetal inner ear, resulting in CHL. Importantly, the majority of pregnant women are exposed to medications during pregnancy; in 2018, 63.3% of pregnant Danish women redeemed at least one prescription during pregnancy [<a href="#bcpt70090-bib-0019" class="usa-link" aria-describedby="bcpt70090-bib-0019">19</a>] and worldwide prescription drug use during pregnancy ranged from 27% to 93% [<a href="#bcpt70090-bib-0020" class="usa-link" aria-describedby="bcpt70090-bib-0020">20</a>].</p>
<p>There has been no systematic data reviewing the relationship between pregnancy drug exposure and CHL. This knowledge is crucial to reduce preventable causes of HL, allow for early diagnostics and optimise treatment should exposure occur. We aimed to systematically review the literature on the potential association between maternal drug exposure and CHL in children.</p></section><section id="bcpt70090-sec-0006"><h2 class="pmc_sec_title">2. Methods</h2>
<p>This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines [<a href="#bcpt70090-bib-0021" class="usa-link" aria-describedby="bcpt70090-bib-0021">21</a>, <a href="#bcpt70090-bib-0022" class="usa-link" aria-describedby="bcpt70090-bib-0022">22</a>] and registered at the International Prospective Register of Systematic Reviews (PROSPERO) on 14 February 2023 (registration number CRD42023399514).</p>
<section id="bcpt70090-sec-0007"><h3 class="pmc_sec_title">2.1. Eligibility Criteria</h3>
<section id="bcpt70090-sec-0008"><h4 class="pmc_sec_title">2.1.1. Study Designs</h4>
<p>Randomised controlled trials (RCTs), cohort studies and case–control studies were included. Reviews, systematic reviews, meta‐analyses, editorials, case reports, case series, cross‐sectional studies, descriptive studies, poster presentations and conference abstracts were excluded due to risk of bias, inability to establish causality and insufficient data.</p></section><section id="bcpt70090-sec-0009"><h4 class="pmc_sec_title">2.1.2. Participants</h4>
<p>Studies on pregnant women of all ages were included. Animal studies were excluded.</p></section><section id="bcpt70090-sec-0010"><h4 class="pmc_sec_title">2.1.3. Intervention</h4>
<p>Studies on the use of all prescribed and over‐the‐counter drugs, regardless of trimester and indication, were included, as were findings on combinations of drugs. Studies of all recreational drugs, alcohol, caffeine, vitamins/supplements or complementary medicine were excluded.</p></section><section id="bcpt70090-sec-0011"><h4 class="pmc_sec_title">2.1.4. Outcome</h4>
<p>Studies reporting on sensorineural CHL in children as their primary or secondary outcome were included, defined as mild, moderate and severe hearing impairment diagnosed in early childhood due to damage to inner ear structures or central auditory pathways. Studies on hearing loss of all degrees of severity were included. Studies on children with congenital infections or genetically induced hearing loss were excluded.</p></section><section id="bcpt70090-sec-0012"><h4 class="pmc_sec_title">2.1.5. Imprecise Reporting</h4>
<p>Studies where intrauterine and postnatal drug exposure in children were reported as combined exposures rather than individually were excluded. Studies reporting hearing loss in conjunction with other outcomes, such as neurodevelopmental outcomes, were also excluded.</p></section><section id="bcpt70090-sec-0013"><h4 class="pmc_sec_title">2.1.6. Language</h4>
<p>As the first author is proficient in English, Danish, Swedish, Norwegian and Turkish, studies published in these languages were evaluated.</p></section><section id="bcpt70090-sec-0014"><h4 class="pmc_sec_title">2.1.7. Full‐Text Articles</h4>
<p>If only an abstract were available, the study was excluded.</p></section></section><section id="bcpt70090-sec-0015"><h3 class="pmc_sec_title">2.2. Information Sources</h3>
<p>PROSPERO and Cochrane Database of Systematic Reviews (CDSR) were searched to identify ongoing or recently completed systematic reviews. The systematic literature search was conducted following the PRISMA guidelines [<a href="#bcpt70090-bib-0021" class="usa-link" aria-describedby="bcpt70090-bib-0021">21</a>, <a href="#bcpt70090-bib-0022" class="usa-link" aria-describedby="bcpt70090-bib-0022">22</a>].</p>
<p>A database search was conducted on Embase, PubMed and Web of Science on 25 January 2023. A second search was conducted on the same databases on 5 September 2024. The search string used in PubMed is shown in Appendix <a href="#bcpt70090-app-0001" class="usa-link">A</a>. A flow diagram of the search and screening process is shown in Figure <a href="#bcpt70090-fig-0001" class="usa-link">1</a>.</p>
<figure class="fig xbox font-sm" id="bcpt70090-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01bf/12375940/7f87b9af98e9/BCPT-137-0-g006.jpg" loading="lazy" id="jats-graphic-1" height="763" width="665" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/bcpt70090-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Flow diagram of the systematic review process.</p></figcaption></figure></section><section id="bcpt70090-sec-0016"><h3 class="pmc_sec_title">2.3. Search Strategy</h3>
<p>The specific search strategies were created with assistance from a Health Sciences Librarian with expertise in systematic review searching, with input from the project team. No lower limit for publication dates was applied. Literature search strategies were developed using the medical subject headings (MeSH) and text words related to the subject. The search strings were performed following the PICO strategy [<a href="#bcpt70090-bib-0023" class="usa-link" aria-describedby="bcpt70090-bib-0023">23</a>], using pregnancy (patient), drug exposure (intervention) and HL in children (outcome). Three major medical electronic databases were used: PubMed, Embase and Web of Science. To ensure literature saturation, the reference lists of included studies were scanned. See Appendix <a href="#bcpt70090-app-0001" class="usa-link">A</a> for the search string used in PubMed.</p></section><section id="bcpt70090-sec-0017"><h3 class="pmc_sec_title">2.4. Search Results</h3>
<p>Search results were imported to the reference program EndNote 20 (Clarivate, London, UK), where duplicates were deleted automatically. The literature was then imported into the online program Covidence (Melbourne, Australia) to check for missed duplicates and to support the screening and selection process.</p>
<p>Two reviewers (A.S.K. and M.Ø.T.) independently screened all titles and abstracts using Covidence. The study was excluded if the title and abstract failed to fulfil the predefined eligibility criteria. If the title and abstract met the predefined eligibility criteria, or if eligibility was uncertain, the article was included for full‐text screening. Disagreement between the reviewers was resolved through discussion. Reviewers were not blinded to the journal titles, authors, or institutions. Microsoft Excel was used as the primary data management tool.</p></section><section id="bcpt70090-sec-0018"><h3 class="pmc_sec_title">2.5. Data Items</h3>
<p>Study characteristics (author, publication year, study design, study size, year of conduct, country or continent), patient characteristics (maternal diseases, trimester of exposure and exclusion/matching/adjusting criteria/randomisation method), exposure characteristics (type of drug, dose of drug, number of exposed and non‐exposed pregnant people), outcome characteristics (gestational age at birth, weight at birth, number of children with and without hearing loss), hearing loss characteristics (type of hearing loss, method of diagnosis and age at diagnosis) were extracted by the first author. Data from all included studies reporting effect estimates (odds ratios (OR), risk ratios (RR) or mean differences) for the outcome CHL was extracted, along with corresponding confidence intervals. Studies where OR were either directly reported or where sufficient information (number of participants in each group) was provided to allow us to calculate OR were used to conduct a meta‐analysis.</p></section><section id="bcpt70090-sec-0019"><h3 class="pmc_sec_title">2.6. Data Synthesis</h3>
<p>We present a quantitative analysis using forest plots where sufficient data were available in the included studies, complemented by a narrative of key findings of the included studies in text and tables. We prioritised using the adjusted estimates when they were presented in the studies; if not, we utilised raw estimates. If none were provided but there was sufficient data about exposed and non‐exposed, we calculated the estimates ourselves. We employed a random‐effects model to account for heterogeneity and calculated pooled effect sizes with 95% confidence intervals.</p></section><section id="bcpt70090-sec-0020"><h3 class="pmc_sec_title">2.7. Quality Assessment and Risk of Bias</h3>
<p>The methodological quality and the risk of bias within the included studies were assessed by the first author using the Newcastle‐Ottawa Scale (NOS) [<a href="#bcpt70090-bib-0024" class="usa-link" aria-describedby="bcpt70090-bib-0024">24</a>] for non‐randomised trials and the Cochrane risk‐of‐bias (ROB2, August 2019 version) [<a href="#bcpt70090-bib-0025" class="usa-link" aria-describedby="bcpt70090-bib-0025">25</a>] for randomised trials. The NOS includes three categories of criteria, giving a total maximum score of 9 points to each study. The ROB2 includes five domains used to grade the risk of bias in the studies, where studies are either graded ‘high risk’, ‘some concerns’ or ‘low risk’.</p>
<p>The quality of evidence for all outcomes was assessed by the first author using The Oxford Centre for Evidence‐Based Medicine 2011 (OCEBM) Levels of Evidence [<a href="#bcpt70090-bib-0026" class="usa-link" aria-describedby="bcpt70090-bib-0026">26</a>], where each study is given a score from 1 to 5, with 1 being the highest level of evidence (systematic review or [RCTs]) and 5 being the lowest level of evidence (expert opinion without critical appraisal).</p>
<p>The quality assessment scores were used to contextualise the strength of individual studies; but did not influence inclusion or weighting in meta‐analyses. Sensitivity analyses by study quality were not conducted.</p></section></section><section id="bcpt70090-sec-0021"><h2 class="pmc_sec_title">3. Results</h2>
<p>A search on PROSPERO did not identify any relevant systematic reviews.</p>
<section id="bcpt70090-sec-0022"><h3 class="pmc_sec_title">3.1. Study Selection</h3>
<p>A total of 1414 publications were identified through the databases Embase (<em>n</em> = 856), PubMed (<em>n</em> = 408) and Web of Science (<em>n</em> = 160). We removed 132 duplicates using Endnote and Covidence, leaving 1282 publications for the initial screening of titles and abstracts. Furthermore, 1195 publications were excluded as they were deemed irrelevant to the specific focus of this systematic review, leaving 85 studies for full‐text screening. We excluded 66 studies due to eligibility criteria; 39 studies due to study design, nine due to participant group, eight studies due to wrong outcome, six studies were imprecise and four did not meet language criteria. A list of excluded but possibly relevant case reports and case series found through the screening process or screening of references is provided in Appendix <a href="#bcpt70090-app-0002" class="usa-link">B</a>. A list of excluded but possibly relevant studies in other languages found through the screening process or screening of references is provided in Appendix <a href="#bcpt70090-app-0003" class="usa-link">C</a>. We included two studies through cross‐reference. A total of 21 studies were included in this systematic review and meta‐analysis.</p></section><section id="bcpt70090-sec-0023"><h3 class="pmc_sec_title">3.2. Study Characteristics</h3>
<p>We included four RCTs, 12 cohort studies [<a href="#bcpt70090-bib-0027" class="usa-link" aria-describedby="bcpt70090-bib-0027">27</a>, <a href="#bcpt70090-bib-0028" class="usa-link" aria-describedby="bcpt70090-bib-0028">28</a>, <a href="#bcpt70090-bib-0029" class="usa-link" aria-describedby="bcpt70090-bib-0029">29</a>, <a href="#bcpt70090-bib-0030" class="usa-link" aria-describedby="bcpt70090-bib-0030">30</a>, <a href="#bcpt70090-bib-0031" class="usa-link" aria-describedby="bcpt70090-bib-0031">31</a>, <a href="#bcpt70090-bib-0032" class="usa-link" aria-describedby="bcpt70090-bib-0032">32</a>, <a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>, <a href="#bcpt70090-bib-0034" class="usa-link" aria-describedby="bcpt70090-bib-0034">34</a>, <a href="#bcpt70090-bib-0035" class="usa-link" aria-describedby="bcpt70090-bib-0035">35</a>, <a href="#bcpt70090-bib-0036" class="usa-link" aria-describedby="bcpt70090-bib-0036">36</a>, <a href="#bcpt70090-bib-0037" class="usa-link" aria-describedby="bcpt70090-bib-0037">37</a>] and five case–control studies [<a href="#bcpt70090-bib-0038" class="usa-link" aria-describedby="bcpt70090-bib-0038">38</a>, <a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>, <a href="#bcpt70090-bib-0040" class="usa-link" aria-describedby="bcpt70090-bib-0040">40</a>, <a href="#bcpt70090-bib-0041" class="usa-link" aria-describedby="bcpt70090-bib-0041">41</a>, <a href="#bcpt70090-bib-0042" class="usa-link" aria-describedby="bcpt70090-bib-0042">42</a>] (Table <a href="#bcpt70090-tbl-0001" class="usa-link">1</a>). Four studies were conducted in Asia, three in South America, three at multiple centres worldwide, three in Europe, three in North America, two in Australia/New Zealand and one in Africa.</p>
<section class="tw xbox font-sm" id="bcpt70090-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Characteristics of included studies on drug exposure and congenital hearing loss.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Author, publication year</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Country</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Study design</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Drug investigated</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Trimester of exposure</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Reported estimate</th>
<th align="center" valign="bottom" rowspan="1" colspan="1"># Children antenatally exposed to drug with hearing loss</th>
<th align="center" valign="bottom" rowspan="1" colspan="1"># Children antenatally exposed to drug without hearing loss</th>
<th align="center" valign="bottom" rowspan="1" colspan="1"># Children antenatally non‐exposed to drug with hearing loss</th>
<th align="center" valign="bottom" rowspan="1" colspan="1"># Children antenatally non‐exposed to drug without hearing loss</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Asztalos et al. 2013 [<a href="#bcpt70090-bib-0043" class="usa-link" aria-describedby="bcpt70090-bib-0043">43</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">20 countries in North‐ and South America, Europe and Asia</td>
<td align="center" valign="top" rowspan="1" colspan="1">RCT</td>
<td align="center" valign="top" rowspan="1" colspan="1">Betamethasone</td>
<td align="center" valign="top" rowspan="1" colspan="1">2nd or 3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">Calculated OR 1.80 (95% CI: 0.71–4.56)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11</td>
<td align="center" valign="top" rowspan="1" colspan="1">862</td>
<td align="center" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">849</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Azizi et al., 2016 [<a href="#bcpt70090-bib-0038" class="usa-link" aria-describedby="bcpt70090-bib-0038">38</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Iran</td>
<td align="center" valign="top" rowspan="1" colspan="1">Case–control</td>
<td align="center" valign="top" rowspan="1" colspan="1">Ototoxic drugs (not specified)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Calculated OR 1.66 (95% CI: 1.11–2.47)</td>
<td align="center" valign="top" rowspan="1" colspan="1">75</td>
<td align="center" valign="top" rowspan="1" colspan="1">300</td>
<td align="center" valign="top" rowspan="1" colspan="1">49</td>
<td align="center" valign="top" rowspan="1" colspan="1">326</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Bang Madsen et al. 2023 [<a href="#bcpt70090-bib-0037" class="usa-link" aria-describedby="bcpt70090-bib-0037">37</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Denmark</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cohort</td>
<td align="center" valign="top" rowspan="1" colspan="1">ADHD medication (Methylphenidate, Amphetamine, Dexamphetamine, Lisdexamphetamine, Modafinil, Atomoxetine and Clonidine)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Throughout pregnancy or new users some time during pregnancy</td>
<td align="center" valign="top" rowspan="1" colspan="1">Adjusted HR 1.04 (95% CI: 0.67–1.62), Calculated OR 1.29 (95% CI: 0.92–1.81)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35</td>
<td align="center" valign="top" rowspan="1" colspan="1">863</td>
<td align="center" valign="top" rowspan="1" colspan="1">32 430</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 032 867</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Borba et al. 2004 [<a href="#bcpt70090-bib-0027" class="usa-link" aria-describedby="bcpt70090-bib-0027">27</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Brazil</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cohort</td>
<td align="center" valign="top" rowspan="1" colspan="1">Chloroquine diphosphate</td>
<td align="center" valign="top" rowspan="1" colspan="1">Four mothers during 1st and five mothers during 1st, 2nd and 3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.55</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">9</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">10</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Crowther et al. 2007 [<a href="#bcpt70090-bib-0044" class="usa-link" aria-describedby="bcpt70090-bib-0044">44</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Australia and New Zealand</td>
<td align="center" valign="top" rowspan="1" colspan="1">RCT</td>
<td align="center" valign="top" rowspan="1" colspan="1">Betamethasone</td>
<td align="center" valign="top" rowspan="1" colspan="1">2nd and 3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 0.77 (95% CI: 0.19–3.06), <em>p</em> = 0.71</td>
<td align="center" valign="top" rowspan="1" colspan="1">4</td>
<td align="center" valign="top" rowspan="1" colspan="1">517</td>
<td align="center" valign="top" rowspan="1" colspan="1">5</td>
<td align="center" valign="top" rowspan="1" colspan="1">521</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Crowther et al. 2019 [<a href="#bcpt70090-bib-0045" class="usa-link" aria-describedby="bcpt70090-bib-0045">45</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Australia and New Zealand</td>
<td align="center" valign="top" rowspan="1" colspan="1">RCT</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dexamethasone vs. Betamethasone</td>
<td align="center" valign="top" rowspan="1" colspan="1">2nd or 3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 1.16 (95% CI: 0.62–2.16), <em>p</em> = 0.65</td>
<td align="center" valign="top" rowspan="1" colspan="1">21</td>
<td align="center" valign="top" rowspan="1" colspan="1">593</td>
<td align="center" valign="top" rowspan="1" colspan="1">18</td>
<td align="center" valign="top" rowspan="1" colspan="1">595</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Fakhim et al. 2010 [<a href="#bcpt70090-bib-0028" class="usa-link" aria-describedby="bcpt70090-bib-0028">28</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Iran</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cohort</td>
<td align="center" valign="top" rowspan="1" colspan="1">Ototoxic drugs, Aminoglycosides (especially Amikacin) were the most common</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Calculated OR 25.75 (2.98–240.08), <em>p</em> = 0.086</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">17</td>
<td align="center" valign="top" rowspan="1" colspan="1">4</td>
<td align="center" valign="top" rowspan="1" colspan="1">1819</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Fasunla et al. 2014 [<a href="#bcpt70090-bib-0029" class="usa-link" aria-describedby="bcpt70090-bib-0029">29</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Nigeria</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cohort</td>
<td align="center" valign="top" rowspan="1" colspan="1">HAART with efavirenz + lamivudine + tenofovir or atazanavir + ritonavir + tenofovir + zidovudine + lamivudine or other combination therapies including lopinavir or abacavir.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">RR 0.13 (95% CI: 0.05–0.32), <em>p</em> = 0.002</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Finch et al. 2021 [<a href="#bcpt70090-bib-0030" class="usa-link" aria-describedby="bcpt70090-bib-0030">30</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">USA, Canada and Europe</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cohort</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cisplatin</td>
<td align="center" valign="top" rowspan="1" colspan="1">2nd</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">16</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">264</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Oxaliplatin</td>
<td align="center" valign="top" rowspan="1" colspan="1">2nd and 3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">11</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">264</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Carboplatin</td>
<td align="center" valign="top" rowspan="1" colspan="1">2nd and 3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">12</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">264</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Platinum agents vs. non‐platinum‐containing agents</td>
<td align="center" valign="top" rowspan="1" colspan="1">2nd and 3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 60.3, <em>p</em> = 0.0003</td>
<td align="center" valign="top" rowspan="1" colspan="1">4</td>
<td align="center" valign="top" rowspan="1" colspan="1">43</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">264</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Foch et al. 2018 [<a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">France</td>
<td align="center" valign="top" rowspan="1" colspan="1">Case–control</td>
<td align="center" valign="top" rowspan="1" colspan="1">Valproic acid/valpromide</td>
<td align="center" valign="top" rowspan="1" colspan="1">1st (100%), 2nd (60%), 3rd (60%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Adjusted OR 5.20 (95% CI: 1.93–14.00)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5</td>
<td align="center" valign="top" rowspan="1" colspan="1">20</td>
<td align="center" valign="top" rowspan="1" colspan="1">1166</td>
<td align="center" valign="top" rowspan="1" colspan="1">25 875</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Systemic corticosteroids</td>
<td align="center" valign="top" rowspan="1" colspan="1">1st (51%), 2nd (35%), 3rd (34%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Adjusted OR 0.75 (95% CI: 0.61–0.93)</td>
<td align="center" valign="top" rowspan="1" colspan="1">102</td>
<td align="center" valign="top" rowspan="1" colspan="1">1069</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">24 826</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Peripheral vasodilators</td>
<td align="center" valign="top" rowspan="1" colspan="1">3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">Univariate OR 3.58 (95% CI: 1.77–7.24)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9</td>
<td align="center" valign="top" rowspan="1" colspan="1">57</td>
<td align="center" valign="top" rowspan="1" colspan="1">1236</td>
<td align="center" valign="top" rowspan="1" colspan="1">27 989</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Dihydroergocryptine</td>
<td align="center" valign="top" rowspan="1" colspan="1">3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">Adjusted OR 3.71 (95% CI: 1.75–7.89)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8</td>
<td align="center" valign="top" rowspan="1" colspan="1">48</td>
<td align="center" valign="top" rowspan="1" colspan="1">1163</td>
<td align="center" valign="top" rowspan="1" colspan="1">25 847</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Fusafungine and bacitracin/tixocortol</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Adjusted OR 2.55 (95% CI: 1.32–4.93)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10</td>
<td align="center" valign="top" rowspan="1" colspan="1">86</td>
<td align="center" valign="top" rowspan="1" colspan="1">1161</td>
<td align="center" valign="top" rowspan="1" colspan="1">25 809</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Antithrombotic agents</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Univariate OR 1.42 (95% CI: 1.02–1.99)</td>
<td align="center" valign="top" rowspan="1" colspan="1">37</td>
<td align="center" valign="top" rowspan="1" colspan="1">591</td>
<td align="center" valign="top" rowspan="1" colspan="1">1208</td>
<td align="center" valign="top" rowspan="1" colspan="1">27 455</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">ASA ≤ 300 mg</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Adjusted OR 1.53 (95% CI: 1.12–2.11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">43</td>
<td align="center" valign="top" rowspan="1" colspan="1">625</td>
<td align="center" valign="top" rowspan="1" colspan="1">1128</td>
<td align="center" valign="top" rowspan="1" colspan="1">25 270</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">NSAIDs: ASA &gt; 300 mg and other NSAIDs</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Adjusted OR 1.00 (95% CI: 0.81–1.12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">102</td>
<td align="center" valign="top" rowspan="1" colspan="1">2281</td>
<td align="center" valign="top" rowspan="1" colspan="1">1069</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 614</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Antihaemorrhagics</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Univariate OR 3.48 (95% CI: 1.47–8.23)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">39</td>
<td align="center" valign="top" rowspan="1" colspan="1">1239</td>
<td align="center" valign="top" rowspan="1" colspan="1">28 007</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Tobramycine</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not significant</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">28 044</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Gentamicine</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Calculated OR 3.22 (95% CI: 0.43–24.48)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">7</td>
<td align="center" valign="top" rowspan="1" colspan="1">1244</td>
<td align="center" valign="top" rowspan="1" colspan="1">28 039</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Netilmicine</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not significant</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">12</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">28 034</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Erythromycine</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Calculated OR 1.11 (95% CI: 0.81–1.52)</td>
<td align="center" valign="top" rowspan="1" colspan="1">46</td>
<td align="center" valign="top" rowspan="1" colspan="1">937</td>
<td align="center" valign="top" rowspan="1" colspan="1">1199</td>
<td align="center" valign="top" rowspan="1" colspan="1">27 109</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Chloroquine</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not significant</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">28 040</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Quinine</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not significant</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">1244</td>
<td align="center" valign="top" rowspan="1" colspan="1">28 040</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Furosemide</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Calculated OR 1.18 (95% CI: 0.16–8.60)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">19</td>
<td align="center" valign="top" rowspan="1" colspan="1">1244</td>
<td align="center" valign="top" rowspan="1" colspan="1">28 027</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Emollients and protectives</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Univariate OR 1.28 (95% CI: 1.03–1.58)</td>
<td align="center" valign="top" rowspan="1" colspan="1">94</td>
<td align="center" valign="top" rowspan="1" colspan="1">1687</td>
<td align="center" valign="top" rowspan="1" colspan="1">1151</td>
<td align="center" valign="top" rowspan="1" colspan="1">26 359</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Cream composed of glycerol, paraffin and vaseline</td>
<td align="center" valign="top" rowspan="1" colspan="1">1st, 2nd and 3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">Adjusted OR 1.28 (95% CI: 1.00–1.64)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">1236</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Gazia et al. 2019 [<a href="#bcpt70090-bib-0031" class="usa-link" aria-describedby="bcpt70090-bib-0031">31</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Italy</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cohort</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 0.91 (95% CI: 0.20–4.16), <em>p</em> = 0.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">16</td>
<td align="center" valign="top" rowspan="1" colspan="1">32</td>
<td align="center" valign="top" rowspan="1" colspan="1">234</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Kasapoglu et al. 2020 [<a href="#bcpt70090-bib-0032" class="usa-link" aria-describedby="bcpt70090-bib-0032">32</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Turkey</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cohort</td>
<td align="center" valign="top" rowspan="1" colspan="1">Magnesium sulphate (+ betamethasone if needed)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2nd and 3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 0.23 (95% CI: 0.05–1.19), <em>p</em> = 0.08</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">89</td>
<td align="center" valign="top" rowspan="1" colspan="1">16</td>
<td align="center" valign="top" rowspan="1" colspan="1">131</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Betamethasone</td>
<td align="center" valign="top" rowspan="1" colspan="1">2nd and 3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 1.59 (95% CI: 0.39–6.43), <em>p</em> = 0.51</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not reported</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Leung et al. 2016 [<a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">USA</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cohort</td>
<td align="center" valign="top" rowspan="1" colspan="1">Magnesium sulphate</td>
<td align="center" valign="top" rowspan="1" colspan="1">2nd and 3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 0.38 (95% CI: 0.2–0.74)</td>
<td align="center" valign="top" rowspan="1" colspan="1">25</td>
<td align="center" valign="top" rowspan="1" colspan="1">186</td>
<td align="center" valign="top" rowspan="1" colspan="1">20</td>
<td align="center" valign="top" rowspan="1" colspan="1">58</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Betamethasone and magnesium sulphate</td>
<td align="center" valign="top" rowspan="1" colspan="1">2nd and 3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 0.31 (95% CI: 0.16–0.60), <em>p</em> &lt; 0,001</td>
<td align="center" valign="top" rowspan="1" colspan="1">32</td>
<td align="center" valign="top" rowspan="1" colspan="1">209</td>
<td align="center" valign="top" rowspan="1" colspan="1">25</td>
<td align="center" valign="top" rowspan="1" colspan="1">69</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Betamethasone</td>
<td align="center" valign="top" rowspan="1" colspan="1">2nd and 3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 0.41 (95% CI: 0.2–0.86), <em>p</em> = 0.018</td>
<td align="center" valign="top" rowspan="1" colspan="1">20</td>
<td align="center" valign="top" rowspan="1" colspan="1">175</td>
<td align="center" valign="top" rowspan="1" colspan="1">13</td>
<td align="center" valign="top" rowspan="1" colspan="1">35</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Ampicillin</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 0.63 (95% CI: 0.33–1.19), <em>p</em> = 0.15</td>
<td align="center" valign="top" rowspan="1" colspan="1">21</td>
<td align="center" valign="top" rowspan="1" colspan="1">141</td>
<td align="center" valign="top" rowspan="1" colspan="1">24</td>
<td align="center" valign="top" rowspan="1" colspan="1">103</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Ampicillin and sulbactam</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 2.3 (95% CI: 1.08–4.9), <em>p</em> = 0.03 (after adjusting for GA <em>p</em> = 0.12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12</td>
<td align="center" valign="top" rowspan="1" colspan="1">33</td>
<td align="center" valign="top" rowspan="1" colspan="1">33</td>
<td align="center" valign="top" rowspan="1" colspan="1">211</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Clindamycin</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 0.99 (95% CI: 0.36–2.74), <em>p</em> = 0.99</td>
<td align="center" valign="top" rowspan="1" colspan="1">5</td>
<td align="center" valign="top" rowspan="1" colspan="1">27</td>
<td align="center" valign="top" rowspan="1" colspan="1">40</td>
<td align="center" valign="top" rowspan="1" colspan="1">217</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Gentamicin</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 1.8 (95% CI: 0.68–4.48), <em>p</em> = 0.28</td>
<td align="center" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">19</td>
<td align="center" valign="top" rowspan="1" colspan="1">39</td>
<td align="center" valign="top" rowspan="1" colspan="1">225</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Metronidazole</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 1.77 (95% CI: 0.6–5.1), <em>p</em> = 0.29</td>
<td align="center" valign="top" rowspan="1" colspan="1">5</td>
<td align="center" valign="top" rowspan="1" colspan="1">16</td>
<td align="center" valign="top" rowspan="1" colspan="1">40</td>
<td align="center" valign="top" rowspan="1" colspan="1">228</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Azithromycin</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 0.92 (95% CI: 0.1–7.6), <em>p</em> = 0.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">44</td>
<td align="center" valign="top" rowspan="1" colspan="1">238</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Amoxicillin and clavulanate</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 0.66 (95% CI: 0.1–5.4), <em>p</em> = 0.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">8</td>
<td align="center" valign="top" rowspan="1" colspan="1">44</td>
<td align="center" valign="top" rowspan="1" colspan="1">236</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Penicillin</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.22</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">8</td>
<td align="center" valign="top" rowspan="1" colspan="1">45</td>
<td align="center" valign="top" rowspan="1" colspan="1">236</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Nitrofurantoin</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.25</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">7</td>
<td align="center" valign="top" rowspan="1" colspan="1">45</td>
<td align="center" valign="top" rowspan="1" colspan="1">237</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Erythromycin</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> = 0.39</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">4</td>
<td align="center" valign="top" rowspan="1" colspan="1">45</td>
<td align="center" valign="top" rowspan="1" colspan="1">240</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Maternal antibiotics</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 0.55 (95% CI: 0.28–1.11), <em>p</em> = 0.095</td>
<td align="center" valign="top" rowspan="1" colspan="1">30</td>
<td align="center" valign="top" rowspan="1" colspan="1">191</td>
<td align="center" valign="top" rowspan="1" colspan="1">15</td>
<td align="center" valign="top" rowspan="1" colspan="1">53</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Other (sulfamethoxazole and trimethoprim, cefotetan, ceftriaxone, cephalexin and cefazolin)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 1.05 (95% CI: 0.5–2.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11</td>
<td align="center" valign="top" rowspan="1" colspan="1">57</td>
<td align="center" valign="top" rowspan="1" colspan="1">34</td>
<td align="center" valign="top" rowspan="1" colspan="1">187</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Patatt et al. 2021 [<a href="#bcpt70090-bib-0034" class="usa-link" aria-describedby="bcpt70090-bib-0034">34</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Brazil</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cohort</td>
<td align="center" valign="top" rowspan="1" colspan="1">Antimalarial drugs (chloroquine, coartem, quinine + clindamycin and primaquine)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1st, 2nd and 3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>p</em> &lt; 0.001</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">32</td>
<td align="center" valign="top" rowspan="1" colspan="1">21</td>
<td align="center" valign="top" rowspan="1" colspan="1">474</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Silva et al. 2015 [<a href="#bcpt70090-bib-0035" class="usa-link" aria-describedby="bcpt70090-bib-0035">35</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Amazonas</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cohort</td>
<td align="center" valign="top" rowspan="1" colspan="1">Antimalarial drugs (chloroquine (66.7%), primaquine, coartem, quinie or unknown)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1st (33.3%), 2nd (26.7%), 3rd (30.0%) and unknown (13.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">RR 5.64 (95% CI: 1.17–27.3), <em>p</em> = 0.031</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">28</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">251</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Soraisham et al. 2011 [<a href="#bcpt70090-bib-0046" class="usa-link" aria-describedby="bcpt70090-bib-0046">46</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Canada</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cohort</td>
<td align="center" valign="top" rowspan="1" colspan="1">Indomethacin</td>
<td align="center" valign="top" rowspan="1" colspan="1">2nd</td>
<td align="center" valign="top" rowspan="1" colspan="1">Calculated OR of 1.32 (95% CI: 0.27–6.49), <em>p</em> = 0.74</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">73</td>
<td align="center" valign="top" rowspan="1" colspan="1">5</td>
<td align="center" valign="top" rowspan="1" colspan="1">241</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">The MAGPIE Follow Up Trial. 2006 [<a href="#bcpt70090-bib-0047" class="usa-link" aria-describedby="bcpt70090-bib-0047">47</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">19 countries in Africa, Asia, North‐ and South America and Europe</td>
<td align="center" valign="top" rowspan="1" colspan="1">RCT</td>
<td align="center" valign="top" rowspan="1" colspan="1">Magnesium sulphate</td>
<td align="center" valign="top" rowspan="1" colspan="1">3rd</td>
<td align="center" valign="top" rowspan="1" colspan="1">Calculated OR 2.02 (95% CI: 0.2–20.72)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">1633</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">1647</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Tsao et al. 2023 [<a href="#bcpt70090-bib-0040" class="usa-link" aria-describedby="bcpt70090-bib-0040">40</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Taiwan</td>
<td align="center" valign="top" rowspan="1" colspan="1">Case–control</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gentamicin and furosemid</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">adjOR 1.01 (95% CI: 0.96–1.07)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2599</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 336</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 273</td>
<td align="center" valign="top" rowspan="1" colspan="1">53 029</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Tsao et al. 2024 [<a href="#bcpt70090-bib-0041" class="usa-link" aria-describedby="bcpt70090-bib-0041">41</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Taiwan</td>
<td align="center" valign="top" rowspan="1" colspan="1">Case–control</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gentamicin and furosemid</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">adj OR 0.97 (95% CI: 0.89–1.06)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1585</td>
<td align="center" valign="top" rowspan="1" colspan="1">2011</td>
<td align="center" valign="top" rowspan="1" colspan="1">6852</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 128</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Steroids</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">adj OR 0.99 (95% CI: 0.90–1.09)</td>
<td align="center" valign="top" rowspan="1" colspan="1">655</td>
<td align="center" valign="top" rowspan="1" colspan="1">2941</td>
<td align="center" valign="top" rowspan="1" colspan="1">2177</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 803</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Magnesium sulphate</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">adj OR 1.01 (95% CI: 0.90–1.14)</td>
<td align="center" valign="top" rowspan="1" colspan="1">435</td>
<td align="center" valign="top" rowspan="1" colspan="1">1216</td>
<td align="center" valign="top" rowspan="1" colspan="1">3161</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 674</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Steroids + magnesium sulphate</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">adj OR 0.79 (95% CI: 0.67–0.93)</td>
<td align="center" valign="top" rowspan="1" colspan="1">276</td>
<td align="center" valign="top" rowspan="1" colspan="1">3320</td>
<td align="center" valign="top" rowspan="1" colspan="1">880</td>
<td align="center" valign="top" rowspan="1" colspan="1">17 100</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Wang et al. 2023 [<a href="#bcpt70090-bib-0042" class="usa-link" aria-describedby="bcpt70090-bib-0042">42</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">China</td>
<td align="center" valign="top" rowspan="1" colspan="1">Case–control</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dexamethasone</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 28 weeks, 28–32 weeks or &gt; 32 weeks</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 1.1 (95% CI: 0.62–1.96)</td>
<td align="center" valign="top" rowspan="1" colspan="1">57</td>
<td align="center" valign="top" rowspan="1" colspan="1">50</td>
<td align="center" valign="top" rowspan="1" colspan="1">242</td>
<td align="center" valign="top" rowspan="1" colspan="1">249</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Dexamethasone + magnesium sulphate</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 28 weeks, 28–32 weeks or &gt; 32 weeks</td>
<td align="center" valign="top" rowspan="1" colspan="1">OR 0.98 (95% CI: 0.61–1.57)</td>
<td align="center" valign="top" rowspan="1" colspan="1">196</td>
<td align="center" valign="top" rowspan="1" colspan="1">249</td>
<td align="center" valign="top" rowspan="1" colspan="1">103</td>
<td align="center" valign="top" rowspan="1" colspan="1">91</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Waters et al. 2008 [<a href="#bcpt70090-bib-0036" class="usa-link" aria-describedby="bcpt70090-bib-0036">36</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">USA</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cohort</td>
<td align="center" valign="top" rowspan="1" colspan="1">Betamethasone or dexamethasone</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Multivariate OR = 0.83 (95% CI: 0.5–1.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">63</td>
<td align="center" valign="top" rowspan="1" colspan="1">417</td>
<td align="center" valign="top" rowspan="1" colspan="1">32</td>
<td align="center" valign="top" rowspan="1" colspan="1">162</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/bcpt70090-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="bcpt70090-note-0002"><p>Abbreviations: ASA: acetylsalicylic acid, ADHD: attention deficit hyperactivity disorder, adjOR: adjusted odds ratio, CI: confidence interval, HR: hazard ratio, HAART: highly active antiretroviral therapy, NSAID: non‐steroidal anti‐inflammatory drug, OR: odds ratio, RCT: randomised controlled trial, RR: risk ratio, USA: United States of America.</p></div></div></section><p>There were four publications from the 2000s, eight from the 2010s and four from the 2020s.</p>
<p>The 21 studies examined a total of 60 drugs from 13 different categories: corticosteroids alone [<a href="#bcpt70090-bib-0032" class="usa-link" aria-describedby="bcpt70090-bib-0032">32</a>, <a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>, <a href="#bcpt70090-bib-0036" class="usa-link" aria-describedby="bcpt70090-bib-0036">36</a>, <a href="#bcpt70090-bib-0041" class="usa-link" aria-describedby="bcpt70090-bib-0041">41</a>, <a href="#bcpt70090-bib-0042" class="usa-link" aria-describedby="bcpt70090-bib-0042">42</a>, <a href="#bcpt70090-bib-0043" class="usa-link" aria-describedby="bcpt70090-bib-0043">43</a>, <a href="#bcpt70090-bib-0044" class="usa-link" aria-describedby="bcpt70090-bib-0044">44</a>, <a href="#bcpt70090-bib-0045" class="usa-link" aria-describedby="bcpt70090-bib-0045">45</a>], magnesium sulphate alone or in combination with corticosteroids [<a href="#bcpt70090-bib-0032" class="usa-link" aria-describedby="bcpt70090-bib-0032">32</a>, <a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>, <a href="#bcpt70090-bib-0040" class="usa-link" aria-describedby="bcpt70090-bib-0040">40</a>, <a href="#bcpt70090-bib-0041" class="usa-link" aria-describedby="bcpt70090-bib-0041">41</a>, <a href="#bcpt70090-bib-0042" class="usa-link" aria-describedby="bcpt70090-bib-0042">42</a>, <a href="#bcpt70090-bib-0047" class="usa-link" aria-describedby="bcpt70090-bib-0047">47</a>], antibiotics [<a href="#bcpt70090-bib-0028" class="usa-link" aria-describedby="bcpt70090-bib-0028">28</a>, <a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>, <a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>, <a href="#bcpt70090-bib-0040" class="usa-link" aria-describedby="bcpt70090-bib-0040">40</a>, <a href="#bcpt70090-bib-0041" class="usa-link" aria-describedby="bcpt70090-bib-0041">41</a>], antimalarials [<a href="#bcpt70090-bib-0027" class="usa-link" aria-describedby="bcpt70090-bib-0027">27</a>, <a href="#bcpt70090-bib-0034" class="usa-link" aria-describedby="bcpt70090-bib-0034">34</a>, <a href="#bcpt70090-bib-0035" class="usa-link" aria-describedby="bcpt70090-bib-0035">35</a>, <a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>], non‐steroidal anti‐inflammatory drugs (NSAIDs) [<a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>, <a href="#bcpt70090-bib-0046" class="usa-link" aria-describedby="bcpt70090-bib-0046">46</a>], antiretrovirals [<a href="#bcpt70090-bib-0029" class="usa-link" aria-describedby="bcpt70090-bib-0029">29</a>], antineoplastic drugs [<a href="#bcpt70090-bib-0030" class="usa-link" aria-describedby="bcpt70090-bib-0030">30</a>], neurological drugs [<a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>], diuretics [<a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>], topical agents [<a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>], attention deficit hyperactivity disorder (ADHD) medication [<a href="#bcpt70090-bib-0037" class="usa-link" aria-describedby="bcpt70090-bib-0037">37</a>], drugs not specified [<a href="#bcpt70090-bib-0038" class="usa-link" aria-describedby="bcpt70090-bib-0038">38</a>].</p>
<p>Twelve [<a href="#bcpt70090-bib-0027" class="usa-link" aria-describedby="bcpt70090-bib-0027">27</a>, <a href="#bcpt70090-bib-0028" class="usa-link" aria-describedby="bcpt70090-bib-0028">28</a>, <a href="#bcpt70090-bib-0029" class="usa-link" aria-describedby="bcpt70090-bib-0029">29</a>, <a href="#bcpt70090-bib-0030" class="usa-link" aria-describedby="bcpt70090-bib-0030">30</a>, <a href="#bcpt70090-bib-0031" class="usa-link" aria-describedby="bcpt70090-bib-0031">31</a>, <a href="#bcpt70090-bib-0032" class="usa-link" aria-describedby="bcpt70090-bib-0032">32</a>, <a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>, <a href="#bcpt70090-bib-0034" class="usa-link" aria-describedby="bcpt70090-bib-0034">34</a>, <a href="#bcpt70090-bib-0035" class="usa-link" aria-describedby="bcpt70090-bib-0035">35</a>, <a href="#bcpt70090-bib-0036" class="usa-link" aria-describedby="bcpt70090-bib-0036">36</a>, <a href="#bcpt70090-bib-0038" class="usa-link" aria-describedby="bcpt70090-bib-0038">38</a>, <a href="#bcpt70090-bib-0042" class="usa-link" aria-describedby="bcpt70090-bib-0042">42</a>] of 21 (57%) studies reported the assessment method used to diagnose hearing loss. The methods included otoacoustic emissions (OAE), transient evoked otoacoustic emissions (TEAOE/TOAE), auditory brainstem response (ABR), automated auditory brainstem response (AABR/A‐BAEP) and pure tone audiometry (Table <a href="#bcpt70090-tbl-0002" class="usa-link">2</a>). In fifteen [<a href="#bcpt70090-bib-0027" class="usa-link" aria-describedby="bcpt70090-bib-0027">27</a>, <a href="#bcpt70090-bib-0030" class="usa-link" aria-describedby="bcpt70090-bib-0030">30</a>, <a href="#bcpt70090-bib-0032" class="usa-link" aria-describedby="bcpt70090-bib-0032">32</a>, <a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>, <a href="#bcpt70090-bib-0034" class="usa-link" aria-describedby="bcpt70090-bib-0034">34</a>, <a href="#bcpt70090-bib-0035" class="usa-link" aria-describedby="bcpt70090-bib-0035">35</a>, <a href="#bcpt70090-bib-0036" class="usa-link" aria-describedby="bcpt70090-bib-0036">36</a>, <a href="#bcpt70090-bib-0037" class="usa-link" aria-describedby="bcpt70090-bib-0037">37</a>, <a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>, <a href="#bcpt70090-bib-0042" class="usa-link" aria-describedby="bcpt70090-bib-0042">42</a>, <a href="#bcpt70090-bib-0043" class="usa-link" aria-describedby="bcpt70090-bib-0043">43</a>, <a href="#bcpt70090-bib-0044" class="usa-link" aria-describedby="bcpt70090-bib-0044">44</a>, <a href="#bcpt70090-bib-0045" class="usa-link" aria-describedby="bcpt70090-bib-0045">45</a>, <a href="#bcpt70090-bib-0046" class="usa-link" aria-describedby="bcpt70090-bib-0046">46</a>, <a href="#bcpt70090-bib-0047" class="usa-link" aria-describedby="bcpt70090-bib-0047">47</a>] of 21 (71%) studies, drug intake was the primary exposure (Table <a href="#bcpt70090-tbl-0003" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="bcpt70090-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Detailed characteristics and methodological features of included studies.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Author, publication year</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Patient recruitment, year of conduct</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Maternal diseases</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Exclusion/matching/adjusting/randomisation method</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Type of hearing loss and method of diagnosis</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Case–control studies</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Azizi et al. 2016 [<a href="#bcpt70090-bib-0038" class="usa-link" aria-describedby="bcpt70090-bib-0038">38</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Newly born infants seen at the social welfare centre of Kermanshah 2013</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exclusion: Missing information in the files, lost‐to‐follow up. Matching: One control selected for each case through a systematic sampling method.</td>
<td align="center" valign="top" rowspan="1" colspan="1">HL or deafness diagnosis based on TEOAE and ABR.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Foch et al. 2018 [<a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">EFEMERIS database 2004–2015</td>
<td align="center" valign="top" rowspan="1" colspan="1">Chronic disease, diseases during pregnancy, congenital infection, diabetes, arterial hypertension and pre‐eclampsia</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exlusion: Gene related deafness, children not attending 24‐month health certificate. Adjustment: Prematurity, gender, congenital infection, ear malformation, birth asphyxia and recurrent otitis at 24 months.</td>
<td align="center" valign="top" rowspan="1" colspan="1">HL diagnosis based on hearing examination on the 24‐month certificate.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Tsao et al. 2023 [<a href="#bcpt70090-bib-0040" class="usa-link" aria-describedby="bcpt70090-bib-0040">40</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Nationwide Taiwan databases, 2002–2015</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Multivariate conditional logistic regression analysis, adjusted for potential confounders (not specified)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Hearing impairment registered as ICD‐9‐CM 389 and 794.15</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Tsao et al. 2024 [<a href="#bcpt70090-bib-0041" class="usa-link" aria-describedby="bcpt70090-bib-0041">41</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Nationwide Taiwan databases, 2004–2015</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Multivariate conditional logistic regression analysis, adjusted for potential confounders (not specified)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Hearing impairment registered as ICD‐9‐CM 389 and 794.15</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Wang et al. 2023 [<a href="#bcpt70090-bib-0042" class="usa-link" aria-describedby="bcpt70090-bib-0042">42</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">West China Second University Hospital, Sichuan University from 2018 to 2020</td>
<td align="center" valign="top" rowspan="1" colspan="1">Premature birth</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>Exlusion: congenital brain defects, neural tube defects, ear malformations or family history of hereditary deafness. Matching: difference in GA between case and control group was within 1 week and IVF or no IVF was performed at</p>
<p>the same time. Adjustment: age of the mother, chorioamnionitis, treatment with antenatal magnesium sulphate.</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Hearing screening failure, defined as hearing level exceeded 30 dB NHL in one or two ears during AABR.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Cohort studies</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Bang Madsen et al. 2023 [<a href="#bcpt70090-bib-0037" class="usa-link" aria-describedby="bcpt70090-bib-0037">37</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Data from Danish nationwide registers, 1998–2015</td>
<td align="center" valign="top" rowspan="1" colspan="1">ADHD</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exclusion: missing/unlikely gestational age, chromosomal abnormalitis, missing paternal links, mothers prescribing other psychotropic medications, mothers with only one prescribed ADHD medication. Adjustment: maternal age, parity, maternal psychiatric history, in‐ or outpatient admission to psychiatric ward within 2 years prior to pregnancy and until delivery, use of other psychotropic medications during pregnancy, number of hospitalisations during pregnancy not related to psychiatry, smoking during pregnancy, living alone, education, birthyear and psychiatric history of the father.</td>
<td align="center" valign="top" rowspan="1" colspan="1">ICD‐codes H90, H91.0, H91.8, H91.9, H93.2, Z03.7A</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Borba et al. 2004 [<a href="#bcpt70090-bib-0027" class="usa-link" aria-describedby="bcpt70090-bib-0027">27</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Data from structured questionnaires and medical records of children of patients with SLE at the Rheumatology Division of University of Sao Paulo.</td>
<td align="center" valign="top" rowspan="1" colspan="1">SLE</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exclusion: history of recurrent otitis, acoustic trauma or ototoxic antibiotic treatment (aminoglycosides, macrolides, furosemide, ethacrynic acid and acetyl salicylic acid), no exposure during first trimester, children &lt; 4 years of age.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Sensorineural HL diagnosis based on PTA including analysis of high‐frequency and low‐frequency PTA.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Fakhim et al. 2010 [<a href="#bcpt70090-bib-0028" class="usa-link" aria-describedby="bcpt70090-bib-0028">28</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">High risk infants selected from ICU ward of Kodakan, Alzahra and Talegani hospitals, low risk infants selected from women hospitals (not specified), 2004–2006</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exclusion: not specified, infants with blood bilirubin moren than 20 mg/dL or requiring blood exchange possibly excluded.</td>
<td align="center" valign="top" rowspan="1" colspan="1">All with a risk score (including in utero drug exposure) were screened with OAE. In case of impairment, the children were treated with antibiotics for two weeks and a second OAE was performed. In case of continuous impairment, ABR was performed and diagnosis of HL was given if hearing treshold was &gt; 30 dB at ABR in one ear. If the child had blood bilirubin &gt; 20 mg/dL or required blood exchange, ABR was done initially.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Fasunla et al. 2014 [<a href="#bcpt70090-bib-0029" class="usa-link" aria-describedby="bcpt70090-bib-0029">29</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Newborns at the postnatal HIV clinics at the University College Hospital, Ibadan and Adeoyo Maternity Hospital, 2012–2013</td>
<td align="center" valign="top" rowspan="1" colspan="1">HIV</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exclusion: stillborn, unhealthy child at 1 month old.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Sensorineural HL diagnosis based on ABR.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Finch et al. 2021 [<a href="#bcpt70090-bib-0030" class="usa-link" aria-describedby="bcpt70090-bib-0030">30</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">The Cancer and Pregnancy Registry enrolling pregnant women with cancer, 1995–2018</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exclusion: women diagnosed with cancer within the first year after giving birth, temporary hearing issues secondary to ear canal fluid or recurrent otitis media.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Sensorineural HL diagnosis (according to the Clark classification of HL) based on initial screening with OAE. After failing OAE, AABR was conducted to classify the level of HL.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Gazia et al. 2019 [<a href="#bcpt70090-bib-0031" class="usa-link" aria-describedby="bcpt70090-bib-0031">31</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">NICU infants at The Department of Audiology of Palermo University, 2010—unknown end date</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not specified</td>
<td align="center" valign="top" rowspan="1" colspan="1">Matching: for age and gender.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Sensorineural HL diagnosis based on ABR (treshold &gt; 40 dB), TEOAE and tympanometry.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Kasapoglu et al. 2020 [<a href="#bcpt70090-bib-0032" class="usa-link" aria-describedby="bcpt70090-bib-0032">32</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Medical records of preterm infants at a tertiary university hospital, 2015–2017</td>
<td align="center" valign="top" rowspan="1" colspan="1">Indications: neuroprotection, tocolysis or prophylaxis for eclampsia</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exclusion: newborns with history of intrauterine infections, lethal congenital abnormalities, craniofacial anomalies and newborns dying after birth. Adjustment: GA at delivery, magnesium sulphate and betamethasone.</td>
<td align="center" valign="top" rowspan="1" colspan="1">HL defined as pass/fail ABR (Madsen Accuscreen). If stimulus to produce a response did not exceed 30 dB in both ears, they passed.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Leung et al. 2016 [<a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Medical records of preterm neonates from the NICUs of University of Maryland Medical Centre and Mercy Medical Centre, 1999–2003</td>
<td align="center" valign="top" rowspan="1" colspan="1">For Betamethasone and Magnesium Sulphate: Premature birth, preeclampsia/eclampsia. For antibiotics: Group B streptococcus, latency, suspected chorioamnionitis and maternal infection</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exclusion: Congenital brain/neural tube defects, congenital infections, no available cord blood or venous sample within 12 h of birth. Adjustment: for GA.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Initial screening with AABR (treshold &gt; 30 dB). If failed screen, AABR repeated. HL defined as two AABR screen failures in one or both ears.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Patatt et al. 2021 [<a href="#bcpt70090-bib-0034" class="usa-link" aria-describedby="bcpt70090-bib-0034">34</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Interviews and records from medical files, HBAP NHS database, Clinica Limiar database, the newborn's vaccination card, the pregnant woman's card and data collection form used to include and study patients from HBAP and Clíníca de Avaliacao e Reabilitacao da Audicao—Limiar, 2014–2015</td>
<td align="center" valign="top" rowspan="1" colspan="1">Malaria (
<em>P. vivax</em>
 and P. falciparum)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exclusion: newborns with other risk indicators for HL, non‐Brazilian mothers, birth at the hospital, not complete follow‐up, not recieving prenatal care, not participating in the hearing screening program and no consent.</td>
<td align="center" valign="top" rowspan="1" colspan="1">HL diagnosis based on initial TEOAE testing of newborns and retesting after 15 days if initial TEOAE failed. Newborns of mothers who recieved antimalarial drugs and newborns who failed the second TEOAE was tested with A‐BAEP.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Silva et al. 2015 [<a href="#bcpt70090-bib-0035" class="usa-link" aria-describedby="bcpt70090-bib-0035">35</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Data from medical records and/or interviews through a NHS program conductet at a tertiary referral hospital including high‐risk pregnant women and newborns at high risk, 2011–2013</td>
<td align="center" valign="top" rowspan="1" colspan="1">Malaria (plasmodium vivax and plasmodium falciparum)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exclusion: children not completing the NHS program, if variables of interest abscent, if communication difficulties with parents, parent/guardians not signing a consent form. Matching: GA, birth weight, risk factors for HL in childhood (toxoplasmosis, rubella, CMV, herpes, syphilis and family history of HL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">HL based on screening with TOAE for low risk newborns those without (RFHL, such as toxoplasmosis, rubella, CMV, herpes, syphilis, newborns of women recieving antimalaria drugs during pregnancy and family history of HL in childhood) and combined TOAE/AABR for those with RFHL. HL defined as probability of HL due to fail in hearing screening.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Soraisham et al. 2011 [<a href="#bcpt70090-bib-0046" class="usa-link" aria-describedby="bcpt70090-bib-0046">46</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Data from maternal charts, a regional NICU, 2000–2003</td>
<td align="center" valign="top" rowspan="1" colspan="1">Premature birth</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exclusion: stillborn, children dying after birth, loss to follow up, children with birth weight &gt; 1250 g and GA &lt; 28 weeks, children with major congenital or chromosomal anomalies, no neurodevelopmental assessment, no consent. Adjustment: GA, surgical PDA ligation, IVH, BPD and postnatal steroid use.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Sensorineural HL diagnosis based on examination by an audiologist. Deafness defined as sensorineural HL requiring amplification.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Waters et al. 2008 [<a href="#bcpt70090-bib-0036" class="usa-link" aria-describedby="bcpt70090-bib-0036">36</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Neonatal database at Christiana Hospital, July 1998–July 2004</td>
<td align="center" valign="top" rowspan="1" colspan="1">Infants &lt; 1500 g</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exclusion: infants with a partial/inadequate exam, patients reviecing only partial therapy or more than one course of steroids, infants labelled as ‘suspect’ on OAE. Adjusting: multivariate analysis with logistic regression performed to control for confounding variables.</td>
<td align="center" valign="top" rowspan="1" colspan="1">HL defined as ‘fail’ on OAE.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Randomised controlled trials</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Asztalos et al. 2013 [<a href="#bcpt70090-bib-0043" class="usa-link" aria-describedby="bcpt70090-bib-0043">43</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Participating centres, enrollment 2001–2006 and follow‐up 2006–2012</td>
<td align="center" valign="top" rowspan="1" colspan="1">Risk of preterm birth</td>
<td align="center" valign="top" rowspan="1" colspan="1">Central randomisation with stratification according to centre and GA at enrollment. Exclusion: GA not 25–32 weeks, women not remaining pregnant 14–21 days following therapy, women not remaining at risk of preterm birth after therapy and lost‐to‐follow up.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Deafness.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Crowther et al. 2007 [<a href="#bcpt70090-bib-0044" class="usa-link" aria-describedby="bcpt70090-bib-0044">44</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Newborns of women in ACTORDS trial</td>
<td align="center" valign="top" rowspan="1" colspan="1">Risk of preterm delivery</td>
<td align="center" valign="top" rowspan="1" colspan="1">Women randomly assigned through a central telephone randomisation service with stratification according to centre, GA and number of foetuses. Adjustment: GA at trial entry, antepartum haemorrhage and preterm prelabour rupture of the membranes. Exclusion: stilborn, children dying before discharge, children dying before follow‐up and no paediatric/psychological examination.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Deafness defined as requirement of hearing aids at follow‐up at 2 years corrected age.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Crowther et al. 2019 [<a href="#bcpt70090-bib-0045" class="usa-link" aria-describedby="bcpt70090-bib-0045">45</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Data from medical records, examination by paediatrics and questionnaires, 14 maternity hospitals that provide care for preterm babies, 2009–2013</td>
<td align="center" valign="top" rowspan="1" colspan="1">Risk of preterm birth</td>
<td align="center" valign="top" rowspan="1" colspan="1">Randomised through a central randomisation service. Adjustment: for hospital, GA at entry, number of foetuses, language spoken at home, mother's education, gender of child. Exclusion: Contraindications to antenatal corticosteroids, no consent, chorioamnionitis, women already recieved antenatal corticosteroids in second stage or labour, known fetal lung maturation, dead child before discharge and dead child before follow‐up.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Deafness defined as requirement of hearing aids or worse at 2 years corrected age.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">The MAGPIE follow up trial. 2006 [<a href="#bcpt70090-bib-0047" class="usa-link" aria-describedby="bcpt70090-bib-0047">47</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Data from questionnaires filled by a health professional (shortened if language or culture demanded it) filled at clinic or at home visit, register data from UK cases on pregnant women from 125 centres in 19 countries in Africa, Asia, North‐ and South America and Europe, 1998–2001</td>
<td align="center" valign="top" rowspan="1" colspan="1">Pre‐eclampsia</td>
<td align="center" valign="top" rowspan="1" colspan="1">Randomly assigned participants. Exclusion: stillborn, lost‐to‐follow up (no response or died). Adjustment: GA, maternal anticonvulsant before trial entry, gender of the child, women with multiple pregnancies and children admitted to a special care baby unit.</td>
<td align="center" valign="top" rowspan="1" colspan="1">HL defined as requirement of hearing aids.</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/bcpt70090-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="bcpt70090-note-0003"><p>Abbreviations: ABR: auditory brainstem response, AABR: automated auditory brainstem response, ADHD: attention deficit hyperactivity disorder, A‐BAEP: automated brainstem auditory evoked potential, BPD: bronchopulmonary dysplasia, CMV: cytomegalovirus, dB: decibel, GA: gestational age, HL: hearing loss, HIV: human immunodeficiency virus, ICD: international classification of diseases, IVH: intraventricular haemorrhage, IVF: in vitro fertilisation, ICU: intensive care unit, NHL: normal hearing level, NHS: newborn hearing screening, NICU: neonatal intensive care unitOAE: otoacoustic emission, PDA: patent ductus arteriosus, PTA: pure tone audiometry, RFHL: risk factors for hearing loss, SLE: systemic lupus erythematosus, TEOAE: transient evoked otoacoustic emission, UK: United Kingdom.</p></div></div></section><section class="tw xbox font-sm" id="bcpt70090-tbl-0003"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Critical appraisal and quality assessment of included studies.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Author</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Limitations presented by the study authors</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Other shortcomings of the study</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">CEBM levels of evidence (max = 1, min = 5)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">NOS (min = 0, max = 9) /ROB2 scaling</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Was drug exposure the primarily investigated exposure</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Case–control studies</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Azizi et al. 2016 [<a href="#bcpt70090-bib-0038" class="usa-link" aria-describedby="bcpt70090-bib-0038">38</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">False positive cases.</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Unclear whether all cases and controls are examined by same methods (TEOAE and ABR). TEOAE conducted at different time points (early birth, first month, first to third month, third month onward). 375 children considered as cases after initial TEOAE screening, although only 72 children had HL/deafness after repeated examination (the method of repetition not specified).</p>
<p>•The authors have defined the study as a cross‐sectional study, but the study design suggests that it is a case–control study. The cases and controls have hovewer not been matched and potential confounders have not been adjusted for in the analysis.</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>5</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>1</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Foch et al. 2018 [<a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>]</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Database does not contain information on type or degree of HL.</p>
<p>• Risk factors for HL (gene mutations, family history, hyperbilirubinaemia) not systematically recorded.</p>
<p>• Only prescribed and dispensed drugs taken into account—over‐the‐counter drugs dispensed during hospitalisation not taken into account.</p>
<p>• No information on the mothers' compliance.</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Age at diagnosis (2 years) may be too early to diagnose all with HL.</p>
<p>• No systematic distinguish between sensorineural and conductive HL.</p>
<p>• Method of diagnosis is described as ‘hearing examination on the 24‐month certificate’ but not further specified.</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>4</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>9</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Tsao et al. 2023 [<a href="#bcpt70090-bib-0040" class="usa-link" aria-describedby="bcpt70090-bib-0040">40</a>]</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>•Retrospective, observational study based on a large population database with risk of introducung selection bias.</p>
<p>•Uses ICD‐9‐CM codes, which lack specificity regarding labouratory data, disease severity, HL subtypes.</p>
<p>•Possible underestimation of genetic components due to the expenses of genetic testing.</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Method of diagnosis of HL not reported but based on ICD‐codes, which might underestimate the true number of children with HL.</p>
<p>• Gentamicin and Furosemid reported as one category.</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>4</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>5</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Tsao et al. 2024 [<a href="#bcpt70090-bib-0041" class="usa-link" aria-describedby="bcpt70090-bib-0041">41</a>]</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>•Retrospective, observational study based on a large population database with risk of introducung selection bias.</p>
<p>•Majority of cases are Asian.</p>
<p>•Used ICD‐9‐CM codes, which lack specificity regarding severity of morbidities associated with preterm birth and other diseases.</p>
<p>•No information on incidence of uni−/bilateral HL and outcome data.</p>
<p>•Possible underestimation of genetic components.</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>•Method of diagnosis of HL not reported but based on ICD‐codes, which might underestimate the true number of children with HL.</p>
<p>•Gentamicin and Furosemid reported as one category.</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>4</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>5</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Wang et al. 2023 [<a href="#bcpt70090-bib-0042" class="usa-link" aria-describedby="bcpt70090-bib-0042">42</a>]</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>•The study can not exclude the effect of abnormal hearing screening due to incomplete development of the newborn on HL.</p>
<p>•The study did not explore the effect of antenatal steroid use of different doses on development of HL.</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">• Age at diagnosis was from 48 h after birth to before discharge from NICU, which is too early to diagnose all with HL and will include both false positives and false negatives.</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>4</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>6</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Cohort studies</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Bang Madsen et al. 2023 [<a href="#bcpt70090-bib-0037" class="usa-link" aria-describedby="bcpt70090-bib-0037">37</a>]</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>•Low number of antenatally exposed children and sample size insufficient to evaluate associations for different types of drugs.</p>
<p>•Based on registry data and cannot include subclinical conditions and does not contain information on alcohol or illegal drug use.</p>
<p>•Risk of misclassification when using redeemed prescriptions to define status of exposure.</p>
<p>•Did not include doses of ADHD medication, which can underestimate exposure time.</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">• Method of diagnosis of HL not reported but based on ICD‐codes, which might underestimate the true number of children with HL.</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>3</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>8</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Borba et al. 2004 [<a href="#bcpt70090-bib-0027" class="usa-link" aria-describedby="bcpt70090-bib-0027">27</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">None presented.</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Inclusion criteria for outcome was age above 4, which could lead to survival bias.</p>
<p>• Small study size, only <em>n</em> = 9 in exposed and <em>n</em> = 10 in non‐exposed group and no children with HL in either group.</p>
<p>• No adjustment for several potential confounders (GA, familiar disposition, perinatal asphyxia, NICU stay, hyperbilirubinaemia, intrauterine infections or genetic HL).</p>
<p>• Four of nine mothers in the exposed group discountinued their drugs during pregnancy but no detailed information on durage of drug use.</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>3</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>5</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Fakhim et al. 2010 [<a href="#bcpt70090-bib-0028" class="usa-link" aria-describedby="bcpt70090-bib-0028">28</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">None presented.</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• No information on age of diagnosis.</p>
<p>• High‐risk and low‐risk infants selected from two different centres, potentially leading to selection bias.</p>
<p>• Small study size of exposed group (<em>n</em> = 18). No information on or adjustment for several potential confounders (GA, familiar disposition, perinatal asphyxia, NICU stay, postnatal aminoglycoside use, intrauterine infections or genetical HL).</p>
<p>• All infants with impaired initial OAE have been treated with unspecified antibiotics for 2 weeks but a possible causal relationship between postnatal antibiotic treatment and HL has not been taken into account.</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>5</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>2</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Fasunla et al. 2014 [<a href="#bcpt70090-bib-0029" class="usa-link" aria-describedby="bcpt70090-bib-0029">29</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">No data on toxoplasmosis, CMV and rubella. Small study.</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Age at diagnoses (2.87 years +/−1.05 years) may be too early to diagnose all with HL.</p>
<p>• Study size not reported.</p>
<p>• The study mainly investigates differences in outcomes in newborns of HIV exposed and HIV non‐exposed mothers, but they also compare the hearing of newborns in the treated vs. non‐treated HIV exposed group. There is therefore no control group of mothers without HIV. Unhealthy children at 1‐month old were excluded, potentially leading to both selection and information bias.</p>
<p>• No information on or adjustment for potential confounders (familiar disposition, perinatal asphyxia, NICU stay, hyperbilirubinaemia, postnatal aminoglycoside use, intrauterine infections and genetic HL).</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>3</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>3</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Finch et al. 2021 [<a href="#bcpt70090-bib-0030" class="usa-link" aria-describedby="bcpt70090-bib-0030">30</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">None presented.</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Small study (<em>n</em> = 19, <em>n</em> = 11, <em>n</em> = 13 exposed, respectively).</p>
<p>• Three of the 4 newborns that failed the initialt screening with OAE had a normal AABR but were still included as HLcases.</p>
<p>• No information on or adjustment for potential confounders (familiar disposition, perinatal asphyxia, NICU stay, hyperbilirubinaemia, postnatal aminoglycoside use, intrauterine infections and genetic HL).</p>
<p>• The majority of this study is descriptive.</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>3</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>5</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Gazia et al. 2019 [<a href="#bcpt70090-bib-0031" class="usa-link" aria-describedby="bcpt70090-bib-0031">31</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">None presented.</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Age at diagnosis was 4–20 weeks at first diagnostic ABR and may be too early to diagnose all with HL.</p>
<p>• Only few included in exposed group (<em>n</em> = 18).</p>
<p>• Sample includes only NICU infants, who have an apriori higher risk of HL.</p>
<p>• No information on or adjustment for potential confounders (familiar disposition, perinatal asphyxia, hyperbilirubinaemia, postnatal aminoglycoside use, intrauterine infections and genetic HL).</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>3</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>4</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Kasapoglu et al. 2020 [<a href="#bcpt70090-bib-0032" class="usa-link" aria-describedby="bcpt70090-bib-0032">32</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Suggest larger and well‐designed studies for future research.</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Age at diagnosis was newborn stage, which may be too early to diagnose all with HL.</p>
<p>• Only few included in exposed group (<em>n</em> = 19). Only preterm newborns, who have an apriori higher risk of HL, are included and the results can therefore not be extrapolated to general population.</p>
<p>• No adjustment made for several potential confounders (familiar disposition, perinatal asphyxia, hyperbilirubinaemia, postnatal aminoglycoside use or genetic HL).</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>3</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>5</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Leung et al. 2016 [<a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Lack of follow‐up confirmation of hearing screen results. Only studies a high‐risk population (premature infants).</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Age of diagnosis was prior to discharge from NICU, which may be too early to diagnose all with HL.</p>
<p>• Study size only reported for exposed group.</p>
<p>• Only children at NICU, who have an apriori higher risk of HL, are included and the results can therefore not be extrapolated to general population.</p>
<p>• No information of or adjustment for several confounders (familiar disposition, perinatal asphyxia, hyperbilirubinaemia or genetic HL).</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>3</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>6</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Patatt et al. 2021 [<a href="#bcpt70090-bib-0034" class="usa-link" aria-describedby="bcpt70090-bib-0034">34</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Change of study design to case–control more appropriate because of low incidence of malaria infection in pregnancy.</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Age of diagnosis was before or up to 22 days after discharge, which may be too early to diagnose all with HL.</p>
<p>• Only few included in the exposed group (<em>n</em> = 32).</p>
<p>• All exposed mothers' children were tested with A‐BAEP, but only the children in the non‐exposed group who failed the TEOAE twice was tested with A‐BAEP, which could lead to information bias.</p>
<p>• No adjustment made for GA.</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>3</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>5</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Silva et al. 2015 [<a href="#bcpt70090-bib-0035" class="usa-link" aria-describedby="bcpt70090-bib-0035">35</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">None presented.</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• No information on age of diagnosis.</p>
<p>• Only few included in exposed group (<em>n</em> = 30).</p>
<p>• The data is collected from newborns at a high‐risk centre, and the results can therefore not be extrapolated to general population.</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>3</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>2</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Soraisham et al. 2011 [<a href="#bcpt70090-bib-0046" class="usa-link" aria-describedby="bcpt70090-bib-0046">46</a>]</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Retrospective study, risk of selection bias.</p>
<p>• Pregnancy induced hypertension significantly higher in non‐exposed group (indomethacin).</p>
<p>• No data on use of magnesium sulphate.</p>
<p>• Mothers not recieving indomethacin might have presented with advanced preterm labour or delivered due to maternal or fetal indications.</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Age of diagnosis was 30–42 months, which may be too early to diagnose all with HL.</p>
<p>• Only preterm newborns, who have an apriori higher risk of HL, are included and the results can therefore not be extrapolated to general population.</p>
<p>• No adjustment made for several confounders (GA, familiar disposition, perinatal asphyxia, hyperbilirubinaemia, postnatal aminoglycoside use, intrauterine infections and genetic HL).</p>
<p>• Some pregnant women in the exposed‐ and non‐exposed groups have also been exposed to antihypertensive drugs and steroids but the results are not adjusted for intake of these or other drugs.</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>4</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>5</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Waters et al. 2008 [<a href="#bcpt70090-bib-0036" class="usa-link" aria-describedby="bcpt70090-bib-0036">36</a>]</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>•Limited power to detect small changes in failed hearing screen bas on exposure due to small study size.</p>
<p>•Not possible to control for all confounders, including family history of HL, aminoglycoside og diuretic usage.</p>
<p>•Outcome based on OAE results, which is only a screening test.</p>
<p>•Exposure was limited to only single course or no course administration.</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Study only based on a single hospital database.</p>
<p>•Age at diagnosis was prior to discharge from the NICU, which is too early to diagnose all children with HL.</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>3</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>5</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td colspan="2" align="left" valign="top" rowspan="1">Randomised controlled trials</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Asztalos et al. 2013 [<a href="#bcpt70090-bib-0043" class="usa-link" aria-describedby="bcpt70090-bib-0043">43</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Analysis not prespecified in the study.</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Age of diagnosis was before or after 2 years, which may be too early to diagnose all with HL.</p>
<p>• The authors calculate no estimates for the risk of the investigated drug on HL but only all neuromotor disabilities.</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>2</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Some concerns</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Crowther et al. 2007 [<a href="#bcpt70090-bib-0044" class="usa-link" aria-describedby="bcpt70090-bib-0044">44</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Neurosensory examination in 2 years of age may be too early for detecting HL and need follow‐up later on.</td>
<td align="left" valign="top" rowspan="1" colspan="1">• Age of diagnosis was 2 years, which may be too early to diagnose all with HL.</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>2</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Some concerns</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Crowther et al. 2019 [<a href="#bcpt70090-bib-0045" class="usa-link" aria-describedby="bcpt70090-bib-0045">45</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Data not collected on the use of postnatal corticosteroids and might have differed in the exposed vs. non‐exposed group.</td>
<td align="left" valign="top" rowspan="1" colspan="1">• Age of diagnosis was 2 years or before, which may be too early to diagnose all with HL.</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>2</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Low risk</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">The MAGPIE Follow Up Trial. 2006 [<a href="#bcpt70090-bib-0047" class="usa-link" aria-describedby="bcpt70090-bib-0047">47</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Use of several different assessment tools, some neurodevelopmental assesments not complete, not all childrenf from the primary study included in this follow‐up study (those included were usually more low risk. Those excluded usually from families in countries with high PNM).</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>• Age of diagnosis was 18 months, which may be too early to diagnose all with HL.</p>
<p>• Lost‐to‐follow up was predominantly in developing countries.</p>
<p>• Only one exposed was deaf.</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>2</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">High risk</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/bcpt70090-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="bcpt70090-note-0004"><p>Abbreviations: ABR: auditory brainstem response, ADHD: attention deficit hyperactivity disorder, AABR: automated auditory brainstem response, A‐BAEP: automated brainstem auditory evoked potential, PNM: perinatal mortalityCEBM: Centre for Evidence‐Based Medicine, CMV: cytomegalovirus, GA: gestational age, HL: hearing loss, HIV: human immunodeficiency virus, ICD: international classification of diseases, NDS: Newcastle‐Ottawa Scale, NICU: neonatal intensive care unit, OAE: otoacoustic emission, RoB2: Risk of Bias 2, TEOAE: transient evoked otoacoustic emission.</p></div></div></section><p>The age at hearing loss diagnosis was provided in 18 studies [<a href="#bcpt70090-bib-0027" class="usa-link" aria-describedby="bcpt70090-bib-0027">27</a>, <a href="#bcpt70090-bib-0029" class="usa-link" aria-describedby="bcpt70090-bib-0029">29</a>, <a href="#bcpt70090-bib-0030" class="usa-link" aria-describedby="bcpt70090-bib-0030">30</a>, <a href="#bcpt70090-bib-0031" class="usa-link" aria-describedby="bcpt70090-bib-0031">31</a>, <a href="#bcpt70090-bib-0032" class="usa-link" aria-describedby="bcpt70090-bib-0032">32</a>, <a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>, <a href="#bcpt70090-bib-0034" class="usa-link" aria-describedby="bcpt70090-bib-0034">34</a>, <a href="#bcpt70090-bib-0036" class="usa-link" aria-describedby="bcpt70090-bib-0036">36</a>, <a href="#bcpt70090-bib-0038" class="usa-link" aria-describedby="bcpt70090-bib-0038">38</a>, <a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>, <a href="#bcpt70090-bib-0040" class="usa-link" aria-describedby="bcpt70090-bib-0040">40</a>, <a href="#bcpt70090-bib-0041" class="usa-link" aria-describedby="bcpt70090-bib-0041">41</a>, <a href="#bcpt70090-bib-0043" class="usa-link" aria-describedby="bcpt70090-bib-0043">43</a>, <a href="#bcpt70090-bib-0044" class="usa-link" aria-describedby="bcpt70090-bib-0044">44</a>, <a href="#bcpt70090-bib-0045" class="usa-link" aria-describedby="bcpt70090-bib-0045">45</a>, <a href="#bcpt70090-bib-0046" class="usa-link" aria-describedby="bcpt70090-bib-0046">46</a>, <a href="#bcpt70090-bib-0047" class="usa-link" aria-describedby="bcpt70090-bib-0047">47</a>] and ranged from a non‐specified age (‘newborn’) to 11 years of age.</p></section><section id="bcpt70090-sec-0024"><h3 class="pmc_sec_title">3.3. Summary of Effect Estimates</h3>
<p>An OR or adjusted OR estimate together with 95% confidence intervals was reported for 37 drugs or drug combinations (adjusted factors are presented in Table <a href="#bcpt70090-tbl-0002" class="usa-link">2</a>). Additionally, the OR for 16 drugs in 10 studies [<a href="#bcpt70090-bib-0027" class="usa-link" aria-describedby="bcpt70090-bib-0027">27</a>, <a href="#bcpt70090-bib-0028" class="usa-link" aria-describedby="bcpt70090-bib-0028">28</a>, <a href="#bcpt70090-bib-0030" class="usa-link" aria-describedby="bcpt70090-bib-0030">30</a>, <a href="#bcpt70090-bib-0034" class="usa-link" aria-describedby="bcpt70090-bib-0034">34</a>, <a href="#bcpt70090-bib-0035" class="usa-link" aria-describedby="bcpt70090-bib-0035">35</a>, <a href="#bcpt70090-bib-0037" class="usa-link" aria-describedby="bcpt70090-bib-0037">37</a>, <a href="#bcpt70090-bib-0038" class="usa-link" aria-describedby="bcpt70090-bib-0038">38</a>, <a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>, <a href="#bcpt70090-bib-0043" class="usa-link" aria-describedby="bcpt70090-bib-0043">43</a>, <a href="#bcpt70090-bib-0046" class="usa-link" aria-describedby="bcpt70090-bib-0046">46</a>] could be calculated using the reported numbers of exposed and non‐exposed cases and controls. A RR estimate together with 95% confidence intervals was reported in two publications for two drug or drug combinations. Results for all studies are summarised in Table <a href="#bcpt70090-tbl-0001" class="usa-link">1</a>. Whenever ORs were reported or calculated, they were used to perform a meta‐analysis, which was visually displayed using forest plots using the software package R and a random‐effects model.</p></section><section id="bcpt70090-sec-0025"><h3 class="pmc_sec_title">3.4. Drug‐Specific Meta‐Analyses</h3>
<section id="bcpt70090-sec-0026"><h4 class="pmc_sec_title">3.4.1. Studies on Magnesium Sulphate and/or Systemic Steroids</h4>
<p>The overall effect estimate of the meta‐analysis on magnesium sulphate with or without steroids was OR 0.65 (95% CI: 0.42–1.00) in favour of magnesium sulphate or magnesium sulphate in combination with steroids [<a href="#bcpt70090-bib-0032" class="usa-link" aria-describedby="bcpt70090-bib-0032">32</a>, <a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>, <a href="#bcpt70090-bib-0041" class="usa-link" aria-describedby="bcpt70090-bib-0041">41</a>, <a href="#bcpt70090-bib-0042" class="usa-link" aria-describedby="bcpt70090-bib-0042">42</a>, <a href="#bcpt70090-bib-0047" class="usa-link" aria-describedby="bcpt70090-bib-0047">47</a>] (Figure <a href="#bcpt70090-fig-0002" class="usa-link">2</a>). The overall effect estimate of the meta‐analysis on betamethasone and systemic corticosteroids given alone was OR 0.86 (95% CI: 0.69–1.08) in favour of systemic corticosteroids [<a href="#bcpt70090-bib-0032" class="usa-link" aria-describedby="bcpt70090-bib-0032">32</a>, <a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>, <a href="#bcpt70090-bib-0036" class="usa-link" aria-describedby="bcpt70090-bib-0036">36</a>, <a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>, <a href="#bcpt70090-bib-0041" class="usa-link" aria-describedby="bcpt70090-bib-0041">41</a>, <a href="#bcpt70090-bib-0043" class="usa-link" aria-describedby="bcpt70090-bib-0043">43</a>, <a href="#bcpt70090-bib-0044" class="usa-link" aria-describedby="bcpt70090-bib-0044">44</a>] (Figure <a href="#bcpt70090-fig-0003" class="usa-link">3</a>). One study found an adjusted OR of 1.16 (95% CI: 0.62–2.16) for dexamethasone compared to betamethasone [<a href="#bcpt70090-bib-0045" class="usa-link" aria-describedby="bcpt70090-bib-0045">45</a>].</p>
<figure class="fig xbox font-sm" id="bcpt70090-fig-0002"><h5 class="obj_head">FIGURE 2.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01bf/12375940/0ba2fd713e77/BCPT-137-0-g005.jpg" loading="lazy" id="jats-graphic-3" height="544" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/bcpt70090-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Forest plot of odds ratios for magnesium sulphate alone or in combination with systemic steroids and congenital hearing loss. Studies included in the forest plots reported either an OR or an adjusted OR and 95% confidence intervals, or these could be calculated using reported raw numbers. Numbers in parentheses correspond to individual study identifiers. OR: odds ratio. CI: confidence interval. NI: no information.</p></figcaption></figure><figure class="fig xbox font-sm" id="bcpt70090-fig-0003"><h5 class="obj_head">FIGURE 3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01bf/12375940/d2cddfbbe3b6/BCPT-137-0-g001.jpg" loading="lazy" id="jats-graphic-5" height="513" width="709" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/bcpt70090-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Forest plot for systemic steroids where an OR or an adjusted OR and 95% confidence intervals were reported or could be calculated using reported raw numbers. Numbers in parentheses correspond to individual study identifiers. OR: odds ratio. CI: confidence interval.</p></figcaption></figure></section><section id="bcpt70090-sec-0027"><h4 class="pmc_sec_title">3.4.2. Studies on Acetylic Salicylic Acid and Other NSAIDs</h4>
<p>We identified only two studies on NSAIDs including acetylsalicylic acid (ASA). Foch et al. [<a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>] first studied the association for antithrombotics as a group and found an overall OR of 1.42 (95% CI: 1.02–1.99). In a subgroup analysis, they found an OR of 1.53 (95% CI: 1.12–2.11) for a daily dosage of ASA ≤ 300 mg and an OR of 1.00 (95% CI: 0.81–1.12) for a daily dosage of ASA &gt; 300 mg and other NSAIDs. An OR of 1.32 (95% CI: 0.27–6.49) for indomethacin was calculated using the numbers reported in the study of Soraisham et al. [<a href="#bcpt70090-bib-0046" class="usa-link" aria-describedby="bcpt70090-bib-0046">46</a>]; a meta‐analysis of ASA and NSAIDs at all doses yields an overall point estimate of OR 1.21 (95% CI: 0.87–1.68) (Figure <a href="#bcpt70090-fig-0004" class="usa-link">4</a>).</p>
<figure class="fig xbox font-sm" id="bcpt70090-fig-0004"><h5 class="obj_head">FIGURE 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01bf/12375940/542fa97e772c/BCPT-137-0-g003.jpg" loading="lazy" id="jats-graphic-7" height="458" width="709" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/bcpt70090-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Forest plot for acetylsalicylic acid and other NSAIDs where an OR or an adjusted OR and 95% confidence intervals were either reported or could be calculated using reported numbers. Numbers in parentheses correspond to individual study identifiers. OR: odds ratio. CI: confidence interval.</p></figcaption></figure></section><section id="bcpt70090-sec-0028"><h4 class="pmc_sec_title">3.4.3. Studies on Antibiotics</h4>
<p>Six studies investigated the relationship between antenatally administered antibiotics and CHL in children. A number of antibiotics in pregnancy indicated a possible association with HL. A meta‐analysis of all antibiotics together yielded an overall point estimate of OR 1.23 (95% CI: 0.97–1.57) [<a href="#bcpt70090-bib-0028" class="usa-link" aria-describedby="bcpt70090-bib-0028">28</a>, <a href="#bcpt70090-bib-0031" class="usa-link" aria-describedby="bcpt70090-bib-0031">31</a>, <a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>, <a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>, <a href="#bcpt70090-bib-0040" class="usa-link" aria-describedby="bcpt70090-bib-0040">40</a>, <a href="#bcpt70090-bib-0041" class="usa-link" aria-describedby="bcpt70090-bib-0041">41</a>] (Figure <a href="#bcpt70090-fig-0005" class="usa-link">5</a>).</p>
<figure class="fig xbox font-sm" id="bcpt70090-fig-0005"><h5 class="obj_head">FIGURE 5.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01bf/12375940/4fa42e68c573/BCPT-137-0-g002.jpg" loading="lazy" id="jats-graphic-9" height="797" width="709" alt="FIGURE 5"></p>
<div class="p text-right font-secondary"><a href="figure/bcpt70090-fig-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Forest plot for antibiotics where an OR or an adjusted OR and 95% confidence intervals were either reported or could be calculated using reported numbers. Numbers in parentheses correspond to individual study identifiers. *Reporting that it was no longer significant when adjusted for GA, but without reporting adjusted OR or CIs. **Sulfamethoxazole and trimethoprim, cefotetan, ceftriaxone, cephalexin, cefazolin. ***The authors reported that in this group aminoglycosides (especially amikacin) were the most common. ****Furosemide, dexamethasone, vancomycin, gentamicin, tobramycin. OR: odds ratio. CI: confidence interval.</p></figcaption></figure></section><section id="bcpt70090-sec-0029"><h4 class="pmc_sec_title">3.4.4. Studies on Other Drugs</h4>
<p>An odds ratio was reported or could be calculated for a number of other classes of drugs investigated in seven studies [<a href="#bcpt70090-bib-0027" class="usa-link" aria-describedby="bcpt70090-bib-0027">27</a>, <a href="#bcpt70090-bib-0029" class="usa-link" aria-describedby="bcpt70090-bib-0029">29</a>, <a href="#bcpt70090-bib-0030" class="usa-link" aria-describedby="bcpt70090-bib-0030">30</a>, <a href="#bcpt70090-bib-0034" class="usa-link" aria-describedby="bcpt70090-bib-0034">34</a>, <a href="#bcpt70090-bib-0035" class="usa-link" aria-describedby="bcpt70090-bib-0035">35</a>, <a href="#bcpt70090-bib-0037" class="usa-link" aria-describedby="bcpt70090-bib-0037">37</a>, <a href="#bcpt70090-bib-0038" class="usa-link" aria-describedby="bcpt70090-bib-0038">38</a>, <a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>] (Figure <a href="#bcpt70090-fig-0006" class="usa-link">6</a>). Additionally, one study investigated the effect of antiretroviral therapy combinations and found an RR of 0.13 (95% CI: 0.05–0.32) [<a href="#bcpt70090-bib-0029" class="usa-link" aria-describedby="bcpt70090-bib-0029">29</a>].</p>
<figure class="fig xbox font-sm" id="bcpt70090-fig-0006"><h5 class="obj_head">FIGURE 6.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01bf/12375940/7bb02e021cf1/BCPT-137-0-g004.jpg" loading="lazy" id="jats-graphic-11" height="666" width="709" alt="FIGURE 6"></p>
<div class="p text-right font-secondary"><a href="figure/bcpt70090-fig-0006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Forest plot of other drugs or drug combinations where an OR or an adjusted OR and 95% confidence intervals were reported. Numbers in parentheses correspond to individual study identifiers. *Chloroquine, coartem, quinine + clindamycin, primaquine. **66.7% was chloroquine. ***Methylphenidate, amphetamine, dexamphetamine, lisdexamphetamine, modafinil, atomoxetine, clonidine. OR: odds ratio. CI: confidence interval.</p></figcaption></figure></section></section></section><section id="bcpt70090-sec-0030"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>This systematic review and meta‐analysis identified 21 studies on antenatal drugs and CHL. The studies were heterogeneous in terms of study design and exposure. Given the observational design of most studies, causal relationships cannot be inferred due to the inherent risk of confounding, selection bias and lack of randomisation. Therefore, any observed association should be interpreted cautiously.</p>
<section id="bcpt70090-sec-0031"><h3 class="pmc_sec_title">4.1. Classes of Drugs Considered</h3>
<p>Key drugs investigated were magnesium sulphate, systemic steroids, ASA and other NSAIDs and antibiotics. Magnesium sulphate and systemic steroids, either alone or in combination, showed potential protective effects. There was modest evidence of an increase in the risk when ASA was given at lower doses but not at higher doses. Several antibiotics, including gentamicin and metronidazole, showed some evidence of an increased risk. Several other drugs showed weaker evidence of an association with CHL, including anti‐neoplastic agents and valproic acid.</p></section><section id="bcpt70090-sec-0032"><h3 class="pmc_sec_title">4.2. Corticosteroids</h3>
<p>Antenatally administered systemic corticosteroids in infants subsequently born preterm are associated with reductions in cerebral palsy, lower risk of neurodevelopmental impairment and lower incidence of bronchopulmonary dysplasia, possibly due to improved respiratory function and lower rates of intraventricular haemorrhage [<a href="#bcpt70090-bib-0048" class="usa-link" aria-describedby="bcpt70090-bib-0048">48</a>, <a href="#bcpt70090-bib-0049" class="usa-link" aria-describedby="bcpt70090-bib-0049">49</a>, <a href="#bcpt70090-bib-0050" class="usa-link" aria-describedby="bcpt70090-bib-0050">50</a>]. Antenatal corticosteroids may directly protect against congenital sensorineural CHL by reducing inflammation caused by chorioamnionitis [<a href="#bcpt70090-bib-0051" class="usa-link" aria-describedby="bcpt70090-bib-0051">51</a>] and by improving blood circulation to inner ear cells and brain areas regulating hearing. However, antenatal administration of antenatal steroids to women who subsequently deliver at term has been associated with mental and behavioural disorders in children in the long term [<a href="#bcpt70090-bib-0052" class="usa-link" aria-describedby="bcpt70090-bib-0052">52</a>].</p></section><section id="bcpt70090-sec-0033"><h3 class="pmc_sec_title">4.3. Magnesium Sulphate</h3>
<p>Magnesium sulphate, often given with corticosteroids, is used as a neuroprotectant for pregnancies at risk of preterm delivery [<a href="#bcpt70090-bib-0053" class="usa-link" aria-describedby="bcpt70090-bib-0053">53</a>]. Studies on magnesium sulphate primarily focus on mortality and cerebral palsy [<a href="#bcpt70090-bib-0054" class="usa-link" aria-describedby="bcpt70090-bib-0054">54</a>], but magnesium alone has been shown to reduce hearing damage caused by acoustic trauma in guinea pigs [<a href="#bcpt70090-bib-0055" class="usa-link" aria-describedby="bcpt70090-bib-0055">55</a>, <a href="#bcpt70090-bib-0056" class="usa-link" aria-describedby="bcpt70090-bib-0056">56</a>, <a href="#bcpt70090-bib-0057" class="usa-link" aria-describedby="bcpt70090-bib-0057">57</a>]. We speculate that the potential mechanism could be due to its ability to preserve inner hair cells and cochlear function and protect these areas from damage related to prematurity. Another possible mechanism is that magnesium lowers the risk of complications of prematurity and therefore protects against the development of HL in the newborn.</p></section><section id="bcpt70090-sec-0034"><h3 class="pmc_sec_title">4.4. Acetylsalicylic Acid</h3>
<p>Our systematic review found that low doses (ASA ≤ 300 mg/day), but not high doses (&gt; 300 mg/day) of ASA were associated with hearing loss, based on the study by Foch et al. [<a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>]. This is in contrast with evidence from adults, where high doses of salicylates, commonly used as an analgesic, can induce reversible hearing loss [<a href="#bcpt70090-bib-0012" class="usa-link" aria-describedby="bcpt70090-bib-0012">12</a>, <a href="#bcpt70090-bib-0058" class="usa-link" aria-describedby="bcpt70090-bib-0058">58</a>] through vasoconstriction and ischaemic damage [<a href="#bcpt70090-bib-0059" class="usa-link" aria-describedby="bcpt70090-bib-0059">59</a>]. We hypothesise that this discrepancy may be due to the timing and duration of the exposure, rather than the daily dosage itself. High doses of ASA are typically discontinued in the third trimester due to an increased risk of premature ductal closure [<a href="#bcpt70090-bib-0060" class="usa-link" aria-describedby="bcpt70090-bib-0060">60</a>, <a href="#bcpt70090-bib-0061" class="usa-link" aria-describedby="bcpt70090-bib-0061">61</a>], whereas low doses are typically administered from before the 16th gestational week and throughout the pregnancy to women at risk of preeclampsia. The extended exposure and possibly higher cumulative doses during critical developmental periods could influence fetal physiology, contributing to the higher risk of CHL.</p></section><section id="bcpt70090-sec-0035"><h3 class="pmc_sec_title">4.5. Antibiotics</h3>
<p>Several antibiotics have well‐documented ototoxic effects in children and adults [<a href="#bcpt70090-bib-0058" class="usa-link" aria-describedby="bcpt70090-bib-0058">58</a>, <a href="#bcpt70090-bib-0062" class="usa-link" aria-describedby="bcpt70090-bib-0062">62</a>]. Aminoglycosides are toxic to inner hair cells of the cochlea, the stria vascularis, marginal cells and spiral ganglion neurons and damage to these structures may contribute to hearing loss [<a href="#bcpt70090-bib-0058" class="usa-link" aria-describedby="bcpt70090-bib-0058">58</a>]. This is in accordance with our findings, which provide some evidence for an association between specific antibiotics, including gentamicin and metronidazole and CHL.</p></section><section id="bcpt70090-sec-0036"><h3 class="pmc_sec_title">4.6. Antimalarials</h3>
<p>Evidence linking antimalarial drug usage in utero to CHL is limited. A systematic review concluded that it might be the case for not all but for some antimalarials, through loss of outer cochlear hair cells and damage of the neural cells in the cochlea [<a href="#bcpt70090-bib-0063" class="usa-link" aria-describedby="bcpt70090-bib-0063">63</a>]. This could explain the varied results, underlining the necessity of examining these drugs separately rather than as a group.</p></section><section id="bcpt70090-sec-0037"><h3 class="pmc_sec_title">4.7. Antineoplastic Agents</h3>
<p>Previous studies have found an association between treatment with platinum analogues for cancer in children and adults that increases the risk of hearing loss [<a href="#bcpt70090-bib-0064" class="usa-link" aria-describedby="bcpt70090-bib-0064">64</a>, <a href="#bcpt70090-bib-0065" class="usa-link" aria-describedby="bcpt70090-bib-0065">65</a>] through oxidative stress, DNA damage and apoptosis in cochlear cells [<a href="#bcpt70090-bib-0066" class="usa-link" aria-describedby="bcpt70090-bib-0066">66</a>, <a href="#bcpt70090-bib-0067" class="usa-link" aria-describedby="bcpt70090-bib-0067">67</a>]. A similar mechanism could affect the foetus when exposed antenatally.</p></section><section id="bcpt70090-sec-0038"><h3 class="pmc_sec_title">4.8. Valproic Acid</h3>
<p>Valproic acid is teratogenic through possible mechanisms, such as oxidative stress, folate antagonism and histone deacetylase inhibition [<a href="#bcpt70090-bib-0068" class="usa-link" aria-describedby="bcpt70090-bib-0068">68</a>, <a href="#bcpt70090-bib-0069" class="usa-link" aria-describedby="bcpt70090-bib-0069">69</a>]. However, there is a lack of evidence of its effect on the development of the inner ear and hearing. We identified only one study [<a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>] investigating this association, suggesting strong evidence of increased risk of CHL following pregnancy exposure to valproic acid.</p></section><section id="bcpt70090-sec-0039"><h3 class="pmc_sec_title">4.9. Dihydroergocryptine</h3>
<p>Dopamine receptors expressed in the cochlea indicate they have a role in auditory function; however, evidence on how they affect hearing development is unclear [<a href="#bcpt70090-bib-0070" class="usa-link" aria-describedby="bcpt70090-bib-0070">70</a>]. This could explain why antenatal exposure to dihydroergocryptine could alter hearing.</p></section><section id="bcpt70090-sec-0040"><h3 class="pmc_sec_title">4.10. Antiretroviral Therapy</h3>
<p>For highly active antiretroviral therapy in HIV/AIDS treatment, the study by Fasunla et al. [<a href="#bcpt70090-bib-0029" class="usa-link" aria-describedby="bcpt70090-bib-0029">29</a>] found a strong protective effect (RR = 0.13, 95% CI: 0.05–0.32). We speculate that this is due to a direct therapeutic effect on HIV/AIDS, limiting the negative impact of the disease on the development of the fetal ear.</p></section></section><section id="bcpt70090-sec-0041"><h2 class="pmc_sec_title">5. Limitations of the Evidence Included in This Review</h2>
<section id="bcpt70090-sec-0042"><h3 class="pmc_sec_title">5.1. Study Design</h3>
<p>The studies in this systematic review were highly heterogeneous in terms of study size, study design and methods of analysis, making it difficult to systematically compare the studies across all parameters. For some of the exposures, the combined evidence was based on very few exposed, limiting the power of the analyses.</p>
<p>Only four of the 16 studies [<a href="#bcpt70090-bib-0043" class="usa-link" aria-describedby="bcpt70090-bib-0043">43</a>, <a href="#bcpt70090-bib-0044" class="usa-link" aria-describedby="bcpt70090-bib-0044">44</a>, <a href="#bcpt70090-bib-0045" class="usa-link" aria-describedby="bcpt70090-bib-0045">45</a>, <a href="#bcpt70090-bib-0047" class="usa-link" aria-describedby="bcpt70090-bib-0047">47</a>] were RCTs; 12 were cohort studies [<a href="#bcpt70090-bib-0027" class="usa-link" aria-describedby="bcpt70090-bib-0027">27</a>, <a href="#bcpt70090-bib-0028" class="usa-link" aria-describedby="bcpt70090-bib-0028">28</a>, <a href="#bcpt70090-bib-0029" class="usa-link" aria-describedby="bcpt70090-bib-0029">29</a>, <a href="#bcpt70090-bib-0030" class="usa-link" aria-describedby="bcpt70090-bib-0030">30</a>, <a href="#bcpt70090-bib-0031" class="usa-link" aria-describedby="bcpt70090-bib-0031">31</a>, <a href="#bcpt70090-bib-0032" class="usa-link" aria-describedby="bcpt70090-bib-0032">32</a>, <a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>, <a href="#bcpt70090-bib-0034" class="usa-link" aria-describedby="bcpt70090-bib-0034">34</a>, <a href="#bcpt70090-bib-0035" class="usa-link" aria-describedby="bcpt70090-bib-0035">35</a>, <a href="#bcpt70090-bib-0036" class="usa-link" aria-describedby="bcpt70090-bib-0036">36</a>, <a href="#bcpt70090-bib-0037" class="usa-link" aria-describedby="bcpt70090-bib-0037">37</a>, <a href="#bcpt70090-bib-0046" class="usa-link" aria-describedby="bcpt70090-bib-0046">46</a>] and five were case–control studies [<a href="#bcpt70090-bib-0038" class="usa-link" aria-describedby="bcpt70090-bib-0038">38</a>, <a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>, <a href="#bcpt70090-bib-0040" class="usa-link" aria-describedby="bcpt70090-bib-0040">40</a>, <a href="#bcpt70090-bib-0041" class="usa-link" aria-describedby="bcpt70090-bib-0041">41</a>, <a href="#bcpt70090-bib-0042" class="usa-link" aria-describedby="bcpt70090-bib-0042">42</a>]. Although RCTs are often considered the gold standard for drawing causal inferences due to their better control for confounders [<a href="#bcpt70090-bib-0071" class="usa-link" aria-describedby="bcpt70090-bib-0071">71</a>], they are not feasible or ethical for investigating antenatal drug exposure and hearing loss as the primary outcome in children.</p>
<p>In studies where HL and/or drug exposure are not the primary outcomes, the study design and methods might be more prone to using less specific and thorough methods for assessing these variables, leading to both misclassification and underreporting—for example, in the study by Azizi et al. [<a href="#bcpt70090-bib-0038" class="usa-link" aria-describedby="bcpt70090-bib-0038">38</a>] it is unclear whether all cases and controls were examined by the same diagnostic methods.</p></section><section id="bcpt70090-sec-0043"><h3 class="pmc_sec_title">5.2. Age and Method of Diagnosis of Hearing Loss and Follow‐Up</h3>
<p>This systematic review included studies from 47 different countries. A global survey on newborn hearing screening [<a href="#bcpt70090-bib-0072" class="usa-link" aria-describedby="bcpt70090-bib-0072">72</a>] found that, among these countries, 18 (38.3%) had a universal newborn hearing screening program, 19 (40.4%) did not and for 10 countries (21.3%) the status was unknown. The absence of newborn hearing screening in many countries creates a critical gap in early hearing loss detection. While maternal records often provide detailed information about medical exposures during pregnancy, the lack of early screening means that HL in newborns frequently goes undetected until later in childhood or adulthood. This delay postpones intervention and makes it difficult to link hearing loss to prenatal drug exposure. Over time, this connection becomes less likely to be considered, as other postnatal factors may arise that could contribute to hearing loss.</p>
<p>The definition of hearing loss in all studies ranged from unspecified hearing loss to more specific criteria, such as hearing screening in newborns with OAE and AABR, to more definitive methods like diagnostic ABR and pure‐tone audiometry. The test method also varied, from only using single screening methods (e.g., OAE) to using several diagnostic methods in combination. The age of diagnosis ranged from shortly after birth up to several years. The lack of standardisation in defining and diagnosing cases could cause an over‐ or underrepresentation of cases in each study. Several studies relied on screening tools (e.g., OAE or AABR); this might have produced false positives and very few of the studies followed up with confirmatory audiometry or ABR to confirm sensorineural hearing loss. The inconsistent follow‐up increases the likelihood that some reported cases reflect false‐positive findings rather than true CHL. Conversely, these screening tools may also yield false negatives, potentially underestimating the true prevalence of CHL. Further, as diagnosis of hearing loss may be difficult in newborns and younger children and if diagnosed later may be affected by postnatal contributors to hearing impairment, i.e., traumatic hearing loss, a potential bias may have been introduced in studies with longer follow‐up.</p></section><section id="bcpt70090-sec-0044"><h3 class="pmc_sec_title">5.3. Dose and Timing</h3>
<p>Teratogenicity may be dose‐dependent and related to timing in pregnancy [<a href="#bcpt70090-bib-0073" class="usa-link" aria-describedby="bcpt70090-bib-0073">73</a>], data on drug dosage were limited in the included studies. Furthermore, for the majority of the investigated drugs in the included studies, the trimester of exposure was not reported.</p>
<p>These limitations are likely to have contributed to the inconsistent findings. The prevalence of CHL in the included RCTs ranged from 0.09% to 3% and in the other study designs from 0% to 16.5%. In comparison, the prevalence of CHL requiring treatment is 0.4% in Danish children [<a href="#bcpt70090-bib-0074" class="usa-link" aria-describedby="bcpt70090-bib-0074">74</a>].</p></section><section id="bcpt70090-sec-0045"><h3 class="pmc_sec_title">5.4. Confounders</h3>
<p>To accurately assess the impact of specific drug exposures on hearing, known risk factors for hearing loss must be considered and controlled for in the analysis. Several pre‐, peri‐ and postnatal risk factors associated with early childhood hearing loss include genetic disposition, neonatal intensive care over 5 days, hyperbilirubinaemia requiring exchange transfusion, aminoglycoside administration for over 5 days, congenital infections and several congenital malformations [<a href="#bcpt70090-bib-0003" class="usa-link" aria-describedby="bcpt70090-bib-0003">3</a>]. Many studies included in this systematic review did not systematically assess or exclude children with genetic hearing loss, anatomic malformations or congenital infections, such as CMV. Most included studies adjusted for few or no risk factors (Table <a href="#bcpt70090-tbl-0002" class="usa-link">2</a>). Genetic hearing loss and congenital infections were exclusion criteria in this review; however, only one study was excluded based on this criterion and most studies did not investigate these causes, potentially inadvertently including these patient groups. The lack of proper adjustment for known confounders in most studies could lead to spurious associations between antenatal drug exposure and CHL.</p>
<p>Many of the drugs administered perinatally are related to the risk of premature birth. Of 21 included studies, seven studies only included preterm infants or children with low birth weight [<a href="#bcpt70090-bib-0031" class="usa-link" aria-describedby="bcpt70090-bib-0031">31</a>, <a href="#bcpt70090-bib-0032" class="usa-link" aria-describedby="bcpt70090-bib-0032">32</a>, <a href="#bcpt70090-bib-0033" class="usa-link" aria-describedby="bcpt70090-bib-0033">33</a>, <a href="#bcpt70090-bib-0036" class="usa-link" aria-describedby="bcpt70090-bib-0036">36</a>, <a href="#bcpt70090-bib-0041" class="usa-link" aria-describedby="bcpt70090-bib-0041">41</a>, <a href="#bcpt70090-bib-0042" class="usa-link" aria-describedby="bcpt70090-bib-0042">42</a>, <a href="#bcpt70090-bib-0046" class="usa-link" aria-describedby="bcpt70090-bib-0046">46</a>]; 13 included either only term or both term and preterm children [<a href="#bcpt70090-bib-0027" class="usa-link" aria-describedby="bcpt70090-bib-0027">27</a>, <a href="#bcpt70090-bib-0028" class="usa-link" aria-describedby="bcpt70090-bib-0028">28</a>, <a href="#bcpt70090-bib-0029" class="usa-link" aria-describedby="bcpt70090-bib-0029">29</a>, <a href="#bcpt70090-bib-0030" class="usa-link" aria-describedby="bcpt70090-bib-0030">30</a>, <a href="#bcpt70090-bib-0034" class="usa-link" aria-describedby="bcpt70090-bib-0034">34</a>, <a href="#bcpt70090-bib-0035" class="usa-link" aria-describedby="bcpt70090-bib-0035">35</a>, <a href="#bcpt70090-bib-0037" class="usa-link" aria-describedby="bcpt70090-bib-0037">37</a>, <a href="#bcpt70090-bib-0039" class="usa-link" aria-describedby="bcpt70090-bib-0039">39</a>, <a href="#bcpt70090-bib-0040" class="usa-link" aria-describedby="bcpt70090-bib-0040">40</a>, <a href="#bcpt70090-bib-0043" class="usa-link" aria-describedby="bcpt70090-bib-0043">43</a>, <a href="#bcpt70090-bib-0044" class="usa-link" aria-describedby="bcpt70090-bib-0044">44</a>, <a href="#bcpt70090-bib-0045" class="usa-link" aria-describedby="bcpt70090-bib-0045">45</a>, <a href="#bcpt70090-bib-0047" class="usa-link" aria-describedby="bcpt70090-bib-0047">47</a>] and one included children of unknown gestational age at birth [<a href="#bcpt70090-bib-0038" class="usa-link" aria-describedby="bcpt70090-bib-0038">38</a>]. Several studies have found a negative association between gestational age, birth weight and neurodevelopmental impairment [<a href="#bcpt70090-bib-0075" class="usa-link" aria-describedby="bcpt70090-bib-0075">75</a>, <a href="#bcpt70090-bib-0076" class="usa-link" aria-describedby="bcpt70090-bib-0076">76</a>]. Drugs like steroids, magnesium sulphate and antibiotics, administered to manage preterm birth risks, may therefore be subject to confounding by indication. For all antenatally administered drugs studied, it is crucial to differentiate between the drug's effects and those of the treated condition on CHL, to avoid confounding by indication. This potential for confounding by indication, particularly in high‐risk pregnancies requiring medical treatment, is a major inherent limitation in evaluating drug‐specific effects.</p>
<p>A further important limitation is that not all studies reported adjusted effect estimates and we therefore used unadjusted effect estimates or calculated crude estimates from available data, potentially increasing the risk of residual confounding. As the unadjusted effect estimates and calculated estimates do not account for known risk factors, the pooled estimates should be interpreted with caution and observed associations may potentially be explained by unmeasured confounders.</p></section><section id="bcpt70090-sec-0046"><h3 class="pmc_sec_title">5.5. Socioeconomic Factors</h3>
<p>None of the included studies considered socioeconomic factors, although this may influence health‐seeking behaviour and health literacy, access and drug use in pregnant people and affect child health outcomes.</p></section><section id="bcpt70090-sec-0047"><h3 class="pmc_sec_title">5.6. Polypharmacy</h3>
<p>Most of the included studies did not mention the use of multiple drugs in the interpretation of their results. However challenging, polypharmacy is an important factor when conducting studies on the effects of drug use, as many patients consume multiple medications, either prescribed or over‐the‐counter. Some associations could therefore possibly be due to drug–drug interactions known to be related to polypharmacy.</p>
<p>In this systematic review and meta‐analysis, only 21 studies fulfilled the eligibility criteria; many of these studies were of too small a size to detect an association with a rare outcome such as CHL. Although some found associations between the investigated drugs and CHL, none of these results are unfortunately sufficient to draw clinical conclusions.</p></section></section><section id="bcpt70090-sec-0048"><h2 class="pmc_sec_title">6. Strengths and Limitations of the Review Process</h2>
<section id="bcpt70090-sec-0049"><h3 class="pmc_sec_title">6.1. Language Criteria</h3>
<p>While screening and evaluating studies in several different languages stated in the Methods section minimises language bias within those languages, it introduces a potential limitation by excluding studies published in other major languages, such as French, Chinese and Spanish. This restriction may potentially have led to the exclusion of relevant findings, reducing the global representativeness of the review. We were able to identify 11 possibly relevant publications that could not be included in the systematic review due to language criteria (Appendix <a href="#bcpt70090-app-0003" class="usa-link">C</a>). Several non‐analytical studies that could potentially contain additional important information were excluded due to study design.</p></section><section id="bcpt70090-sec-0050"><h3 class="pmc_sec_title">6.2. Effect Estimates Not Reported</h3>
<p>An important limitation in our meta‐analysis was the lack of reporting of effect estimates in some included studies. While the necessary numbers of study participants were provided, we calculated an effect estimate to include in our meta‐analysis. This allowed for a more comprehensive inclusion of available data but also led to unadjusted effect estimates, as we were not able to account for potential confounders that the original studies might have adjusted for in their analyses. Therefore, the pooled effect estimates may overestimate the effect of antenatal exposure to the investigated drug on the development of CHL.</p></section><section id="bcpt70090-sec-0051"><h3 class="pmc_sec_title">6.3. Future Perspectives</h3>
<p>The limitations of the review process highlight the need for a cautious interpretation of our results and underline the need for research using population‐linked data from multiple countries, although this approach cannot account for over‐the‐counter drugs or all confounders. Alternatively, conducting cohort or case–control studies using large registries on sensorineural hearing loss or deafness could be considered, recognising that this method may be prone to bias. Future larger clinical studies should account for the many factors associated with exposure (dosage of drug, trimester of exposure) and outcome (other known risk factors associated with CHL) and explicitly adjust for potential confounders, such as congenital CMV, genetic predisposition, maternal infections and socioeconomic factors. Confounding by indication should also be considered, especially in high‐risk pregnancies where drug exposure is more common. The methods used to diagnose hearing loss should be standardised, e.g., by performing newborn hearing screening and follow up as indicated using gold standard methods and there should be a sufficient time window for follow up, diagnosing all childhood hearing loss cases while excluding cases caused by other factors later in life. Finally, international collaboration using standardised data collection methods could improve sample sizes and generalisability.</p></section></section><section id="bcpt70090-sec-0052"><h2 class="pmc_sec_title">7. Conclusion</h2>
<p>This systematic review and meta‐analysis identified several antenatal drugs potentially related to CHL and some that may protect against it, including magnesium sulphate and systemic steroids. We found a reverse dose–response effect of ASA, which may be explained by a cumulative dosage effect or that the fetal ear is more susceptible in the late part of the pregnancy. Several antibiotics, including gentamicin, metronidazole and aminoglycosides, may increase the risk of CHL but part of these associations might be explained by confounding by indication due to the underlying disease. Given the widespread use of drugs during pregnancy and the negative impact of hearing loss on child development, large, rigorous studies are warranted.</p></section><section id="bcpt70090-sec-0053"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>A.S.K., C.Z.S., T.O. and L.H.P. conceptualised the systematic review and designed the methods; L.H.P. supervised the project. The literature screening was carried out by A.S.K. and M.Ø.T. A.S.K. wrote the paper with support from M.Ø.T., C.Z.S., D.P.B., J.E.M., T.O. and L.H.P. All authors approved the final version of this paper.</p></section><section id="bcpt70090-sec-0055"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflicts of interest.</p></section><section id="bcpt70090-sec-0054" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors would like to thank Health Librarian Jane Kjemtrup Andersen for her assistance and support in developing the search strategies and for providing studies that were not accessible online.</p></section><section id="bcpt70090-app-0001" class="app"><h2 class="pmc_sec_title">Appendix A. Search String Used in PubMed—Search Performed on 25 January 2023 and 5 September 2024</h2>
<p>(‘pregnancy’[MeSH Terms] OR ‘pregnan*’[Text Word] OR ‘gestation*’[Text Word] OR ‘matern*’[Text Word]) AND (‘chemically induced disorders’[MeSH Terms] OR ‘drug therapy’[MeSH Terms] OR ‘maternal exposure’[MeSH Terms] OR ‘teratogens’[MeSH Terms] OR ‘teratogenesis’[MeSH Terms] OR ‘teratology’[MeSH Terms] OR ‘maternal fetal exchange’[MeSH Terms] OR ‘ototoxicity’[MeSH Terms] OR ‘abnormalities, drug induced’[MeSH Terms] OR ‘chemically induced’[MeSH Subheading] OR ‘pharmacotherap*’[Text Word] OR ‘teratolog*’[Text Word] OR ‘maternal exposure*’[Text Word] OR ‘intrauterine exposure*’[Text Word] OR ‘in utero exposure*’[Text Word] OR ‘transplacental exposure*’[Text Word] OR ‘maternal fetal exchange*’[Text Word] OR ‘vestibulotoxic*’[Text Word] OR ‘ototoxic*’[Text Word] OR ‘cochleotoxic*’[Text Word] OR ‘drug related’[Text Word] OR ‘drug induced’[Text Word] OR ‘medication induced’[Text Word] OR ‘chemically induced’[Text Word] OR ‘drug exposure*’[Text Word]) AND (‘hearing loss’[MeSH Terms] OR ‘hearing loss, unilateral’[MeSH Terms] OR ‘hearing loss, bilateral’[MeSH Terms] OR ‘hearing loss, sensorineural’[MeSH Terms] OR ‘deafness’[MeSH Terms] OR ‘ear, inner’[MeSH Terms] OR ‘hearing impair*’[Text Word] OR ‘deafness*’[Text Word] OR ‘hearing loss*’[Text Word] OR ‘hypoacus*’[Text Word]) AND (‘infan*’[Text Word] OR ‘newborn*’[Text Word] OR ‘new born*’[Text Word] OR ‘perinat*’[Text Word] OR ‘neonat*’[Text Word] OR ‘baby’[Text Word] OR ‘babies’[Text Word] OR ‘toddler*’[Text Word] OR ‘minors*’[Text Word] OR ‘boy’[Text Word] OR ‘boys’[Text Word] OR ‘boyhood’[Text Word] OR ‘girl*’[Text Word] OR ‘kid’[Text Word] OR ‘kids’[Text Word] OR ‘child’[Text Word] OR ‘child*’[Text Word] OR ‘children*’[Text Word] OR ‘schoolchild*’[Text Word] OR ‘school child’[Text Word] OR ‘school child*’[Text Word] OR ‘juvenil*’[Text Word] OR ‘youth*’[Text Word] OR ‘teen*’[Text Word] OR ‘underage*’[Text Word] OR ‘paediatrics’[MeSH Terms] OR ‘paediatric*’[Text Word] OR ‘paediatric*’[Text Word] OR ‘peadiatric*’[All Fields] OR ‘school’[Text Word] OR ‘school*’[Text Word] OR ‘prematur*’[Text Word] OR ‘preterm*’[Text Word])</p></section><section id="bcpt70090-app-0002" class="app"><h2 class="pmc_sec_title">Appendix B. Possibly Relevant Case Reports and Case Series</h2>
<ol id="bcpt70090-list-0001" class="list" style="list-style-type:decimal">
<li id="bcpt70090-li-0001"><p>Barbero P, Lotersztein V, Bronberg R, Perez M, Alba L. Acitretin embryopathy: a case report. Birth Defects Res A Clin Mol Teratol. 2004;70 [10]:831–3.</p></li>
<li id="bcpt70090-li-0002"><p>Ciorba A, Melchiorri C, Moretto S, Pelucchi S, Aimoni C. Hearing loss in methimazole embryopathy: cues from a case. Minerva Pediatr. 2019;71 [5]:479–80.</p></li>
<li id="bcpt70090-li-0003"><p>Costa JR, Coutinho MB, Soares T, Meireles L. Oculo‐auriculo‐vertebral spectrum and maternal drug ingestion: cause or coincidence? Hearing Balanc Commun. 2023;21 (1):47–53.</p></li>
<li id="bcpt70090-li-0004"><p>da Silva LPA, Queiros F, Lima I. Aetiology of Hearing Impairment in Children and Adolescents of a Reference Centre AP<span class="font-variant-small-caps">ad</span>A in the city of Salvador, state of Bahia. Brazilian Journal of Otorhinolaryngology. 2006;72 (1):33–6.</p></li>
<li id="bcpt70090-li-0005"><p>Dumić M, Cvitanović M, Ŝarić B, Ŝpehar A, Batinica S. Choanal stenosis, hypothelia, deafness, recurrent dacryocystitis, neck fistulas, short stature and microcephaly: Report of a case. American Journal of Medical Genetics. 2002;113 (3):295–7.</p></li>
<li id="bcpt70090-li-0006"><p>Ewart‐Toland A, Yankowitz J, Winder A, Imagire R, Cox VA, Aylsworth AS, et al. Oculoauriculovertebral abnormalities in children of diabetic mothers. American Journal of Medical Genetics. 2000;90 (4):303–9.</p></li>
<li id="bcpt70090-li-0007"><p>Foulds N, Walpole I, Elmslie F, Mansour S. Carbimazole embryopathy: an emerging phenotype. Am J Med Genet A. 2005;132A (2):130–5.</p></li>
<li id="bcpt70090-li-0008"><p>Geijteman E, Wensveen C, Duvekot JJ, Zuylen L. A child with severe hearing loss associated with maternal Cisplatin treatment during pregnancy. Obstetrics and gynaecology (New York 1953). 2014;124(2, PART 2 Suppl 1):454–6.</p></li>
<li id="bcpt70090-li-0009"><p>Hart CW, Naunton RF. The Ototoxicity of Chloroquine Phosphate. Archives of Otolaryngology. 1964;80 (4):407–12.</p></li>
<li id="bcpt70090-li-0010"><p>Hoeltzenbein M, Stieler K, Panse M, Wacker E, Schaefer C. Allopurinol Use during Pregnancy—Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative of Teratogenicity. PLoS One. 2013;8 (6):e66637‐e.</p></li>
<li id="bcpt70090-li-0011"><p>Hünseler C, Paneitz A, Friedrich D, Lindner U, Oberthuer A, Körber F, et al. Angiotensin II receptor blocker induced fetopathy: 7 cases. Klin Padiatr. 2011;223 (1):10–4.</p></li>
<li id="bcpt70090-li-0012"><p>Jørgensen MB, Kristensen HK, Buch NH. Thalidomide‐induced aplasia of the inner ear. Journal of Laryngology and Otology. 1964;78 (12):1095–101.</p></li>
<li id="bcpt70090-li-0013"><p>Kanno O. Electroencephalographic Study of 137 Patients with Thalidomide Embryopathy. Psychiatry and clinical neurosciences. 1987;41 (2):197–205.</p></li>
<li id="bcpt70090-li-0014"><p>Khanna BK, Bhatia ML. Congenital deaf mutism following streptomycin therapy to mother during pregnancy. A case of streptomycin ototoxicity in utero. Indian J Chest Dis. 1969;11 (1):51–3.</p></li>
<li id="bcpt70090-li-0015"><p>Lee SM, Kim HM, Lee JS, Yoon CS, Park MS, Park KI, et al. A case of suspected isotretinoin‐induced malformation in a baby of a mother who became pregnant 1 month after discontinuation of the drug. Yonsei medical journal. 2009;50 (3):445–7.</p></li>
<li id="bcpt70090-li-0016"><p>Moerike S, Pantzar JT, De Sa D. Temporal bone pathology in foetuses exposed to isotretinoin. Pediatr Dev Pathol. 2002;5 (4):405–9.</p></li>
<li id="bcpt70090-li-0017"><p>Nadeem SMD, Hashmat SMD, Defreitas MJMD, Westreich KDMD, Shatat IFMDMS, Selewski DTMD, et al. Renin Angiotensin System Blocker Fetopathy: A Midwest Paediatric Nephrology Consortium Report. The Journal of Paediatrics. 2015;167 (4):881–5.</p></li>
<li id="bcpt70090-li-0018"><p>Overcash RT, Marc‐Aurele KL, Hull AD, Ramos GA. Maternal iodine exposure: A case of fetal goitre and neonatal hearing loss. Paediatrics. 2016;137 (4).</p></li>
<li id="bcpt70090-li-0019"><p>Rabaiotti E, Girardelli S, Valsecchi L, Bergamini A, Petrone M, Mangili G, et al. Carboplatin use in pregnancy for stage IB3 cervical cancer: Case report and review of the literature. J Adolesc Young Adult Oncol. 2020;9 (3):445–8.</p></li>
<li id="bcpt70090-li-0020"><p>Robinson GC, Cambon KG. Hearing loss in infants of tuberculous mothers treated with streptomycin during pregnancy. N Engl J Med. 1964;271 (18):949–51.</p></li>
<li id="bcpt70090-li-0021"><p>Rosen RC, Lightner ES. Phenotypic malformations in association with maternal trimethadione therapy. J Pediatr. 1978;92 (2):240–4.</p></li>
<li id="bcpt70090-li-0022"><p>Stoll C, Alembik Y, Dott B. Limb reduction defects in the first generation and deafness in the second generation of intrauterine exposed foetuses to diethylstilbestrol. Ann Genet. 2003;46 (4):459–65.</p></li>
<li id="bcpt70090-li-0023"><p>Van Abel KM, Nelson ME, Collar RM, Lesperance MM. Development of canal cholesteatoma in a patient with prenatal isotretinoin exposure. International Journal of Paediatric Otorhinolaryngology. 2010;74 (9):1082–4.</p></li>
<li id="bcpt70090-li-0024"><p>Van Houtte E, Casselman J, Janssens S, De Kegel A, Maes L, Dhooge I. Middle and inner ear malformations in two siblings exposed to valproic acid during pregnancy: a case report. Int J Pediatr Otorhinolaryngol. 2014;78 (11):2007–10.</p></li>
<li id="bcpt70090-li-0025"><p>Wang M, Yin Z, Miao J, Wu Y. The fetal outcomes after neoadjuvant platinum and paclitaxel chemotherapy during pregnancy: analysis of three cases and review of the literature. Archives of gynaecology and obstetrics. 2022;305 (1):49–54.</p></li>
<li id="bcpt70090-li-0026"><p>Wolf D, Foulds N, Daya H. Antenatal carbimazole and choanal atresia: a new embryopathy. Arch Otolaryngol Head Neck Surg. 2006;132 (9):1009–11.</p></li>
<li id="bcpt70090-li-0027"><p>Zizlavsky S, Supartono N, Zachreini I, Bashiruddin J, Hajar Haryuna TS, Savitri E, et al. Factors associated with the time of diagnosis and habilitation of congenital hearing loss in Indonesia: A multicentre study. International Journal of Paediatric Otorhinolaryngology. 2022;163:111369.</p></li>
</ol></section><section id="bcpt70090-app-0003" class="app"><h2 class="pmc_sec_title">Appendix C. Possibly Relevant Reports in Other Languages</h2>
<section id="bcpt70090-sec-0061"><h3 class="pmc_sec_title">German</h3>
<ul id="bcpt70090-list-0002" class="list" style="list-style-type:none">
<li id="bcpt70090-li-0028">
<span class="label">1</span><p class="display-inline">Joss R, Brunner K. Pregnancy following tumour therapy. Schweiz Med Wochenschr. 1979;109 (24):904–7.</p>
</li>
<li id="bcpt70090-li-0029">
<span class="label">2</span><p class="display-inline">Kleinsasser O, Schlothane R. Ear malformations in the framework of thalidomide embryopathy (based on a survey of 70 infants born during 1959–1962). Z Laryngol Rhinol Otol. 1964;43:344–67.</p>
</li>
<li id="bcpt70090-li-0030">
<span class="label">3</span><p class="display-inline">Plöchl E, Tasser C. Analysis of 104 children with hearing defects (author's transl). Padiatr Padol. 1980;15 (4):375–84.</p>
</li>
</ul></section><section id="bcpt70090-sec-0062"><h3 class="pmc_sec_title">French</h3>
<ul id="bcpt70090-list-0003" class="list" style="list-style-type:none">
<li id="bcpt70090-li-0031">
<span class="label">4</span><p class="display-inline">Bavoux F, Vetel J. Drug‐induced deafness in the child. Gazette Medicale de France. 1979;86 (10):1027–8.</p>
</li>
<li id="bcpt70090-li-0032">
<span class="label">5</span><p class="display-inline">Gagnon N, Montreuil F. Deaf‐mutism in French Canadians. Aetiology of the deafness. Union Med Can. 1964;93:1071–8.</p>
</li>
</ul></section><section id="bcpt70090-sec-0063"><h3 class="pmc_sec_title">Japanese</h3>
<ul id="bcpt70090-list-0004" class="list" style="list-style-type:none">
<li id="bcpt70090-li-0033">
<span class="label">6</span><p class="display-inline">Arimoto H, editor. Ocular findings of thalidomide embryopathy. Teratology; 1984: Wiley‐Liss Div John Miley &amp; Sons Inc., 605 Third Ave, New York, NY 10158–0012.</p>
</li>
<li id="bcpt70090-li-0034">
<span class="label">7</span><p class="display-inline">Muto R, Ohashi H. Fetal aminoglycoside ototoxicity. Ryoikibetsu Shokogun Shirizu. 2001 (33):674–5.</p>
</li>
</ul></section><section id="bcpt70090-sec-0064"><h3 class="pmc_sec_title">Spanish</h3>
<ul id="bcpt70090-list-0005" class="list" style="list-style-type:none"><li id="bcpt70090-li-0035">
<span class="label">8</span><p class="display-inline">Sánchez Sainz‐Trápaga C, Gutiérrez Fonseca R, Ibáñez Ruiz C, Moro Serrano M. Relationship between a case of severe hearing loss and use of gentamicin in the pregnant mother. An Esp Pediatr. 1998;49 (4):397–8.</p>
</li></ul></section><section id="bcpt70090-sec-0065"><h3 class="pmc_sec_title">Italian</h3>
<ul id="bcpt70090-list-0006" class="list" style="list-style-type:none"><li id="bcpt70090-li-0036">
<span class="label">9</span><p class="display-inline">Grande F, Vespa F. Investigations of transplacental audio‐toxicity of dihydrostreptomycin. Arch Tisiol Mal Appar Respir. 1963;18:772–88.</p>
</li></ul></section><section id="bcpt70090-sec-0066"><h3 class="pmc_sec_title">Russian</h3>
<ul id="bcpt70090-list-0007" class="list" style="list-style-type:none"><li id="bcpt70090-li-0037">
<span class="label">10</span><p class="display-inline">Matyanova EV, Kosheleva NM, Kostareva OM, Fedorova EV, Klimenchenko NI. Pregnancy outcomes in patients with rheumatoid arthritis and systemic lupus erythematosus. Part II. Neonatal outcomes. Rheumatology Science and Practice. 2019.</p>
</li></ul></section><section id="bcpt70090-sec-0067"><h3 class="pmc_sec_title">Polish</h3>
<ul id="bcpt70090-list-0008" class="list" style="list-style-type:none"><li id="bcpt70090-li-0038">
<span class="label">11</span><p class="display-inline">Kocoń S, Wiatr M, Stręk P, Składzień J, Muszyński P, Przeklasa‐Muszyńska A. Analiza czynników mających wpływ na nieprawidłowy wynik emisji otoakustycznej u niemowląt. Otolaryngol Pol. 2013;67 (4):209–13.</p>
</li></ul></section><section id="bcpt70090-sec-0068"><h3 class="pmc_sec_title">Romanian</h3>
<ul id="bcpt70090-list-0009" class="list" style="list-style-type:none"><li id="bcpt70090-li-0039">
<span class="label">12</span><p class="display-inline">[THE ROLE OF DISEASES OF MOTHERS IN PREGNANCY, LABOUR AND THE PUERPERIUM IN THE ORIGIN OF DEAFNESS IN THE NEWBORN]. GIRBEA S, POPESCU D, TURCANU L, DUNAREANU O, POPOVICI VA</p>
</li></ul></section></section><section id="notes1"><p>

Kücükyildiz A., Thunbo M., Swan C., et al., “Maternal Exposure to Medications and the Risk of Congenital and Early‐Onset Hearing Loss in Children: A Systematic Review and a Meta‐Analysis,” Basic &amp; Clinical Pharmacology &amp; Toxicology
137, no. 3 (2025): e70090, 10.1111/bcpt.70090.

</p>
<section id="bcpt70090-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="bcpt70090-note-0001"><p>
<strong>Funding:</strong> This systematic review is conducted in relation to the Ph.D. studies of A.S.K. and fully financed by the GN Foundation, GN Store Nord Foundation (Lautrupbjerg 7, DK‐2750 Ballerup, Denmark), Gerda Mørup‐Petersen's Scholarship, Gangstedfonden, Christian og Ottilia Brorsons Rejselegater, Guildal Fondet, Kurt Sørensens Fond, Frimodt‐Heinecke Fonden, Glashofs Legat, Lizzi &amp; Mogens Staal Fonden, The Nordic Federation of Obstetrics and Gynaecology Fund, Hannibal Sanders Fond, Læge Sofus Carl Emil Friis &amp; Hustru Friis' Legat, Carl &amp; Ellen Hertz's Legat and Fonden til Lægevidenskabens Fremme. D.P.B., was supported by a National Health and Medical Research Council (NHMRC, Australia) Investigator Grant (1175744) and by the State Government of Victoria's Operational Infrastructure Support Program and Murdoch Children's Research Institute Population Health Theme Funding for 2023. L.H.P. is supported by a Borregaard Clinical Ascending Investigator Grant from the Novo Nordisk Foundation (NNF18OC0054457). The funding organisations are not involved in any aspects of the project and have no input on the interpretation or publication of the study results. The Department of Clinical Medicine (Aarhus University, Denmark) maintains exclusive authority and responsibility for all aspects of data handling and management.</p></div></div></section></section><section id="bcpt70090-sec-0057"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></section><section id="bcpt70090-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="bcpt70090-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="bcpt70090-bib-0001">
<span class="label">1.</span><cite>
Parving A., Hauch A.‐M., and Christensen B., “Hearing Loss in Children—Epidemiology, Age at Identification and Causes Through 30 Years,” Ugeskrift for Laeger
165, no. 6 (2003): 574–579.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/12608025/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ugeskrift%20for%20Laeger&amp;title=Hearing%20Loss%20in%20Children%E2%80%94Epidemiology,%20Age%20at%20Identification%20and%20Causes%20Through%2030%20Years&amp;author=A.%20Parving&amp;author=A.%E2%80%90M.%20Hauch&amp;author=B.%20Christensen&amp;volume=165&amp;issue=6&amp;publication_year=2003&amp;pages=574-579&amp;pmid=12608025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0002">
<span class="label">2.</span><cite>
Dietz A., Löppönen T., Valtonen H., Hyvärinen A., and Löppönen H., “Prevalence and Etiology of Congenital or Early Acquired Hearing Impairment in Eastern Finland,” International Journal of Pediatric Otorhinolaryngology
73, no. 10 (2009): 1353–1357, 10.1016/j.ijporl.2009.06.009.
</cite> [<a href="https://doi.org/10.1016/j.ijporl.2009.06.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19616857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Pediatric%20Otorhinolaryngology&amp;title=Prevalence%20and%20Etiology%20of%20Congenital%20or%20Early%20Acquired%20Hearing%20Impairment%20in%20Eastern%20Finland&amp;author=A.%20Dietz&amp;author=T.%20L%C3%B6pp%C3%B6nen&amp;author=H.%20Valtonen&amp;author=A.%20Hyv%C3%A4rinen&amp;author=H.%20L%C3%B6pp%C3%B6nen&amp;volume=73&amp;issue=10&amp;publication_year=2009&amp;pages=1353-1357&amp;pmid=19616857&amp;doi=10.1016/j.ijporl.2009.06.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0003">
<span class="label">3.</span><cite>
Finitzo T., Sininger Y., Brookhouser P., and Epstein S., “Year 2000 Position Statement: Principles and Guidelines for Early Hearing Detection and Intervention Programs,” Pediatrics (Evanston)
106, no. 4 (2000): 798–817, 10.1542/peds.106.4.798.</cite> [<a href="https://doi.org/10.1542/peds.106.4.798" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatrics%20(Evanston)&amp;title=Year%202000%20Position%20Statement:%20Principles%20and%20Guidelines%20for%20Early%20Hearing%20Detection%20and%20Intervention%20Programs&amp;author=T.%20Finitzo&amp;author=Y.%20Sininger&amp;author=P.%20Brookhouser&amp;author=S.%20Epstein&amp;volume=106&amp;issue=4&amp;publication_year=2000&amp;pages=798-817&amp;doi=10.1542/peds.106.4.798&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0004">
<span class="label">4.</span><cite>
Yates L. M. and Thomas S. H. L., “Prescribing Medicines in Pregnancy,” Medicine (Abingdon 1995, UK ed)
44, no. 7 (2016): 438–443, 10.1016/j.mpmed.2016.04.012.</cite> [<a href="https://doi.org/10.1016/j.mpmed.2016.04.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Medicine%20(Abingdon%201995,%20UK%20ed)&amp;title=Prescribing%20Medicines%20in%20Pregnancy&amp;author=L.%20M.%20Yates&amp;author=S.%20H.%20L.%20Thomas&amp;volume=44&amp;issue=7&amp;publication_year=2016&amp;pages=438-443&amp;doi=10.1016/j.mpmed.2016.04.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0005">
<span class="label">5.</span><cite>
Morzaria S., Westerberg B. D., and Kozak F. K., “Systematic Review of the Etiology of Bilateral Sensorineural Hearing Loss in Children,” International Journal of Pediatric Otorhinolaryngology
68, no. 9 (2004): 1193–1198, 10.1016/j.ijporl.2004.04.013.
</cite> [<a href="https://doi.org/10.1016/j.ijporl.2004.04.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15302152/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Pediatric%20Otorhinolaryngology&amp;title=Systematic%20Review%20of%20the%20Etiology%20of%20Bilateral%20Sensorineural%20Hearing%20Loss%20in%20Children&amp;author=S.%20Morzaria&amp;author=B.%20D.%20Westerberg&amp;author=F.%20K.%20Kozak&amp;volume=68&amp;issue=9&amp;publication_year=2004&amp;pages=1193-1198&amp;pmid=15302152&amp;doi=10.1016/j.ijporl.2004.04.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0006">
<span class="label">6.</span><cite>
Johansson M., Karltorp E., Edholm K., Drott M., and Berninger E., “A Prospective Study of Etiology and Auditory Profiles in Infants With Congenital Unilateral Sensorineural Hearing Loss,” Journal of Clinical Medicine
11, no. 14 (2022): 3966, 10.3390/jcm11143966.
</cite> [<a href="https://doi.org/10.3390/jcm11143966" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9324637/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35887730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Medicine&amp;title=A%20Prospective%20Study%20of%20Etiology%20and%20Auditory%20Profiles%20in%20Infants%20With%20Congenital%20Unilateral%20Sensorineural%20Hearing%20Loss&amp;author=M.%20Johansson&amp;author=E.%20Karltorp&amp;author=K.%20Edholm&amp;author=M.%20Drott&amp;author=E.%20Berninger&amp;volume=11&amp;issue=14&amp;publication_year=2022&amp;pages=3966&amp;pmid=35887730&amp;doi=10.3390/jcm11143966&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0007">
<span class="label">7.</span><cite>
van Wieringen A., Boudewyns A., Sangen A., Wouters J., and Desloovere C., “Unilateral Congenital Hearing Loss in Children: Challenges and Potentials,” Hearing Research
372 (2019): 29–41, 10.1016/j.heares.2018.01.010.
</cite> [<a href="https://doi.org/10.1016/j.heares.2018.01.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29395617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hearing%20Research&amp;title=Unilateral%20Congenital%20Hearing%20Loss%20in%20Children:%20Challenges%20and%20Potentials&amp;author=A.%20van%20Wieringen&amp;author=A.%20Boudewyns&amp;author=A.%20Sangen&amp;author=J.%20Wouters&amp;author=C.%20Desloovere&amp;volume=372&amp;publication_year=2019&amp;pages=29-41&amp;pmid=29395617&amp;doi=10.1016/j.heares.2018.01.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0008">
<span class="label">8.</span><cite>
Helwany M. and Tadi P., “Embryology, Ear,” (2020).</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/32491520/" class="usa-link">PubMed</a>]</li>
<li id="bcpt70090-bib-0009">
<span class="label">9.</span><cite>
Whitfield T. T., “Development of the Inner Ear,” Current Opinion in Genetics &amp; Development
32 (2015): 112–118.
</cite> [<a href="https://doi.org/10.1016/j.gde.2015.02.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25796080/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Genetics%20&amp;%20Development&amp;title=Development%20of%20the%20Inner%20Ear&amp;author=T.%20T.%20Whitfield&amp;volume=32&amp;publication_year=2015&amp;pages=112-118&amp;pmid=25796080&amp;doi=10.1016/j.gde.2015.02.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0010">
<span class="label">10.</span><cite>
Rybak L. P., Ramkumar V., and Mukherjea D., “Ototoxicity of Non‐Aminoglycoside Antibiotics,” Frontiers in Neurology
12 (2021): 652674, 10.3389/fneur.2021.652674.
</cite> [<a href="https://doi.org/10.3389/fneur.2021.652674" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7985331/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33767665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Neurology&amp;title=Ototoxicity%20of%20Non%E2%80%90Aminoglycoside%20Antibiotics&amp;author=L.%20P.%20Rybak&amp;author=V.%20Ramkumar&amp;author=D.%20Mukherjea&amp;volume=12&amp;publication_year=2021&amp;pages=652674&amp;pmid=33767665&amp;doi=10.3389/fneur.2021.652674&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0011">
<span class="label">11.</span><cite>
Ding D., McFadden S. L., Woo J. M., and Salvi R. J., “Ethacrynic Acid Rapidly and Selectively Abolishes Blood Flow in Vessels Supplying the Lateral Wall of the Cochlea,” Hearing Research
173, no. 1 (2002): 1–9, 10.1016/S0378-5955(02)00585-3.
</cite> [<a href="https://doi.org/10.1016/S0378-5955(02)00585-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12372630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hearing%20Research&amp;title=Ethacrynic%20Acid%20Rapidly%20and%20Selectively%20Abolishes%20Blood%20Flow%20in%20Vessels%20Supplying%20the%20Lateral%20Wall%20of%20the%20Cochlea&amp;author=D.%20Ding&amp;author=S.%20L.%20McFadden&amp;author=J.%20M.%20Woo&amp;author=R.%20J.%20Salvi&amp;volume=173&amp;issue=1&amp;publication_year=2002&amp;pages=1-9&amp;pmid=12372630&amp;doi=10.1016/S0378-5955(02)00585-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0012">
<span class="label">12.</span><cite>
Cazals Y., “Auditory Sensori‐Neural Alterations Induced by Salicylate,” Progress in Neurobiology
62, no. 6 (2000): 583–631, 10.1016/S0301-0082(00)00027-7.
</cite> [<a href="https://doi.org/10.1016/S0301-0082(00)00027-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10880852/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Progress%20in%20Neurobiology&amp;title=Auditory%20Sensori%E2%80%90Neural%20Alterations%20Induced%20by%20Salicylate&amp;author=Y.%20Cazals&amp;volume=62&amp;issue=6&amp;publication_year=2000&amp;pages=583-631&amp;pmid=10880852&amp;doi=10.1016/S0301-0082(00)00027-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0013">
<span class="label">13.</span><cite>
Bortoli R. and Santiago M., “Chloroquine Ototoxicity,” Clinical Rheumatology
26, no. 11 (2007): 1809–1810, 10.1007/s10067-007-0662-6.
</cite> [<a href="https://doi.org/10.1007/s10067-007-0662-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17594118/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Rheumatology&amp;title=Chloroquine%20Ototoxicity&amp;author=R.%20Bortoli&amp;author=M.%20Santiago&amp;volume=26&amp;issue=11&amp;publication_year=2007&amp;pages=1809-1810&amp;pmid=17594118&amp;doi=10.1007/s10067-007-0662-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0014">
<span class="label">14.</span><cite>
Jing X. I. E., Talaska A. E., and Schacht J., “New Developments in Aminoglycoside Therapy and Ototoxicity: Pathology of the Inner Ear,” Hearing Research
281, no. 1–2 (2011): 28–37.
</cite> [<a href="https://doi.org/10.1016/j.heares.2011.05.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3169717/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21640178/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hearing%20Research&amp;title=New%20Developments%20in%20Aminoglycoside%20Therapy%20and%20Ototoxicity:%20Pathology%20of%20the%20Inner%20Ear&amp;author=X.%20I.%20E.%20Jing&amp;author=A.%20E.%20Talaska&amp;author=J.%20Schacht&amp;volume=281&amp;issue=1%E2%80%932&amp;publication_year=2011&amp;pages=28-37&amp;pmid=21640178&amp;doi=10.1016/j.heares.2011.05.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0015">
<span class="label">15.</span><cite>
Sheppard A., Hayes S. H., Chen G. D., Ralli M., and Salvi R., “Review of Salicylate‐Induced Hearing Loss, Neurotoxicity, Tinnitus and Neuropathophysiology,” Acta Otorhinolaryngologica Italica
34, no. 2 (2014): 79–93.
</cite> [<a href="/articles/PMC4025186/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24843217/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Otorhinolaryngologica%20Italica&amp;title=Review%20of%20Salicylate%E2%80%90Induced%20Hearing%20Loss,%20Neurotoxicity,%20Tinnitus%20and%20Neuropathophysiology&amp;author=A.%20Sheppard&amp;author=S.%20H.%20Hayes&amp;author=G.%20D.%20Chen&amp;author=M.%20Ralli&amp;author=R.%20Salvi&amp;volume=34&amp;issue=2&amp;publication_year=2014&amp;pages=79-93&amp;pmid=24843217&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0016">
<span class="label">16.</span><cite>
Hoshino T., Tabuchi K., and Hara A., “Effects of NSAIDs on the Inner Ear: Possible Involvement in Cochlear Protection,” Pharmaceuticals (Basel)
3, no. 5 (2010): 1286–1295, 10.3390/ph3051286.
</cite> [<a href="https://doi.org/10.3390/ph3051286" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4033980/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27713301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals%20(Basel)&amp;title=Effects%20of%20NSAIDs%20on%20the%20Inner%20Ear:%20Possible%20Involvement%20in%20Cochlear%20Protection&amp;author=T.%20Hoshino&amp;author=K.%20Tabuchi&amp;author=A.%20Hara&amp;volume=3&amp;issue=5&amp;publication_year=2010&amp;pages=1286-1295&amp;pmid=27713301&amp;doi=10.3390/ph3051286&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0017">
<span class="label">17.</span><cite>
Ding D., Liu H., Qi W., et al., “Ototoxic Effects and Mechanisms of Loop Diuretics,” Journal of Otology
11, no. 4 (2016): 145–156, 10.1016/j.joto.2016.10.001.
</cite> [<a href="https://doi.org/10.1016/j.joto.2016.10.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6002634/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29937824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Otology&amp;title=Ototoxic%20Effects%20and%20Mechanisms%20of%20Loop%20Diuretics&amp;author=D.%20Ding&amp;author=H.%20Liu&amp;author=W.%20Qi&amp;volume=11&amp;issue=4&amp;publication_year=2016&amp;pages=145-156&amp;pmid=29937824&amp;doi=10.1016/j.joto.2016.10.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0018">
<span class="label">18.</span><cite>
Ramkumar V., Mukherjea D., Dhukhwa A., and Rybak L. P., “Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity,” Antioxidants
10, no. 12 (2021): 1919, 10.3390/antiox10121919.
</cite> [<a href="https://doi.org/10.3390/antiox10121919" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8750101/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34943021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antioxidants&amp;title=Oxidative%20Stress%20and%20Inflammation%20Caused%20by%20Cisplatin%20Ototoxicity&amp;author=V.%20Ramkumar&amp;author=D.%20Mukherjea&amp;author=A.%20Dhukhwa&amp;author=L.%20P.%20Rybak&amp;volume=10&amp;issue=12&amp;publication_year=2021&amp;pages=1919&amp;pmid=34943021&amp;doi=10.3390/antiox10121919&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0019">
<span class="label">19.</span><cite>
Thunbo M. Ø., Vendelbo J. H., Witte D. R., Larsen A., and Pedersen L. H., “Use of Medication in Pregnancy on the Rise: Study on 1.4 Million Danish Pregnancies From 1998 to 2018,” Acta Obstetricia et Gynecologica Scandinavica
103, no. 6 (2024): 1210–1223, 10.1111/aogs.14805.
</cite> [<a href="https://doi.org/10.1111/aogs.14805" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11103131/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38491733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Obstetricia%20et%20Gynecologica%20Scandinavica&amp;title=Use%20of%20Medication%20in%20Pregnancy%20on%20the%20Rise:%20Study%20on%201.4%20Million%20Danish%20Pregnancies%20From%201998%20to%202018&amp;author=M.%20%C3%98.%20Thunbo&amp;author=J.%20H.%20Vendelbo&amp;author=D.%20R.%20Witte&amp;author=A.%20Larsen&amp;author=L.%20H.%20Pedersen&amp;volume=103&amp;issue=6&amp;publication_year=2024&amp;pages=1210-1223&amp;pmid=38491733&amp;doi=10.1111/aogs.14805&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0020">
<span class="label">20.</span><cite>
Daw J. R., Hanley G. E., Greyson D. L., and Morgan S. G., “Prescription Drug Use During Pregnancy in Developed Countries: A Systematic Review,” Pharmacoepidemiology and Drug Safety
20, no. 9 (2011): 895–902, 10.1002/pds.2184.
</cite> [<a href="https://doi.org/10.1002/pds.2184" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3423446/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21774029/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacoepidemiology%20and%20Drug%20Safety&amp;title=Prescription%20Drug%20Use%20During%20Pregnancy%20in%20Developed%20Countries:%20A%20Systematic%20Review&amp;author=J.%20R.%20Daw&amp;author=G.%20E.%20Hanley&amp;author=D.%20L.%20Greyson&amp;author=S.%20G.%20Morgan&amp;volume=20&amp;issue=9&amp;publication_year=2011&amp;pages=895-902&amp;pmid=21774029&amp;doi=10.1002/pds.2184&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0021">
<span class="label">21.</span><cite>
Page M. J., McKenzie J. E., Bossuyt P. M., et al., “The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews,” BMJ (Clinical Research ed.)
372 (2021): n71, 10.1136/bmj.n71.</cite> [<a href="https://doi.org/10.1136/bmj.n71" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8005924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33782057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20(Clinical%20Research%20ed.)&amp;title=The%20PRISMA%202020%20Statement:%20An%20Updated%20Guideline%20for%20Reporting%20Systematic%20Reviews&amp;author=M.%20J.%20Page&amp;author=J.%20E.%20McKenzie&amp;author=P.%20M.%20Bossuyt&amp;volume=372&amp;publication_year=2021&amp;pages=n71&amp;pmid=33782057&amp;doi=10.1136/bmj.n71&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0022">
<span class="label">22.</span><cite>
Page M. J., Moher D., Bossuyt P. M., et al., “PRISMA 2020 Explanation and Elaboration: Updated Guidance and Exemplars for Reporting Systematic Reviews,” BMJ (Clinical Research Ed.)
372 (2021.  Mar 29): n160, 10.1136/bmj.n160.</cite> [<a href="https://doi.org/10.1136/bmj.n160" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8005925/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33781993/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20(Clinical%20Research%20Ed.)&amp;title=PRISMA%202020%20Explanation%20and%20Elaboration:%20Updated%20Guidance%20and%20Exemplars%20for%20Reporting%20Systematic%20Reviews&amp;author=M.%20J.%20Page&amp;author=D.%20Moher&amp;author=P.%20M.%20Bossuyt&amp;volume=372&amp;publication_year=2021&amp;pages=n160&amp;pmid=33781993&amp;doi=10.1136/bmj.n160&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0023">
<span class="label">23.</span><cite>
da Costa Santos C. M., de Mattos Pimenta C. A., and Nobre M. R., “The PICO Strategy for the Research Question Construction and Evidence Search,” Revista Latino‐Americana de Enfermagem
15, no. 3 (2007): 508–511, 10.1590/s0104-11692007000300023.
</cite> [<a href="https://doi.org/10.1590/s0104-11692007000300023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17653438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Revista%20Latino%E2%80%90Americana%20de%20Enfermagem&amp;title=The%20PICO%20Strategy%20for%20the%20Research%20Question%20Construction%20and%20Evidence%20Search&amp;author=C.%20M.%20da%20Costa%20Santos&amp;author=C.%20A.%20de%20Mattos%20Pimenta&amp;author=M.%20R.%20Nobre&amp;volume=15&amp;issue=3&amp;publication_year=2007&amp;pages=508-511&amp;pmid=17653438&amp;doi=10.1590/s0104-11692007000300023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0024">
<span class="label">24.</span><cite>
Wells G., Shea B., O'Connell D., et al., “The Newcastle‐Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta‐Analyses,” <a href="https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</a>.</cite>
</li>
<li id="bcpt70090-bib-0025">
<span class="label">25.</span><cite>
Sterne J. A., Savović J., Page M. J., et al., “RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials,” BMJ (Clinical Research Ed.)
366 (2019): l4898.</cite> [<a href="https://doi.org/10.1136/bmj.l4898" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31462531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20(Clinical%20Research%20Ed.)&amp;title=RoB%202:%20A%20Revised%20Tool%20for%20Assessing%20Risk%20of%20Bias%20in%20Randomised%20Trials&amp;author=J.%20A.%20Sterne&amp;author=J.%20Savovi%C4%87&amp;author=M.%20J.%20Page&amp;volume=366&amp;publication_year=2019&amp;pages=l4898&amp;pmid=31462531&amp;doi=10.1136/bmj.l4898&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0026">
<span class="label">26.</span><cite>
Howick J., Chalmers I., Glasziou P., et al., “OCEBM Levels of Evidence 2011,” <a href="https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.cebm.ox.ac.uk/resources/levels‐of‐evidence/ocebm‐levels‐of‐evidence</a>.</cite>
</li>
<li id="bcpt70090-bib-0027">
<span class="label">27.</span><cite>
Borba E. F., Turrini‐Filho J. R., Kumma K. A. M., et al., “Chloroquine Gestational Use in Systemic Lupus Erythematosus: Assessing the Risk of Child Ototoxicity by Pure Tone Audiometry,” Lupus
13, no. 4 (2004): 223–227, 10.1191/0961203304lu528oa.
</cite> [<a href="https://doi.org/10.1191/0961203304lu528oa" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15176656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lupus&amp;title=Chloroquine%20Gestational%20Use%20in%20Systemic%20Lupus%20Erythematosus:%20Assessing%20the%20Risk%20of%20Child%20Ototoxicity%20by%20Pure%20Tone%20Audiometry&amp;author=E.%20F.%20Borba&amp;author=J.%20R.%20Turrini%E2%80%90Filho&amp;author=K.%20A.%20M.%20Kumma&amp;volume=13&amp;issue=4&amp;publication_year=2004&amp;pages=223-227&amp;pmid=15176656&amp;doi=10.1191/0961203304lu528oa&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0028">
<span class="label">28.</span><cite>
Fakhim S. A., Naderpoor M., Shahidi N., et al., “Study of Prevalence and Causes of Hearing Loss in High Risk Neonates Admitted to Neonatal Ward and Neonatal Intensive Care Unit,” Journal of International Advanced Otology
6, no. 3 (2010): 365–370.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20International%20Advanced%20Otology&amp;title=Study%20of%20Prevalence%20and%20Causes%20of%20Hearing%20Loss%20in%20High%20Risk%20Neonates%20Admitted%20to%20Neonatal%20Ward%20and%20Neonatal%20Intensive%20Care%20Unit&amp;author=S.%20A.%20Fakhim&amp;author=M.%20Naderpoor&amp;author=N.%20Shahidi&amp;volume=6&amp;issue=3&amp;publication_year=2010&amp;pages=365-370&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0029">
<span class="label">29.</span><cite>
Fasunla A. J., Nwaorgu O. G., Taiwo B., et al., “Comparison of Hearing Status of HIV‐Exposed and ‐Unexposed Newborns and Immunovirologic Correlates in HIV‐Exposed Newborns,” Otolaryngology‐Head and Neck Surgery
151, no. S1 (2014): P81–P82 Annual Meeting of the American Academy of Otolaryngology‐Head and Neck Surgery Foundation 2014. Orlando, FL United States. (Var.Pagings)., 10.1177/0194599814541627a165.</cite> [<a href="https://doi.org/10.1177/0194599814541627a165" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Otolaryngology%E2%80%90Head%20and%20Neck%20Surgery&amp;title=Comparison%20of%20Hearing%20Status%20of%20HIV%E2%80%90Exposed%20and%20%E2%80%90Unexposed%20Newborns%20and%20Immunovirologic%20Correlates%20in%20HIV%E2%80%90Exposed%20Newborns&amp;author=A.%20J.%20Fasunla&amp;author=O.%20G.%20Nwaorgu&amp;author=B.%20Taiwo&amp;volume=151&amp;issue=S1&amp;publication_year=2014&amp;pages=P81-P82&amp;doi=10.1177/0194599814541627a165&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0030">
<span class="label">30.</span><cite>
Finch L. E. and Cardonick E. H., “Incidence of Childhood Hearing Loss After <em>In Utero</em> Exposure to Platinum Agents,” Prenatal Diagnosis
41, no. 11 (2021): 1467–1474, 10.1002/pd.6035.
</cite> [<a href="https://doi.org/10.1002/pd.6035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34462927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prenatal%20Diagnosis&amp;title=Incidence%20of%20Childhood%20Hearing%20Loss%20After%20In%20Utero%20Exposure%20to%20Platinum%20Agents&amp;author=L.%20E.%20Finch&amp;author=E.%20H.%20Cardonick&amp;volume=41&amp;issue=11&amp;publication_year=2021&amp;pages=1467-1474&amp;pmid=34462927&amp;doi=10.1002/pd.6035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0031">
<span class="label">31.</span><cite>
Gazia F., Abita P., Alberti G., et al., “NICU Infants &amp; SNHL: Experience of A Western Sicily Tertiary Care Centre,” Acta Medica Mediterranea
35, no. 2 (2019): 1001–1007, 10.19193/0393-6384_2019_2_152.</cite> [<a href="https://doi.org/10.19193/0393-6384_2019_2_152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Medica%20Mediterranea&amp;title=NICU%20Infants%20&amp;%20SNHL:%20Experience%20of%20A%20Western%20Sicily%20Tertiary%20Care%20Centre&amp;author=F.%20Gazia&amp;author=P.%20Abita&amp;author=G.%20Alberti&amp;volume=35&amp;issue=2&amp;publication_year=2019&amp;pages=1001-1007&amp;doi=10.19193/0393-6384_2019_2_152&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0032">
<span class="label">32.</span><cite>
Kasapoglu I., Cetinkaya Demir B., Atalay M. A., et al., “Does Antenatal Magnesium Sulphate Improve Hearing Function in Premature Newborns?,” Journal of the Turkish‐German Gynecological Association
21, no. 3 (2020): 187–192, 10.4274/jtgga.galenos.2019.2019.0070.
</cite> [<a href="https://doi.org/10.4274/jtgga.galenos.2019.2019.0070" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7495126/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31927812/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20Turkish%E2%80%90German%20Gynecological%20Association&amp;title=Does%20Antenatal%20Magnesium%20Sulphate%20Improve%20Hearing%20Function%20in%20Premature%20Newborns?&amp;author=I.%20Kasapoglu&amp;author=B.%20Cetinkaya%20Demir&amp;author=M.%20A.%20Atalay&amp;volume=21&amp;issue=3&amp;publication_year=2020&amp;pages=187-192&amp;pmid=31927812&amp;doi=10.4274/jtgga.galenos.2019.2019.0070&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0033">
<span class="label">33.</span><cite>
Leung J. C., Cifra C. L., Agthe A. G., Sun C.‐C. J., and Viscardi R. M., “Antenatal Factors Modulate Hearing Screen Failure Risk in Preterm Infants,” Archives of Disease in Childhood
101, no. 1 (2016): 56–61, 10.1136/archdischild-2014-307843.</cite> [<a href="https://doi.org/10.1136/archdischild-2014-307843" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26195624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Archives%20of%20Disease%20in%20Childhood&amp;title=Antenatal%20Factors%20Modulate%20Hearing%20Screen%20Failure%20Risk%20in%20Preterm%20Infants&amp;author=J.%20C.%20Leung&amp;author=C.%20L.%20Cifra&amp;author=A.%20G.%20Agthe&amp;author=C.%E2%80%90C.%20J.%20Sun&amp;author=R.%20M.%20Viscardi&amp;volume=101&amp;issue=1&amp;publication_year=2016&amp;pages=56-61&amp;pmid=26195624&amp;doi=10.1136/archdischild-2014-307843&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0034">
<span class="label">34.</span><cite>
Patatt F. S. A., Sampaio A. L. L., Tauil P. L., and de Oliveira C., “Hearing of Neonates Without Risk Indicators for Hearing Loss and Use of Antimalarial Drugs During Pregnancy: A Historical Cohort Study in the Northern Region of Brazil,” Brazilian Journal of Otorhinolaryngology
87, no. 1 (2021): 19–27, 10.1016/j.bjorl.2019.06.005.
</cite> [<a href="https://doi.org/10.1016/j.bjorl.2019.06.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9422607/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31387792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brazilian%20Journal%20of%20Otorhinolaryngology&amp;title=Hearing%20of%20Neonates%20Without%20Risk%20Indicators%20for%20Hearing%20Loss%20and%20Use%20of%20Antimalarial%20Drugs%20During%20Pregnancy:%20A%20Historical%20Cohort%20Study%20in%20the%20Northern%20Region%20of%20Brazil&amp;author=F.%20S.%20A.%20Patatt&amp;author=A.%20L.%20L.%20Sampaio&amp;author=P.%20L.%20Tauil&amp;author=C.%20de%20Oliveira&amp;volume=87&amp;issue=1&amp;publication_year=2021&amp;pages=19-27&amp;pmid=31387792&amp;doi=10.1016/j.bjorl.2019.06.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0035">
<span class="label">35.</span><cite>
Da Silva V. B., Sousa M. A., Kuniyoshi I. C., Aurelio F. S., Sampaio A. L. L., and De Oliveira C. A. C. P., “Risk of Hearing Alterations in Newborns of Mothers Treated for Malaria,” International Tinnitus Journal
19, no. 2 (2015): 20–25, 10.5935/0946-5448.20150004.
</cite> [<a href="https://doi.org/10.5935/0946-5448.20150004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27186928/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Tinnitus%20Journal&amp;title=Risk%20of%20Hearing%20Alterations%20in%20Newborns%20of%20Mothers%20Treated%20for%20Malaria&amp;author=V.%20B.%20Da%20Silva&amp;author=M.%20A.%20Sousa&amp;author=I.%20C.%20Kuniyoshi&amp;author=F.%20S.%20Aurelio&amp;author=A.%20L.%20L.%20Sampaio&amp;volume=19&amp;issue=2&amp;publication_year=2015&amp;pages=20-25&amp;pmid=27186928&amp;doi=10.5935/0946-5448.20150004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0036">
<span class="label">36.</span><cite>
Waters T., Silva N., Denney J., Sciscione A., and Paul D., “Neonatal Hearing Assessment in Very Low Birth Weight Infants Exposed to Antenatal Steroids,” Journal of Perinatology
28, no. 1 (2008): 67–70.
</cite> [<a href="https://doi.org/10.1038/sj.jp.7211862" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18033305/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Perinatology&amp;title=Neonatal%20Hearing%20Assessment%20in%20Very%20Low%20Birth%20Weight%20Infants%20Exposed%20to%20Antenatal%20Steroids&amp;author=T.%20Waters&amp;author=N.%20Silva&amp;author=J.%20Denney&amp;author=A.%20Sciscione&amp;author=D.%20Paul&amp;volume=28&amp;issue=1&amp;publication_year=2008&amp;pages=67-70&amp;pmid=18033305&amp;doi=10.1038/sj.jp.7211862&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0037">
<span class="label">37.</span><cite>
Bang Madsen K., Robakis T. K., Liu X., et al., “In Utero Exposure to ADHD Medication and Long‐Term Offspring Outcomes,” Molecular Psychiatry
28, no. 4 (2023): 1739–1746.
</cite> [<a href="https://doi.org/10.1038/s41380-023-01992-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36759544/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Psychiatry&amp;title=In%20Utero%20Exposure%20to%20ADHD%20Medication%20and%20Long%E2%80%90Term%20Offspring%20Outcomes&amp;author=K.%20Bang%20Madsen&amp;author=T.%20K.%20Robakis&amp;author=X.%20Liu&amp;volume=28&amp;issue=4&amp;publication_year=2023&amp;pages=1739-1746&amp;pmid=36759544&amp;doi=10.1038/s41380-023-01992-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0038">
<span class="label">38.</span><cite>
Azizi A., Mansori N., Amirian F., Rahimi S., Dargahi A., and Beidaghi S., “Investigating the Prevalence of Neonatal Hearing Loss and Its Risk Factors in Kermanshah,” Journal of Chemical and Pharmaceutical Sciences
9, no. 4 (2016): 3091–3095.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Chemical%20and%20Pharmaceutical%20Sciences&amp;title=Investigating%20the%20Prevalence%20of%20Neonatal%20Hearing%20Loss%20and%20Its%20Risk%20Factors%20in%20Kermanshah&amp;author=A.%20Azizi&amp;author=N.%20Mansori&amp;author=F.%20Amirian&amp;author=S.%20Rahimi&amp;author=A.%20Dargahi&amp;volume=9&amp;issue=4&amp;publication_year=2016&amp;pages=3091-3095&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0039">
<span class="label">39.</span><cite>
Foch C., Araujo M., Weckel A., et al., “In Utero Drug Exposure and Hearing Disorders in 2‐Year‐Old Children: A Case‐Control Study Using the EFEMERIS Database,” Pharmacoepidemiology and Drug Safety
27, no. Supplement 2 (2018): 381. 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Prague Czechia., 10.1002/pds.4629.</cite> [<a href="https://doi.org/10.1002/pds.4629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacoepidemiology%20and%20Drug%20Safety&amp;title=In%20Utero%20Drug%20Exposure%20and%20Hearing%20Disorders%20in%202%E2%80%90Year%E2%80%90Old%20Children:%20A%20Case%E2%80%90Control%20Study%20Using%20the%20EFEMERIS%20Database&amp;author=C.%20Foch&amp;author=M.%20Araujo&amp;author=A.%20Weckel&amp;volume=27&amp;issue=Supplement%202&amp;publication_year=2018&amp;pages=381&amp;doi=10.1002/pds.4629&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0040">
<span class="label">40.</span><cite>
Tsao P.‐C., Lin H.‐C., Chiu H.‐Y., and Chang Y.‐C., “Maternal, Perinatal, and Postnatal Predisposing Factors of Hearing Loss in Full‐Term Children: A Matched Case‐Control Study,” Neonatology
120, no. 5 (2023): 607–614.
</cite> [<a href="https://doi.org/10.1159/000530646" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37321203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neonatology&amp;title=Maternal,%20Perinatal,%20and%20Postnatal%20Predisposing%20Factors%20of%20Hearing%20Loss%20in%20Full%E2%80%90Term%20Children:%20A%20Matched%20Case%E2%80%90Control%20Study&amp;author=P.%E2%80%90C.%20Tsao&amp;author=H.%E2%80%90C.%20Lin&amp;author=H.%E2%80%90Y.%20Chiu&amp;author=Y.%E2%80%90C.%20Chang&amp;volume=120&amp;issue=5&amp;publication_year=2023&amp;pages=607-614&amp;pmid=37321203&amp;doi=10.1159/000530646&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0041">
<span class="label">41.</span><cite>
Tsao P.‐C., Lin H.‐C., Shen S.‐P., and Chang Y.‐C., “Exploring Predisposing Factors of Hearing Loss in Prematurely Born Children: A Nationwide Case‐Control Study,” Pediatrics and Neonatology (2024).</cite> [<a href="https://doi.org/10.1016/j.pedneo.2024.04.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38811322/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatrics%20and%20Neonatology&amp;title=Exploring%20Predisposing%20Factors%20of%20Hearing%20Loss%20in%20Prematurely%20Born%20Children:%20A%20Nationwide%20Case%E2%80%90Control%20Study&amp;author=P.%E2%80%90C.%20Tsao&amp;author=H.%E2%80%90C.%20Lin&amp;author=S.%E2%80%90P.%20Shen&amp;author=Y.%E2%80%90C.%20Chang&amp;publication_year=2024&amp;pmid=38811322&amp;doi=10.1016/j.pedneo.2024.04.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0042">
<span class="label">42.</span><cite>
Wang Y., Liu L., and Huang Y., “Effect of Antenatal Dexamethasone Therapy on Hearing Screening in Premature Infants: A Retrospective Case‐Control Study,” American Journal of Otolaryngology
44, no. 2 (2023): 103734.
</cite> [<a href="https://doi.org/10.1016/j.amjoto.2022.103734" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36577171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Otolaryngology&amp;title=Effect%20of%20Antenatal%20Dexamethasone%20Therapy%20on%20Hearing%20Screening%20in%20Premature%20Infants:%20A%20Retrospective%20Case%E2%80%90Control%20Study&amp;author=Y.%20Wang&amp;author=L.%20Liu&amp;author=Y.%20Huang&amp;volume=44&amp;issue=2&amp;publication_year=2023&amp;pages=103734&amp;pmid=36577171&amp;doi=10.1016/j.amjoto.2022.103734&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0043">
<span class="label">43.</span><cite>
Asztalos E., Murphy K., Hannah M., et al., “Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study: 5‐Year Outcomes (MACS‐5),” American Journal of Obstetrics and Gynecology
208, no. SUPPL.1 (2013): S2–S3. 33rd Annual Meeting of the Society for Maternal‐Fetal Medicine: The Pregnancy Meeting. San Francisco, CA United States. (var.pagings), 10.1016/j.ajog.2012.10.176.</cite> [<a href="https://doi.org/10.1016/j.ajog.2012.10.176" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Obstetrics%20and%20Gynecology&amp;title=Multiple%20Courses%20of%20Antenatal%20Corticosteroids%20for%20Preterm%20Birth%20Study:%205%E2%80%90Year%20Outcomes%20(MACS%E2%80%905)&amp;author=E.%20Asztalos&amp;author=K.%20Murphy&amp;author=M.%20Hannah&amp;volume=208&amp;issue=SUPPL.1&amp;publication_year=2013&amp;pages=S2-S3&amp;doi=10.1016/j.ajog.2012.10.176&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0044">
<span class="label">44.</span><cite>
Crowther C. A., Doyle L. W., Haslam R. R., Hiller J. E., Harding J. E., and Robinson J. S., “Outcomes at 2 Years of Age After Repeat Doses of Antenatal Corticosteroids,” New England Journal of Medicine
357, no. 12 (2007): 1179–1189, 10.1056/NEJMoa071152.
</cite> [<a href="https://doi.org/10.1056/NEJMoa071152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17881750/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Outcomes%20at%202%20Years%20of%20Age%20After%20Repeat%20Doses%20of%20Antenatal%20Corticosteroids&amp;author=C.%20A.%20Crowther&amp;author=L.%20W.%20Doyle&amp;author=R.%20R.%20Haslam&amp;author=J.%20E.%20Hiller&amp;author=J.%20E.%20Harding&amp;volume=357&amp;issue=12&amp;publication_year=2007&amp;pages=1179-1189&amp;pmid=17881750&amp;doi=10.1056/NEJMoa071152&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0045">
<span class="label">45.</span><cite>
Crowther C. A., Ashwood P., Andersen C. C., et al., “Maternal Intramuscular Dexamethasone Versus Betamethasone Before Preterm Birth (ASTEROID): A Multicentre, Double‐Blind, Randomised Controlled Trial,” Lancet Child &amp; Adolescent Health
3, no. 11 (2019): 769–780, 10.1016/S2352-4642(19)30292-5.
</cite> [<a href="https://doi.org/10.1016/S2352-4642(19)30292-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31523039/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Child%20&amp;%20Adolescent%20Health&amp;title=Maternal%20Intramuscular%20Dexamethasone%20Versus%20Betamethasone%20Before%20Preterm%20Birth%20(ASTEROID):%20A%20Multicentre,%20Double%E2%80%90Blind,%20Randomised%20Controlled%20Trial&amp;author=C.%20A.%20Crowther&amp;author=P.%20Ashwood&amp;author=C.%20C.%20Andersen&amp;volume=3&amp;issue=11&amp;publication_year=2019&amp;pages=769-780&amp;pmid=31523039&amp;doi=10.1016/S2352-4642(19)30292-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0046">
<span class="label">46.</span><cite>
Soraisham A. S., Sauve R., and Singhal N., “Indomethacin Tocolysis and Neurodevelopmental Outcome,” Indian Journal of Pediatrics
78, no. 8 (2011): 946–952, 10.1007/s12098-011-0365-5.
</cite> [<a href="https://doi.org/10.1007/s12098-011-0365-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21318396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indian%20Journal%20of%20Pediatrics&amp;title=Indomethacin%20Tocolysis%20and%20Neurodevelopmental%20Outcome&amp;author=A.%20S.%20Soraisham&amp;author=R.%20Sauve&amp;author=N.%20Singhal&amp;volume=78&amp;issue=8&amp;publication_year=2011&amp;pages=946-952&amp;pmid=21318396&amp;doi=10.1007/s12098-011-0365-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0047">
<span class="label">47.</span><cite>
The Magpie Trial Follow Up Study Management G
, “The Magpie Trial Follow Up Study: Outcome After Discharge From Hospital for Women and Children Recruited to a Trial Comparing Magnesium Sulphate With Placebo for Pre‐Eclampsia [ISRCTN86938761],” BMC Pregnancy and Childbirth
4, no. 1 (2004): 5, 10.1186/1471-2393-4-5.
</cite> [<a href="https://doi.org/10.1186/1471-2393-4-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC416479/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15113445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Pregnancy%20and%20Childbirth&amp;title=The%20Magpie%20Trial%20Follow%20Up%20Study:%20Outcome%20After%20Discharge%20From%20Hospital%20for%20Women%20and%20Children%20Recruited%20to%20a%20Trial%20Comparing%20Magnesium%20Sulphate%20With%20Placebo%20for%20Pre%E2%80%90Eclampsia%20%5BISRCTN86938761%5D&amp;volume=4&amp;issue=1&amp;publication_year=2004&amp;pages=5&amp;pmid=15113445&amp;doi=10.1186/1471-2393-4-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0048">
<span class="label">48.</span><cite>
Sotiriadis A., Tsiami A., Papatheodorou S., Baschat A. A., Sarafidis K., and Makrydimas G., “Neurodevelopmental Outcome After a Single Course of Antenatal Steroids in Children Born Preterm: A Systematic Review and Meta‐Analysis,” Obstetrics and Gynecology (New York 1953)
125, no. 6 (2015): 1385–1396, 10.1097/AOG.0000000000000748.</cite> [<a href="https://doi.org/10.1097/AOG.0000000000000748" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26000510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Obstetrics%20and%20Gynecology%20(New%20York%201953)&amp;title=Neurodevelopmental%20Outcome%20After%20a%20Single%20Course%20of%20Antenatal%20Steroids%20in%20Children%20Born%20Preterm:%20A%20Systematic%20Review%20and%20Meta%E2%80%90Analysis&amp;author=A.%20Sotiriadis&amp;author=A.%20Tsiami&amp;author=S.%20Papatheodorou&amp;author=A.%20A.%20Baschat&amp;author=K.%20Sarafidis&amp;volume=125&amp;issue=6&amp;publication_year=2015&amp;pages=1385-1396&amp;pmid=26000510&amp;doi=10.1097/AOG.0000000000000748&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0049">
<span class="label">49.</span><cite>
Ninan K., Liyanage S. K., Murphy K. E., Asztalos E. V., and McDonald S. D., “Evaluation of Long‐Term Outcomes Associated With Preterm Exposure to Antenatal Corticosteroids: A Systematic Review and Meta‐Analysis,” JAMA Pediatrics
176, no. 6 (2022): e220483, 10.1001/jamapediatrics.2022.0483.
</cite> [<a href="https://doi.org/10.1001/jamapediatrics.2022.0483" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9002717/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35404395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Pediatrics&amp;title=Evaluation%20of%20Long%E2%80%90Term%20Outcomes%20Associated%20With%20Preterm%20Exposure%20to%20Antenatal%20Corticosteroids:%20A%20Systematic%20Review%20and%20Meta%E2%80%90Analysis&amp;author=K.%20Ninan&amp;author=S.%20K.%20Liyanage&amp;author=K.%20E.%20Murphy&amp;author=E.%20V.%20Asztalos&amp;author=S.%20D.%20McDonald&amp;volume=176&amp;issue=6&amp;publication_year=2022&amp;pages=e220483&amp;pmid=35404395&amp;doi=10.1001/jamapediatrics.2022.0483&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0050">
<span class="label">50.</span><cite>
Carlo W. A., McDonald S. A., Fanaroff A. A., et al., “Association of Antenatal Corticosteroids With Mortality and Neurodevelopmental Outcomes Among Infants Born at 22 to 25 Weeks' Gestation,” Journal of the American Medical Association
306, no. 21 (2011): 2348–2358, 10.1001/jama.2011.1752.
</cite> [<a href="https://doi.org/10.1001/jama.2011.1752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3565238/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22147379/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Medical%20Association&amp;title=Association%20of%20Antenatal%20Corticosteroids%20With%20Mortality%20and%20Neurodevelopmental%20Outcomes%20Among%20Infants%20Born%20at%2022%20to%2025%20Weeks'%20Gestation&amp;author=W.%20A.%20Carlo&amp;author=S.%20A.%20McDonald&amp;author=A.%20A.%20Fanaroff&amp;volume=306&amp;issue=21&amp;publication_year=2011&amp;pages=2348-2358&amp;pmid=22147379&amp;doi=10.1001/jama.2011.1752&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0051">
<span class="label">51.</span><cite>
Kim S. H., Choi B. Y., Park J., Jung E. Y., Cho S.‐H., and Park K. H., “Maternal and Placental Factors Associated With Congenital Hearing Loss in Very Preterm Neonates,” Pediatrics and Neonatology
58, no. 3 (2017): 236–244, 10.1016/j.pedneo.2016.05.003.
</cite> [<a href="https://doi.org/10.1016/j.pedneo.2016.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27596679/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatrics%20and%20Neonatology&amp;title=Maternal%20and%20Placental%20Factors%20Associated%20With%20Congenital%20Hearing%20Loss%20in%20Very%20Preterm%20Neonates&amp;author=S.%20H.%20Kim&amp;author=B.%20Y.%20Choi&amp;author=J.%20Park&amp;author=E.%20Y.%20Jung&amp;author=S.%E2%80%90H.%20Cho&amp;volume=58&amp;issue=3&amp;publication_year=2017&amp;pages=236-244&amp;pmid=27596679&amp;doi=10.1016/j.pedneo.2016.05.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0052">
<span class="label">52.</span><cite>
Raikkonen K., Gissler M., Tapiainen T., and Kajantie E., “Associations Between Maternal Antenatal Corticosteroid Treatment and Psychological Developmental and Neurosensory Disorders in Children,” JAMA Network Open
5, no. 8 (2020): e2228518, 10.1001/jamanetworkopen.2022.28518.</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2022.28518" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9403777/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36001315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Network%20Open&amp;title=Associations%20Between%20Maternal%20Antenatal%20Corticosteroid%20Treatment%20and%20Psychological%20Developmental%20and%20Neurosensory%20Disorders%20in%20Children&amp;author=K.%20Raikkonen&amp;author=M.%20Gissler&amp;author=T.%20Tapiainen&amp;author=E.%20Kajantie&amp;volume=5&amp;issue=8&amp;publication_year=2020&amp;pages=e2228518&amp;pmid=36001315&amp;doi=10.1001/jamanetworkopen.2022.28518&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0053">
<span class="label">53.</span><cite>
Wolf H. T., Huusom L. D., Henriksen T. B., Hegaard H. K., Brok J., and Pinborg A., “Magnesium Sulphate for Fetal Neuroprotection at Imminent Risk for Preterm Delivery: A Systematic Review With Meta‐Analysis and Trial Sequential Analysis,” BJOG: An International Journal of Obstetrics and Gynaecology
127, no. 10 (2020): 1180–1188, 10.1111/1471-0528.16238.
</cite> [<a href="https://doi.org/10.1111/1471-0528.16238" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32237069/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BJOG:%20An%20International%20Journal%20of%20Obstetrics%20and%20Gynaecology&amp;title=Magnesium%20Sulphate%20for%20Fetal%20Neuroprotection%20at%20Imminent%20Risk%20for%20Preterm%20Delivery:%20A%20Systematic%20Review%20With%20Meta%E2%80%90Analysis%20and%20Trial%20Sequential%20Analysis&amp;author=H.%20T.%20Wolf&amp;author=L.%20D.%20Huusom&amp;author=T.%20B.%20Henriksen&amp;author=H.%20K.%20Hegaard&amp;author=J.%20Brok&amp;volume=127&amp;issue=10&amp;publication_year=2020&amp;pages=1180-1188&amp;pmid=32237069&amp;doi=10.1111/1471-0528.16238&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0054">
<span class="label">54.</span><cite>
Doyle L. W., Crowther C. A., Middleton P., Marret S., and Rouse D., “Magnesium Sulphate for Women at Risk of Preterm Birth for Neuroprotection of the Fetus,” Cochrane Database of Systematic Reviews
1 (2009): CD004661, 10.1002/14651858.CD004661.pub3.</cite> [<a href="https://doi.org/10.1002/14651858.CD004661.pub3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19160238/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cochrane%20Database%20of%20Systematic%20Reviews&amp;title=Magnesium%20Sulphate%20for%20Women%20at%20Risk%20of%20Preterm%20Birth%20for%20Neuroprotection%20of%20the%20Fetus&amp;author=L.%20W.%20Doyle&amp;author=C.%20A.%20Crowther&amp;author=P.%20Middleton&amp;author=S.%20Marret&amp;author=D.%20Rouse&amp;volume=1&amp;publication_year=2009&amp;pages=CD004661&amp;pmid=19160238&amp;doi=10.1002/14651858.CD004661.pub3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0055">
<span class="label">55.</span><cite>
Xiong M. M. D., Wang J. M. D., Yang C., and Lai H. M. D., “The Cochlea Magnesium Content is Negatively Correlated With Hearing Loss Induced by Impulse Noise,” American Journal of Otolaryngology
34, no. 3 (2013): 209–215, 10.1016/j.amjoto.2012.11.015.
</cite> [<a href="https://doi.org/10.1016/j.amjoto.2012.11.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23332299/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Otolaryngology&amp;title=The%20Cochlea%20Magnesium%20Content%20is%20Negatively%20Correlated%20With%20Hearing%20Loss%20Induced%20by%20Impulse%20Noise&amp;author=M.%20M.%20D.%20Xiong&amp;author=J.%20M.%20D.%20Wang&amp;author=C.%20Yang&amp;author=H.%20M.%20D.%20Lai&amp;volume=34&amp;issue=3&amp;publication_year=2013&amp;pages=209-215&amp;pmid=23332299&amp;doi=10.1016/j.amjoto.2012.11.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0056">
<span class="label">56.</span><cite>
Abaamrane L., Raffin F., Gal M., Avan P., and Sendowski I., “Long‐Term Administration of Magnesium After Acoustic Trauma Caused by Gunshot Noise in Guinea Pigs,” Hearing Research
247, no. 2 (2009): 137–145, 10.1016/j.heares.2008.11.005.
</cite> [<a href="https://doi.org/10.1016/j.heares.2008.11.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19084059/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hearing%20Research&amp;title=Long%E2%80%90Term%20Administration%20of%20Magnesium%20After%20Acoustic%20Trauma%20Caused%20by%20Gunshot%20Noise%20in%20Guinea%20Pigs&amp;author=L.%20Abaamrane&amp;author=F.%20Raffin&amp;author=M.%20Gal&amp;author=P.%20Avan&amp;author=I.%20Sendowski&amp;volume=247&amp;issue=2&amp;publication_year=2009&amp;pages=137-145&amp;pmid=19084059&amp;doi=10.1016/j.heares.2008.11.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0057">
<span class="label">57.</span><cite>
Scheibe F., Haupt H., Mazurek B., and König O., “Therapeutic Effect of Magnesium on Noise‐Induced Hearing Loss,” Noise &amp; Health
3, no. 11 (2001): 79–84.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/12689450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Noise%20&amp;%20Health&amp;title=Therapeutic%20Effect%20of%20Magnesium%20on%20Noise%E2%80%90Induced%20Hearing%20Loss&amp;author=F.%20Scheibe&amp;author=H.%20Haupt&amp;author=B.%20Mazurek&amp;author=O.%20K%C3%B6nig&amp;volume=3&amp;issue=11&amp;publication_year=2001&amp;pages=79-84&amp;pmid=12689450&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0058">
<span class="label">58.</span><cite>
Lanvers‐Kaminsky C., Zehnhoff‐Dinnesen A. G., Parfitt R., and Ciarimboli G., “Drug‐Induced Ototoxicity: Mechanisms, Pharmacogenetics, and Protective Strategies,” Clinical Pharmacology and Therapeutics
101, no. 4 (2017): 491–500, 10.1002/cpt.603.
</cite> [<a href="https://doi.org/10.1002/cpt.603" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28002638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Pharmacology%20and%20Therapeutics&amp;title=Drug%E2%80%90Induced%20Ototoxicity:%20Mechanisms,%20Pharmacogenetics,%20and%20Protective%20Strategies&amp;author=C.%20Lanvers%E2%80%90Kaminsky&amp;author=A.%20G.%20Zehnhoff%E2%80%90Dinnesen&amp;author=R.%20Parfitt&amp;author=G.%20Ciarimboli&amp;volume=101&amp;issue=4&amp;publication_year=2017&amp;pages=491-500&amp;pmid=28002638&amp;doi=10.1002/cpt.603&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0059">
<span class="label">59.</span><cite>
Rizk H. G., Lee J. A., Liu Y. F., Endriukaitis L., Isaac J. L., and Bullington W. M., “Drug‐Induced Ototoxicity: A Comprehensive Review and Reference Guide,” Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
40, no. 12 (2020): 1265–1275.</cite> [<a href="https://doi.org/10.1002/phar.2478" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33080070/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacotherapy:%20The%20Journal%20of%20Human%20Pharmacology%20and%20Drug%20Therapy&amp;title=Drug%E2%80%90Induced%20Ototoxicity:%20A%20Comprehensive%20Review%20and%20Reference%20Guide&amp;author=H.%20G.%20Rizk&amp;author=J.%20A.%20Lee&amp;author=Y.%20F.%20Liu&amp;author=L.%20Endriukaitis&amp;author=J.%20L.%20Isaac&amp;volume=40&amp;issue=12&amp;publication_year=2020&amp;pages=1265-1275&amp;pmid=33080070&amp;doi=10.1002/phar.2478&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0060">
<span class="label">60.</span><cite>
Koren G., Florescu A., Costei A. M., Boskovic R., and Moretti M. E., “Nonsteroidal Antiinflammatory Drugs During Third Trimester and the Risk of Premature Closure of the Ductus Arteriosus: A Meta‐Analysis,” Annals of Pharmacotherapy
40, no. 5 (2006): 824–829, 10.1345/aph.1G428.
</cite> [<a href="https://doi.org/10.1345/aph.1G428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16638921/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Pharmacotherapy&amp;title=Nonsteroidal%20Antiinflammatory%20Drugs%20During%20Third%20Trimester%20and%20the%20Risk%20of%20Premature%20Closure%20of%20the%20Ductus%20Arteriosus:%20A%20Meta%E2%80%90Analysis&amp;author=G.%20Koren&amp;author=A.%20Florescu&amp;author=A.%20M.%20Costei&amp;author=R.%20Boskovic&amp;author=M.%20E.%20Moretti&amp;volume=40&amp;issue=5&amp;publication_year=2006&amp;pages=824-829&amp;pmid=16638921&amp;doi=10.1345/aph.1G428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0061">
<span class="label">61.</span><cite>
Dathe K., Frank J., Padberg S., Hultzsch S., Beck E., and Schaefer C., “Fetal Adverse Effects Following NSAID or Metamizole Exposure in the 2nd and 3rd Trimester: An Evaluation of the German Embryotox Cohort,” BMC Pregnancy and Childbirth
22, no. 1 (2022): 1–666, 10.1186/s12884-022-04986-4.
</cite> [<a href="https://doi.org/10.1186/s12884-022-04986-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9413886/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36028798/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Pregnancy%20and%20Childbirth&amp;title=Fetal%20Adverse%20Effects%20Following%20NSAID%20or%20Metamizole%20Exposure%20in%20the%202nd%20and%203rd%20Trimester:%20An%20Evaluation%20of%20the%20German%20Embryotox%20Cohort&amp;author=K.%20Dathe&amp;author=J.%20Frank&amp;author=S.%20Padberg&amp;author=S.%20Hultzsch&amp;author=E.%20Beck&amp;volume=22&amp;issue=1&amp;publication_year=2022&amp;pages=1-666&amp;pmid=36028798&amp;doi=10.1186/s12884-022-04986-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0062">
<span class="label">62.</span><cite>
Diepstraten F. A., Hoetink A. E., van Grotel M., et al., “Aminoglycoside‐ and Glycopeptide‐Induced Ototoxicity in Children: A Systematic Review,” JAC‐Antimicrobial Resistance
3, no. 4 (2021): dlab184, 10.1093/jacamr/dlab184.
</cite> [<a href="https://doi.org/10.1093/jacamr/dlab184" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8669239/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34917943/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAC%E2%80%90Antimicrobial%20Resistance&amp;title=Aminoglycoside%E2%80%90%20and%20Glycopeptide%E2%80%90Induced%20Ototoxicity%20in%20Children:%20A%20Systematic%20Review&amp;author=F.%20A.%20Diepstraten&amp;author=A.%20E.%20Hoetink&amp;author=M.%20van%20Grotel&amp;volume=3&amp;issue=4&amp;publication_year=2021&amp;pages=dlab184&amp;pmid=34917943&amp;doi=10.1093/jacamr/dlab184&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0063">
<span class="label">63.</span><cite>
Dillard L. K., Fullerton A. M., and McMahon C. M., “Ototoxic Hearing Loss From Antimalarials: A Systematic Narrative Review,” Travel Medicine and Infectious Disease
43 (2021): 102117.
</cite> [<a href="https://doi.org/10.1016/j.tmaid.2021.102117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34129960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Travel%20Medicine%20and%20Infectious%20Disease&amp;title=Ototoxic%20Hearing%20Loss%20From%20Antimalarials:%20A%20Systematic%20Narrative%20Review&amp;author=L.%20K.%20Dillard&amp;author=A.%20M.%20Fullerton&amp;author=C.%20M.%20McMahon&amp;volume=43&amp;publication_year=2021&amp;pages=102117&amp;pmid=34129960&amp;doi=10.1016/j.tmaid.2021.102117&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0064">
<span class="label">64.</span><cite>
van As J. W., van den Berg H., and van Dalen E. C., “Platinum‐Induced Hearing Loss After Treatment for Childhood Cancer,” Cochrane Database of Systematic Reviews
2016, no. 8 (2016): CD010181, 10.1002/14651858.CD010181.pub2.
</cite> [<a href="https://doi.org/10.1002/14651858.CD010181.pub2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6466671/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27486906/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cochrane%20Database%20of%20Systematic%20Reviews&amp;title=Platinum%E2%80%90Induced%20Hearing%20Loss%20After%20Treatment%20for%20Childhood%20Cancer&amp;author=J.%20W.%20van%20As&amp;author=H.%20van%20den%20Berg&amp;author=E.%20C.%20van%20Dalen&amp;volume=2016&amp;issue=8&amp;publication_year=2016&amp;pages=CD010181&amp;pmid=27486906&amp;doi=10.1002/14651858.CD010181.pub2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0065">
<span class="label">65.</span><cite>
Cheung S., Henderson‐Sabes J., Mastick J., et al., “Cancer Survivors and Neurotoxic Chemotherapy: Hearing Loss and Tinnitus,” BMJ Supportive &amp; Palliative Care
13, no. 3 (2023): 345–353, 10.1136/spcare-2022-003684.</cite> [<a href="https://doi.org/10.1136/spcare-2022-003684" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9880249/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35896321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20Supportive%20&amp;%20Palliative%20Care&amp;title=Cancer%20Survivors%20and%20Neurotoxic%20Chemotherapy:%20Hearing%20Loss%20and%20Tinnitus&amp;author=S.%20Cheung&amp;author=J.%20Henderson%E2%80%90Sabes&amp;author=J.%20Mastick&amp;volume=13&amp;issue=3&amp;publication_year=2023&amp;pages=345-353&amp;pmid=35896321&amp;doi=10.1136/spcare-2022-003684&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0066">
<span class="label">66.</span><cite>
Karasawa T. and Steyger P. S., “An Integrated View of Cisplatin‐Induced Nephrotoxicity and Ototoxicity,” Toxicology Letters
237, no. 3 (2015): 219–227, 10.1016/j.toxlet.2015.06.012.
</cite> [<a href="https://doi.org/10.1016/j.toxlet.2015.06.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4516600/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26101797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicology%20Letters&amp;title=An%20Integrated%20View%20of%20Cisplatin%E2%80%90Induced%20Nephrotoxicity%20and%20Ototoxicity&amp;author=T.%20Karasawa&amp;author=P.%20S.%20Steyger&amp;volume=237&amp;issue=3&amp;publication_year=2015&amp;pages=219-227&amp;pmid=26101797&amp;doi=10.1016/j.toxlet.2015.06.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0067">
<span class="label">67.</span><cite>
Rybak L. P., “Mechanisms of Cisplatin Ototoxicity and Progress in Otoprotection,” Current Opinion in Otolaryngology &amp; Head and Neck Surgery
15, no. 5 (2007): 364–369, 10.1097/moo.0b013e3282eee452.
</cite> [<a href="https://doi.org/10.1097/moo.0b013e3282eee452" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17823555/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Otolaryngology%20&amp;%20Head%20and%20Neck%20Surgery&amp;title=Mechanisms%20of%20Cisplatin%20Ototoxicity%20and%20Progress%20in%20Otoprotection&amp;author=L.%20P.%20Rybak&amp;volume=15&amp;issue=5&amp;publication_year=2007&amp;pages=364-369&amp;pmid=17823555&amp;doi=10.1097/moo.0b013e3282eee452&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0068">
<span class="label">68.</span><cite>
Jentink J., Loane M. A., Dolk H., et al., “Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations,” New England Journal of Medicine
362, no. 23 (2010): 2185–2193.
</cite> [<a href="https://doi.org/10.1056/NEJMoa0907328" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20558369/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Valproic%20Acid%20Monotherapy%20in%20Pregnancy%20and%20Major%20Congenital%20Malformations&amp;author=J.%20Jentink&amp;author=M.%20A.%20Loane&amp;author=H.%20Dolk&amp;volume=362&amp;issue=23&amp;publication_year=2010&amp;pages=2185-2193&amp;pmid=20558369&amp;doi=10.1056/NEJMoa0907328&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0069">
<span class="label">69.</span><cite>
Lloyd K. A., “A Scientific Review: Mechanisms of Valproate‐Mediated Teratogenesis,” Bioscience Horizons
6 (2013): hzt003.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Bioscience%20Horizons&amp;title=A%20Scientific%20Review:%20Mechanisms%20of%20Valproate%E2%80%90Mediated%20Teratogenesis&amp;author=K.%20A.%20Lloyd&amp;volume=6&amp;publication_year=2013&amp;pages=hzt003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0070">
<span class="label">70.</span><cite>
Maison S. F., Liu X.‐P., Eatock R. A., Sibley D. R., Grandy D. K., and Liberman M. C., “Dopaminergic Signaling in the Cochlea: Receptor Expression Patterns and Deletion Phenotypes,” Journal of Neuroscience
32, no. 1 (2012): 344–355.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.4720-11.2012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3313790/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22219295/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuroscience&amp;title=Dopaminergic%20Signaling%20in%20the%20Cochlea:%20Receptor%20Expression%20Patterns%20and%20Deletion%20Phenotypes&amp;author=S.%20F.%20Maison&amp;author=X.%E2%80%90P.%20Liu&amp;author=R.%20A.%20Eatock&amp;author=D.%20R.%20Sibley&amp;author=D.%20K.%20Grandy&amp;volume=32&amp;issue=1&amp;publication_year=2012&amp;pages=344-355&amp;pmid=22219295&amp;doi=10.1523/JNEUROSCI.4720-11.2012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0071">
<span class="label">71.</span><cite>
Cartwright N., “Are RCTs the Gold Standard?,” BioSocieties
2, no. 1 (2007): 11–20, 10.1017/S1745855207005029.</cite> [<a href="https://doi.org/10.1017/S1745855207005029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BioSocieties&amp;title=Are%20RCTs%20the%20Gold%20Standard?&amp;author=N.%20Cartwright&amp;volume=2&amp;issue=1&amp;publication_year=2007&amp;pages=11-20&amp;doi=10.1017/S1745855207005029&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0072">
<span class="label">72.</span><cite>
Neumann K., Euler H. A., Chadha S., and White K. R., “A Survey on the Global Status of Newborn and Infant Hearing Screening,” Journal of Early Hearing Detection and Intervention
5, no. 2 (2020): 63–84.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Early%20Hearing%20Detection%20and%20Intervention&amp;title=A%20Survey%20on%20the%20Global%20Status%20of%20Newborn%20and%20Infant%20Hearing%20Screening&amp;author=K.%20Neumann&amp;author=H.%20A.%20Euler&amp;author=S.%20Chadha&amp;author=K.%20R.%20White&amp;volume=5&amp;issue=2&amp;publication_year=2020&amp;pages=63-84&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0073">
<span class="label">73.</span><cite>
Little B. B., Drugs and Pregnancy: A Handbook. Series in Maternal‐Fetal Medicine (CRC Press, 2022).</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Drugs%20and%20Pregnancy:%20A%20Handbook&amp;author=B.%20B.%20Little&amp;publication_year=2022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0074">
<span class="label">74.</span><cite>
Percy‐Smith Lone P. C.‐T., “Cochleaimplantation Til Børn,” Ugeskrift for Læger
185 (2023): V07230480.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/38078473/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ugeskrift%20for%20L%C3%A6ger&amp;title=Cochleaimplantation%20Til%20B%C3%B8rn&amp;author=P.%20C.%E2%80%90T.%20Percy%E2%80%90Smith%20Lone&amp;volume=185&amp;publication_year=2023&amp;pages=V07230480&amp;pmid=38078473&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0075">
<span class="label">75.</span><cite>
van Dommelen P. P., Verkerk P. H., and van Straaten H. L. M. P., “Hearing Loss by Week of Gestation and Birth Weight in Very Preterm Neonates,” Journal of Pediatrics
166, no. 4 (2015): 840–843, 10.1016/j.jpeds.2014.12.041.
</cite> [<a href="https://doi.org/10.1016/j.jpeds.2014.12.041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25661409/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pediatrics&amp;title=Hearing%20Loss%20by%20Week%20of%20Gestation%20and%20Birth%20Weight%20in%20Very%20Preterm%20Neonates&amp;author=P.%20P.%20van%20Dommelen&amp;author=P.%20H.%20Verkerk&amp;author=H.%20L.%20M.%20P.%20van%20Straaten&amp;volume=166&amp;issue=4&amp;publication_year=2015&amp;pages=840-843&amp;pmid=25661409&amp;doi=10.1016/j.jpeds.2014.12.041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70090-bib-0076">
<span class="label">76.</span><cite>
Moore G. P., Lemyre B., Barrowman N., and Daboval T., “Neurodevelopmental Outcomes at 4 to 8 Years of Children Born at 22 to 25 Weeks' Gestational Age: A Meta‐Analysis,” JAMA Pediatrics
167, no. 10 (2013): 967–974.
</cite> [<a href="https://doi.org/10.1001/jamapediatrics.2013.2395" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23979322/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Pediatrics&amp;title=Neurodevelopmental%20Outcomes%20at%204%20to%208%20Years%20of%20Children%20Born%20at%2022%20to%2025%20Weeks'%20Gestational%20Age:%20A%20Meta%E2%80%90Analysis&amp;author=G.%20P.%20Moore&amp;author=B.%20Lemyre&amp;author=N.%20Barrowman&amp;author=T.%20Daboval&amp;volume=167&amp;issue=10&amp;publication_year=2013&amp;pages=967-974&amp;pmid=23979322&amp;doi=10.1001/jamapediatrics.2013.2395&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Basic &amp; Clinical Pharmacology &amp; Toxicology are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1111/bcpt.70090"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/BCPT-137-0.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.3 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12375940/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12375940/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12375940%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375940/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12375940/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12375940/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40851451/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12375940/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40851451/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12375940/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12375940/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="3KlsLUuuUE5GkpmkOuEBwWtn7AbVfxon91sOoBsshJJHvt2z8rbAsT6YpkMRo80X">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
